>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 1; Drug: Control Apo 0.5 然
bRgbRobLiLsbRhbRcLsLsmbLibRsbLibRcLsbRibRibRibRcbRibRgbLebRibRobRiLsbL
ibLgbRobLsbRcLsbRgbRcbRibLibRgbLhbLgbLsbRcbRiLsbLgbRsRiLsbLsLsmbRsbRcb
LibRhbLgbRcbRhbRgbLibLibLsbRhbRhbRsLsbLibRcbRgbRcLsbRhbRgbLsbRcbLgbRsb
RiRsmbRgRsmbRcLsLsRsmbLjbLibLibLsLsmbLgbRcbRiLsbLjbRgbRiRsmbLsbRgbRgbR
obLgbRhbRcbRibLibRcRsmbLibRjbRcLsLibLjbRcbRibLsbRibRibRsbRibRgbLsbRgbR
gbRgbRibRcLsbRibLebLibRsbRobLibLjLsmbRobRiRsmbLibRhRsmbLjLsmbRibLsLsmb
RibRsRsmbRhbLiLsbRjbLcbRgbRcbLhbLibLhbLibRoLsbLsbRibLjbRoLsbRhbRgbLibR
jbRhLsbsbRibLgbRibLibLibLgRsbLiLsRsbRsbLgbLibRhbLobRibLibLcRsbLsbLiRsb
LsbRgbLibLibLsbLsRsLibLsbLcbRgLsbLsbRibRgRsmbRgbRibLgbRgbLobRsbLcbLgbL
ibLgbRibRhbLjbRibRcbLibRhbLobLjbRibLhLsbRibLgbRcbsbRgbLgbRibRhbLjbRibL
jbLcbRcbRibRibRsbsbLcLsmbLhbRgbLobRibRcbRcbLgbLibReLsbRsbRebLhbLoRsbRi
bLobRibLcbRcbLibRcbLgbRiRsmbRebLibRebRjLjbRcbLgbRibRebLsbLibLibRebLcbL
ibLibLcbRebRibLibLcbRsRsmbLjbRiRsmbRiRsmbRsbRcbLsbLjbRjbRibLgLsbLcbLob
RhbLibRgbRcbLibRgbRhbLjbLcbRibLebLsLsmbLcbLhbLhbRhbLibRibLibLjbRcbLibL
cbLcbRcbRjbLgbLhLsbLgbLsbRjbLhbLjbLsbRsbLjbLiRsbRhbRobRhbRibLhRsbRibLj
bRibRsbRobLibLiLsbLibRgbLgbRjbRibRibRibLjbLhbLibLsbLgbLgbRjbRcLsbRgLsb
RcbLjbRgbRibRhbLjbLoRjbLcbLcbLobLiLsbRcbRhbRobRcbRiLsbRgbLcLsmbRgbLgbR
hbLjbLibRcbRcbRcRsmbRibLibRjbRcbLjbLhbRebRibLibRibRibLjbLjbRcRsmbLjbLc
bLcbRcbRebLsbRcbRgbLjbLobLcbRjRsmbLsbRcbLjbRcLsbLibLhLsbLibRgbLcbRibLs
bLjbLibRgbRcbRhbLibLgbRcRsmbRgbLjbRcbLgbRibLjbRsRcbLibLgLsbRebRcbRibLj
bLiLsbRjbLibLsbLibRibLobRibLgbLjbLcbRiRsmbLcbRhbLhbLoLsmbRcbLhbLcbLcbR
cbRcbLhLsbLibLiLsbRibLibRgbLiLsbLsLsmbLiLsbRsLsbLgbLsbLgbLsbLibLsbLgLs
bRsLsbLgbRjbLcbLibRebLibRjbRcbLsbRcbRibLebLjbRebLibLibLibRcbLcbRcbRcbR
ibRcbLgbLcLsmbLibRiLsbLgbLhbLjbLibRcbRgbLibLobRcbRcRsmbLcbLibLhbRcbRcb
RcbLjbRcbRcbRjbRcRsmbLcbLhbLebRibLhLsbRgbLcbRjbLcRsbRibLjLsmbLibLiRsbR
ibLsbLibRibRjbLiLsbLiLsbsbLcLsmbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 2; Drug: Control Apo 0.5 然
bLcbLiLsbRjbRjbLcbRsbsbRjbLcbReRsmbLobRibLjLsmbRsbLgLsbsbLjLsmbRcbRhRs
mbsbRibRgbRgbLsbLibLsbsbRibLobRjbLhbRiLsbLsbLsRsbLjbRgbLgbRebRgbLsbLcb
RobLsbLcbLgbRgbRjbLibRjbRibRsRsmbRibRibRgRsmbRsbLgRsbRsbRgbRsbRgRsmbsb
sbLjbLgbLcbRebRibLebRjbRsRsmbLcbRcRsmbRgbLcbRibRgbRsbRgLsbLsbRoLhbLgbR
sbLsbRgbsbLsbsbsbRjbLebLibLsbLiRsbRibRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 3; Drug: Control Apo 0.5 然
bsbRibLjbLjLsmbRebLcbLsLsmbsbLhbLcbLgbRibLsbLibLsbLsbLgbLsbLgbRgbRsbRc
bLjbRjbLobLcLsmbLsbsbLhbLsLsmbRsbLsbRibsbRgbLcbLgbsbLsRsbRjbRsbRhbLcbs
bRibRgbRibLsbRsbRibRcbLcbRgbLgbLsbsbRebRsLsbRhbLjLsmbLsLsmbRibsbLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 4; Drug: Control Apo 0.5 然
bsbRsbRiRsmbRsbRiRsmbLjbLcLsmbLibLibLibRgbLibLhbRibRgbRobLhbRcbLgbRiRs
mbRibLibRebRcbLgbRiLsbLgbRibLibLibLsbLgbLgbLibLsbRsbRhbRhbLjbRcbLibLiR
sbRsRcRsmbRibLibRhbRgbRsbRibLjbRgbLebLibRjbLibRcbRibLjbsbRibLgbRibLsRs
bLgbRsbRhLsbRsbRibLjbLcbRcbRhbRgbRsRsmbRibLjbLcbsbRcbRiLsbLibRibRsbLgb
RhbRibLibRibLibRjbRsbRibLjbRhRsmbLgbRhbLibRhbsbLibRhbLjbsbLjbLibLcbLcb
LsbLibLsLsmbLiLsbRgbLibRgbLibRcbRiRsmbLjbLobRjbLibRjbLhbLcbRobRgbRjRsm
bRgbRibLibLgbRobLibLsbRhbRibLjbRibRsbRsbLgbRibLibsbLobLibRgbLibLgLsLsm
bRibLibRjbLjbLibReRsmbRiRsmbLgbLibLsbRcRsmbLjbLhbRobRsbLeLsbLibLibRibL
jbRobLjbRcRsmbRibLgbRiLsbLibRjbLibLsbLgbLsbRebLjbRsRcbLjbLibRjbLibLsRj
bLsbRobRhbLcRsbLjbRobLcRsbLsLsmbLjbLhbLcbLjbLgbLiLsbRhbLibRhbLibRibLib
RibRcbLibRibLjbLibsbLibRibRiRsmbLibRjbLibRjRsmbRjbLoRsbLibLjRsbLibRsbR
gbLibRgbLhbRsbLiRsbRjbLcbLibLibRgbRibLhbLgbRsLsbRsbLibRgRsmbLibRsbLibL
ibLib

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 5; Drug: Control Apo 0.5 然
bRsbRjbLgbRobRebsbRebRgbRiRsmbLoRsbRgbRsbLobRcbRcbLgRsbRobRebsbRcbRsbR
cbRsbRibRibLiLsbLsRsLsbRcLsbRibRgbLibRsLsbLobLiLsbRiRsmbRsbLobRgRsRsmm
bRcbLobLibRcRcLsbRgbLsbRiRsmbLsbLcbLcbLibLibLgbLobRcbLgbLoRsRsmbRcbRgb
LobRgbsbLgbRhRsmbRsbLoLsmbRebLoLsmbReRsmbRiRsmbRcbRsRibRcRsmbLcLsmbLib
LgLsbLsLsmbLcLsmbRsRsmbRcbRcbRhbRiRsmbsbRcbRhRsmbRhbRcbRhbRgbRjbRsbRcb
RcbRcbLsbsbLcbRgbLcbLgbLibLoRsbRcRsmbRcbsbRhbRgbLsbLiLsbRibRjRsmbRibLi
bRgbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 6; Drug: Control Apo 0.5 然
bRibLcbLcbRgbLhbRcbRcbRcLsbRjbRhLsbLsRibRcbsbRgbRhbLhLsLsmbsbRgbRebRob
RcbLibLgbLgbLhLsbLgLsbLjbLcbRcbLibLibLgLsbRibLjLsmbLhbRsbRcbLjbRgbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bLebLgbLsbLiLsbRjbRcbRibRgbRibRiLsbLsbRsRsmbLjbRjbLcbLiLsbReLsbRibLjbL
ibRgbRgbLebLoLsmbRgbLsRsbRgbRjbLiLsbRjbRcbRjbRibLgbRiRsmbLsbLjbRiRsRsm
mbRibRgbLgbRibRiLsbRhbLibLsbLhbRibLjbRjbLcbLibLhLsbRibRibRibRjbLibRgbR
gbLjRsbRiLsbLsbRgbsbRcLsbRibRgbLjRsbRjbLibsbRibRiRsmbRsbLgbsbLgbRibRsb
RibLibLjbRcbLjbLcbRjbLjbRibLiLsbRjRsmbLibRjbRcRsmbsbLcLsmbsbRhRsmbRibL
cbLjbLcbRhRsmbRibLjbLcLsmbRhbRcRsmbLjbLiLsbRibLiLsbRsbRibRhbLcbRjbLhbR
jbLibRibRobRibRibLsRsLsbRibRjbLhbRsRsmbRjbRibRhbRjbRcbRhRsLsmbLibRjbLi
bRcbLibRgbRgLsbRibRcLsbRcRsmbRjRsmbLgbRibLibRsRsmbRgbLjbLjbLjbRobRjbLo
b

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bRiRsmbLgbLsbRibRcbRhbLgbLgbRsbLsLsmbRcbRjRgbRiRsmbRibRgbRcbRcbRgbLgbR
gbLgLsbRjbRibRiRsmbLgLsRsbRgRsRsRsmmmbRsbLsbRsRsRsmmbRgbRsbLjbLsbRibRg
bRgRsmbRibRgbLobRjRgbRsLsbRsbRibRjbRsbRjRsmbRsbLjbLcbsbRhbLgbLgbLobRcb
RebLgbRcLsbRjbRcbRjRsmbRsbsbRjRgbRsbRsbLjbLcbLibRcbRiRsmbLsbRgbRsbLsbR
hbRcRsmbRsRibRsRgbLibLiLsbLgbRsLsbLgRsbLsbLcbLibRiRsmbLsbLiRsbRgbLsbRg
bLobRcbRibRcbLgbLibRcbRebRoRsmbRibLgbLiRsbLcbLiLsbLiLsbRsbLgbLgbLsbLsL
smbLgbLibLibRsRsLsLsmmbLsbLibRjbRibRjbRibRibRibLhbLhbLcbRcbRsbLcbLcbRs
bLsbLgbLhbRsbRebRibRgbLobLcbsbRiLsbLsbLibLsbLibLsbLhbRsbRgbRhbRhbRjRsm
bRjbRcbRibRibRsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bRibRgbRobRiRsmbLibLoRsbRibRhbLobLobRibLcbLibLgbRgbLibRgLsbLibRgbLcbRi
bLiLsbRgRsmbRcbLsbRcbLhbRcbRobLcbLiRsbRibRsbLobLobRibLcbRiRsmbRcbRibRg
bLgbRhRsmbRgbLhbLcbLobLcbRjbRibRibRgRsmbLoRsbLibLibLibRibLhbRgbLhbLhbL
hbRibLhbRgbRhbRhbLhRsbRjRsRsmmbsbLcLsmbRjbLibRhbRibLjbRhbLcbLcbLibLobL
hbRcbLcbLobRcbRobLoRsbRhbLcbLcbLcRsbRjbLcbLibLibRhbLibLhbRibLjbLcbLiRs
bLhbRsLiLsbRjbLcbRhbLcbLcRsbLobLibLibRibLcRsbLjbLibRjbRcbRhbLiLsbLjbLc
RsRsmbLibRibRibRiRsmbLjbLoRsbLjbLibLjRsbLcbRcbLibRiRsmbLcLsmbRcbsbLcbR
jbLjbRcbLibRibLjbRcbRjbRobRibRhbRcbLibLgbRgbRsbLgbRcbRibRhbRibRjbLibRi
bLcbsbRhbRgRsmbLcbRcbRebRobRcbRcbLcbLjLsmbRcbsbLhRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bRcRsmbLcbLcbLcbLebRcbLcbLcbRcbLcbLcbLibLebRcbLcbLobLjbLcbRcbLhbsbRsbL
cbRhbsbLcbReRsmbLjLsLsmmbLhbLcbLhbLhbLcbLcbRsbLobsbLjbLjRsbLcbRsbLobRh
bLcbLebLebLjbsbLcbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bRibRsbRobLgbLhbLgbLgbLibRsbLgbRsbLcbRsLsbLcbRsbRgbLhbLibLsbLobLsbLgbR
sbLgbLibLgbLhbLibRgbRjbRgbRjbLibRjbRjLsbRjbLibLibRjbRgbLcbLgbRhbRiLsbR
sLsbLibRibRsbLsbLobRhbRgbRsbLjbRcbsbRebRgbLgRsbRjbLibsbRcbLgbRjbLjbLiR
sbLjbRjbRcbLgbsbLjbRibLgbLibRjbLjbRjbRjbLebLcbLibRgbRjbLhbRsbRjbLibRgb
RgbLgbRgbRcbLibLjbRobLiRsbRjbRjbLgbLsbRcbLebRcbRjLsbRjbRjbLibLibLjbRjb
RjbLgbLcbRobRgbRsbLgbLibRibRgbRgbRgbRjLsbRjbRhbRjbLjbRobLsbLjbRhbLjbRj
bLsLgbLsbLhbLsbRgbRgbRsbRsbRjbRjbLjbLcbRjbRjbRjbLjRsbLsbLiRsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bRcbRgbRibLgLsLsmbRsbRibRsbLcLsmbsbLibRgbLgbsbRgbRgbRsbRsbsbsbsbLgbLjb
LsbLcbLcbLsbRsbRjbRsbRcbRobLibLibRcbsbLibRgbRgLsbRsbRiRsmbRsbLgLsbRsbL
iLsbRjRsmbLgbRgbLgbLibRoLsbRibRsbLgbLibRibLsRcRsmbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bLsbRibLobLibLcbLcbRibRibLcbLgLsbLsbLgLsbLsbLgbLgbLsbLgbRjbLibRebLobRj
bRhbLsbLibLcbRgRsmbRibLjbLhbLibRsbLiRsbRsbLiRsbRgbRsbLsbLsbLgbLgbLgbLg
bLjbRsbsbRsbLhbLhbLibRgbLjbRgRsmbLjbLcbRibRgbLibLobsbLcbRgbLcbRgbLcbRi
bLgbRcbsbRebLsbRjbLcbLcbRhbRibRsbLcbLeLsbRsbLoRsbLiLsbRjbLobRebRsbLcbL
hbLobRgbRsbRcbLibLcbLibRgbLebRjbLcbLgbLsLcbLobLibLibLgbLjbRsLsbReLsbRh
bLibRcbsbRcbRibLiLsbLsbLhbRsbLoRsbLcLsmbRhbsbRsLsRsbsbLsbLibLcRsbRjRsm
bRjbReLsbRobRcLsbLhbLcbLcbLibRgbLjbLibRjbRcbLgbRcbRcbLibLcbRsLsbLobRib
LcbLhbLobRibLcbLoRsbRcbLibRjbLobLsbsbRsbRjbRsbsbsbRcbRcbsbRgbRcbRsbRgb
RcbLjbLcbRjbLobLibLhRsbLibRcbLcbRcbLiLsbRebRsbLsbRsbLsLsmbLjLsmbRibLgb
RhRsmbLgbLsRsbLibRsbRobRgbRcbRcbLibLgbRjbRgbRgbRsbRcbLcbLcbRsbLcbRcbRc
LsbLhbRsbRibLcbRsLsbLgbLsLsRsmbsbsbLsLsmbsbLsbsbsbLsRsbRsLsRsbLobRjbLs
bsbLgbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bLcbsbLcRsLsRsbRsRsmbsbsbLoLsmbLibLhRsLsbRsLsbRiRsmbLcbRgbLcLsmbRsRsmb
sbLibLgbLcLsmbLobsbLebRibLjbRsbLeLsbRibsbLcLsmbLobLibRiRsmbRgbsbLcbRob
LcbLsRsbLobRsRsmbLibLeRsbsbsbRobLobLobLhbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bLibLsbLgLsbLsbLgLsbLgbLsbLiLsbRsRsmbLgbsbLsbLsLsmbLibLgbLgbLgbLgRsbRg
RsmbLsLcbRibLgLsbLsbRjbLhLsbRsbRcRsmbRgbLgRsLsbLcbRebRsbRgbLjbLcRsbLgb
LgbLgbLgLsbLgLsbLgbLgLsbLgbLgbLgbLgbLgbRgbLibLsbLebRcbRebLsLsmbLhbRibL
jbRibLsbLiLsbRsbLibRjbLiLsbLsbLibRjbLibLsbLgbLgbLgbLsbRsbLibRgbLsbLcLs
mbRibLiRsbLibLiRsLsbRgbLibLsbLgbLgbLgbLgbRsLsbLsbLibLgRsbLgbsbsbLgbRsb
LibLgbRgbLgbRgLsbLsbLgbRsLsbLgbLgbLjbLgLsbRsbLgbLsbLsRsbLsbLsRsbLgRsbL
sbLsRsbRsLsbLgbsbLsbLsbRsLsbLsbLgbLsbLsLsmbLjbLgbRsbRsbLgbRsbRsRsmbRsR
smbLsLsmbsbLsbLsLsmbRsbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bRsRsmbLgbLgbRibRsbRsbRiLsbLsRsbRsbRgRsmbRgRsmbLsbLsLsmbRibRsbRgbRsLsb
RsbRgbRoRsRsmmbLsRsbLibRjbRcbLgLsbRcbLgRsbRiLsbRsRsmbRhbRgbLgbRibLgbRo
bRsbRgbRibRibRgbRgbRgbRsbLsbRgbRsbLcbLjbLjbRgbRgbLgLsbLgbRsLsbLsbLgbLs
RsbLgbLsbLsbLsbLgbLsRsbRhbRibLcLsmbRgRsmbLgbLgbRsbLsbLsbLgLsbLgbRsbLob
LsLsmbLgbLibRhbRsbLebRsbRgRsmbsbRcbRibRobsbRgRsmbRsbLgLsbLibRebRibLgLs
bRgbRsbRibLsbLjLsmbRsRcbLgbRhbRibLsbRsbLgbRsRsmbLgbLibRjbRjbLcbLsLsmbL
gbLgbLsLsmbLgbsbRobRibLibRgbRsLsbRoLsbLgbRibRibLgbRsRebRsbLibLiLsbLgbR
gbLcbRgbRgbRjbRibLcLsmbLcbsbLsbRjbLsbRgRsmbLibRsbRsbLgbRgbLiLsbRsbLgbL
sbLgbLsbLjbLibLiLsbLgbLibRgbRobRsbLsbLsbLebRcbLcbRcbRcbLgbRsRsmbLsLsmb
RibLjbRgRsmbLjbRobRsRibRgbLhLsbLgbRjbRiRsmbsbRjbLsLsmbLcbLsLsmbRjbLibR
sbLgbLgLsbLsbLibRsbLgbRsbLibRcbRcbRgRsmbLjbsbLsRsbLibRibRibLgbRsbLgbLi
bLgbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bRjbLjbLibLsbRsbLgbLgbLiRsRjRsmbRcbLsLjbRibLjbLcbLibRsbLsbLgbLsbLsLsmb
RjbsbRcbsbRibLcbLibLsbRjbLgbLcbRiRsmbLsbRiLsbRibRibLhbLsbLcbRibLcbRjbL
obRibLsLibRjbRgbRibsbRsbRsbLgbLebRobLcbLhbLgbRsRsmbRjbsbsbRsbRhbLsRsRs
mbsbLjbRibRgbLjbRibsbLcbLoRsbRjbLcbRsRsmbLcLsmbRjbLobRibLcbRjbLebRgbRi
bLobRiRsmbLgbRsRibLcbLoRsbRibLibLibRjbLoRsbRhLsbLgbLcbRibLhRsbRjbLibLi
bRgbLsbLcbLgbLjbRsbRgRsmbLcbRjbLibRibRsbLiLsbsbLoRsRsmbRjbLibRgbLhbRgb
LhbRibLgbRjbRibRobRcbLjLsmbRhbRibLcLsmbRibLgbRjbLibRsbRjbRsbsbLsLsmbRs
bRsbRgbRsbsbRsbsbRsbRsRsmbRsRsmbLsbLsLsRsmbRsLsbRsRsmbLsbLsbsbRsRsmbRs
RsmbRgRsmbLsbRjbsbLibRjbLsLsmbsbsbsbLsRsLsbLsbsbsbRsbLobLgLsbLibRibRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bRjbRjbRhbLsLsLsmmbRgbRibLebLcbLgbRjbLobRibRgbLobRhbLsbRcLsbRgbRcbRhbR
iRsmbRibRibLcLsmbLcbsbRibRibRiLsbRgRsRsmmbRiLsbLiLsbLebsbRebReRsmbRcRs
mbLsRobRhLsbRiLsbRibRgbRsbsbRsLsbsbsbRibRcbRiLsbRhLsbRhbRiLsbRibRibRib
LgbRibRibRcbRhbRibRibRcRsmbRebRcbRgbRgbRibLcbRjbRibRhbRibRgRsmbRcbRcbR
hbRcbsbRibRcbRhRsmbRebRhbRcbRibRibRjbRibRhbRgbRgbRgbLcbLibLibRibRjRsmb
RiLsRsbRoLsbRgbLgLsbRjbRcbsbsbRcbRobRibLhbLcbLcbRgbRsLsbLsbLcbLsbLibRs
bRgbLcbRibRhbRcbRcRsmbsbRibLsbLcbLcbRjRgbLibRgbRibRgRsRsmmbRsLsbRcRsmb
RhbRcbLiLsbRibRcbRibRhRsRsmmbLibRgRsmbLibsbLcbLcbLhbRsbLhRsbLibLgbsbRs
bLcRsbRsLsbRgbLcbLcbRibRiLsRsbLgbLcbRjbRibRgbRsbRsLsbRgbLjbLhbRgbLsRjb
RibRcbRhbLgbRgLsbRsbLcbsbLcRsbRgbLgRsbLcbLcbRiRsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bLibLcbRsbLcLsmbLcbRgbLibLhbLiRsbLibLcbLcbLcLsRsmbLcLsmbLjbLebLcRsbRsL
ibRibRobLgbRsbLjbLsbLobRibRsRsmbLcbLibLsLsmbLcbRcRsmbRibLgLsbLcbLgbsbL
eLsbLibRsbLgbLcLsmbRibLgbRjLsbLobLibLibRcbLcbLhLsbLobLhbRibsbLcbLjLsLs
mmbsbLgLsbLsLsmbRsbLcbLibRsbLiLsbLhbLibsbsbLobLcbLibLibRjbRcbLjbLcbLcb
LcbLeLsbRjbRcbLgbLobLhbLsRsbLeRsbLsbLsLhbLsRsbRcRsmbLcLsmbLjbRibRibLcb
LoRsbRjbRcbRcbRebRjbRcLsbRibsbRjLjbRibRjLsbLsbRhbLgbRhbRjRsmbsbLjbRibR
oRsmbRgbLcbLobRobLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bLsbRsRsmbLsLsmbLsRsbsbsbsbsbRsbsbRsLsbLjLgbsbsbLsbLsbLsLsLsLsmmmbLsbR
sLsbsbLsbLsbLgbLsbLgbLsbsbsbsbsbLgLsbLsbsbLsbsbLiLsbRsbLsLsmbLoRsRsmbL
sbLsbLsbLibLsbsbLgbLgRsbRsLsbLsbLgbLsLsmbRsbLsbLsLsRsmbRsbLjbLsbsbRgRs
mbLsbLsRsLsbLhbRsbLsbRgbLsbsbLsbsbRsLsbRsRsmbLsbLsbLgbLsLsmbLgbLsbLsLs
mbLsbLcRsbLibsbLsLsmbRsbLibLgbRsRsmbLiRsbLsbLsbLsbLgbRsbLsbLgbLgbLgbLs
bLgbsbLsbsbLsbRjLsbLibLsRsbsbRsbLsbRsbRsbLsbsbLgbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bLgbRibLgbLiRsbRcLsbRibLjLsmbLobLibLsbRsbLsbRcbRiRsmbLsbLcLsmbLibRsbLi
bLsRsbsbRsbRsbLsbLsbsbRsRsmbLgbRsbLsbLgbLgbRjbLcbRcbLcbLsbLibRiRsmbLsb
LsbLgbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLhbLcbLcLsmbLibRsRsmbRsbLobLibLibLibLibRsbRhbLjbRcbLgbLjbRibLcbLibLgb
sbLsbLgbLibLgbsbLgLsbLibRsbRcbRcbRibRgbLsRsbLgbRibRsbLhLsbLgbRsLsbLgbL
sbLsbRsbLobLcbRibsbLgbLibRgbLibLgbLgbRsbLgbLsbRobRsRcbLibLibRjbLibLibs
bLgbRsLsbLgbLsbLgbLgbRgbLibRgbLhbRibLhbLoRsbRgbLibLgbRibLiLsbLiRsbLgbL
sbLibLibLibLsRsLsbLgbLiLsbsbsbLgLsbRjbLibLgbRgbLgbRgRsmbLiLsbLcbLgbRib
LibLiRsbRsbLibRcbLjLiRsbLhRsbRibRebRibRcbLibLibLibRsbLgbLibLiRsbRjbLib
LibLcbLibLgbLjbLgLsbLgbRsLgbLsbLsbLsbRsbLsLgbLsbLibRjbLibsbRsbLhbRsbsb
LiLsbLsRgbLsbLgbLibRibRjbRcbLibLjbLhbsbLobRhbLsbLcbLsbLcbLibLibRjbLgbL
ibRcbLjbLcbLobLhbLsbLhbRsLibLsbLibLsRjRsmbRoRsmbLgbLcbLgbLcRsbLgbLibRs
bLsbsbRcbRcbRcbLgbLoLsLsmmbRsLsbLgbLsbLibLgbRgbLcbRibLobLhbLgbLibRebRh
bLibLjbRobsbLsRsbRobLibLibLibLgbReRsmbLjbLibLsbLobLsRsbRsbRebLebLobLcR
sbLsbLibLgbLsbLcbRcbRcbLgbRobsbLjbRobRsbsbLhbLobLgbLhbLcRsbLgbLgbLjbRc
bRsbRsbLcLsmbLhRsbsbRsbRgbLcbRhbRsbLibRobLcbLibRjbLcRsbLhbsbRibLiRsbLi
bLgbLibLgbLsbsbLibRsbLsRsbLgbRgReb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bLoLsmbRibLsLsmbLobRibLsbLobRibLoLsmbLiLsbRgbRobRcbRibLgbRhbRhRsRsmmbR
hbLibRibRcbRibRsbLsRsLsbRsbLsbRsRsmbLsbLsbLsbsbRsRsmbRibRcbLgbRsbLjLsm
bRcbRobRgLsbLiRsbRhbRibLsbRgbRoLsbLibRiRsmbRobLhbRsbLhbRhbRiLsbRibRgLs
bRsRsmbLgbLiLsbLsbLibLcRsbRibRibLsbRsbRcRsmbLcbRjbLcbRgbLibRjbLobRibRi
bRhbRcbLibRiRsmbLibRgbRcbLobLcbRjbLjbRcbRibLgRsbRibRsbRhLsbLibRibRoRsm
bRhbRibLsbRibRgbLjbLsbRibLobLoRsbRiLsRsbRcbRgbLobLobRcbRgbRsLsbLobLobL
gbRibRibRobRibRgLsLsmbRjbRibRgbRgbLsbRibLobRiRsmbRobRhbRibLibRibRebRib
LoLsmbLibRjbRcbRobLibRjbRibRhbLgbRibRcLsbRgRsmbRgbRibRibRgbRsbLgbRgbLi
LsbRsLsbLgbRjbLibRgLsbLgbLgbLobRiLsbRgbLgbRibsbRgbsbLsbLsbRsbLgLsbLibR
hRsmbRibRiRsmbRhbLcbLoRsbLgRsbRjbsbRibLibRcbLgbRhRsRsmmbLjbLsRobRibLgL
sbLsbRibRibRhLsbLibRibLsbLgbRibRiRsmbRgbLgbRibRibRgbRibRgLsbRgbRibRsbR
sbLobLgbRgbRjbLibLibRebLibRebRsbRobRibLobLcbLhbLibRibLcbRjbRhbRcbRgLsb
RibRsbRcbLcLsmbLobLsbRhbRibRibRcLsbRgbLgbRgbRcbRhbLiLsbRoLsbRobRgbRgbL
ibRjbRhbRhbLobRjbLibRcbRcbRhbLgbRhbRcbsbRhbLoRsRsmbRhbRibRgbLsbRoLsRsb
LjbRcbLgbRobRcLsRsLsbRibLibRgbLgbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bRgbLgbRibRcbRibRgbLgLsbRsbLibLibLsbLcbLsbRoRsmbLibRgbRibRsbRjLsbRoRsm
bLjbLcbRgLsLsmbLjbLjLsmbLjbLcLsmbRsRebRgRsmbLjbRibLsbRgbLgbLsbRoRsmbRg
LsbLsbLsRsbLsbLiRsbLgLsLsmbLsbLsLsmbLgbRgbLgbRsbRsLgbRsbLibLsbLgLsbRgb
sbLgbLsbLgbRsbLibRsbRsbLgRsbLsbRiRsmbRcRsmbRgbLibRibLcbLhbRibLhbRibRcR
smbRgbRgbRjbRsbLgLsLsmbLsbLgbRsbLgbRgbRjbLibRjbLibRibLibLsbRjRsmbRebRs
bRsbRsRsmbRgbRsbLsbRgRsmbLgbLsbRibLsbRgbsbLsbsbRgbLsbRsbRsbRibLjbRibLg
bLeLsbLgbsbsbRobLcbLibRgbLgLsbLsbLibLobRibRibLgbRiRsmbLibRsbRgbRgbLjbR
jbRgbRhbLibLgbRibRcbLiRsbRgbRjRsmbRgbLebLobRjbLgbRjbRcbLiRsbRjbRcbRcbR
jbRcLsLsmbRgbLiRsbRgbLibRsbRsLibRsbLibRjbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 25; Drug: Control Apo 0.5 然
bRjbLcbRcLsLsmbRiLsbLobLhbRhbLsbRsbRobRcbLcbRcbLcbRcbLcbLoLsLsmmbRsbLc
RsbLcbLcbLhbRcbRobLhbRibRobLcbRobLsbLgbRcbRiLsbLgbRibRobLibRhbRcbLhbRc
bLcbRibLjbLibRibLcbRibRjbLhbLibLcLsmbRhbLibRibLsbLgbLsbLsLsmbRcbRcRsmb
LibRobRhbLibRgbRibLhbLgbRgbLibLiRsbLhbLsbLoRsRsmbRibLibRibLibRibLibLib
RobRcbRobLjbRhbRcbLhLsbLcLsmbLhbLibRcbLcbsbLsbRiRsmbLsbRsLsbRcbLgbLgbR
iRsmbRoLsbLibLgbRjbRjbsbRcbLcbsbRjbLibRcbLhbLibRgbRjLsbLhbRibRjLsRsbLi
bRsbLsbRsLhbLhbLibRobLgbRcbRibLsLsmbLjRsLsbLcbRibLjbRjbLjRsbLibRgbLsbR
jbRibLibsbRhbLsbRsbRjbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 26; Drug: Control Apo 0.5 然
bRiRsmbLsbRibRsbRsbRgbsbRibRgbsbLsbRgbRgbRiRsmbLsLsmbRiRsmbRibsbRsbRib
LgbLibRhbRgbLeLsbRjbLcbLcLsmbLsbLibLiLsbRgbRcbRiRsmbLebRjbLoLsmbLsbReb
sbRgbRjbLjLgbsbRiLsbRgbRsLsbRhbsbLsbRhbLsLsmbRsRsmbRgbRgbRgbRsbRsbRgbR
sbRgbLsbRgbRsbRgbRgbRsLsbRgbRsbRibRgbLsbRiRsmbRsbRebRsLsbRibRsbLibRgbR
jbRsbRiLsbRgbRgbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 27; Drug: Control Apo 0.5 然
bRsbLgbLjbRsbRsbRsbLcbRiRsRsmmbLgbLobRibLibLgbLgLsbLsLsmbLgbLibLcbLiLs
bLibRhbRsbRobRobLibLobLibRsbRsbLgbLhLsbRjbRhbLobLibRibLcbLcbLibRsbRsbL
ibLhbRcbLcRsbLcbRcbLibRjbRcbRobLibRsbLobRcLsRsbLcbLcRsbRibRhbLhLsbRibL
sbLibRibRcbRgbLgbLobLjbRcbLgbRibLhLsbRibLibRcbRobLibLibRibLcbRcbRobLhb
RcbRobRcbRsbLhbRhbLjbRobLjbLcbRiLsbLiLsbRjbRobLcbLobsbRcLsRsbRcbRobRob
RcbLcLsmbLobLibRhbRobRcbRobLcbLhbRcbLibLcbLjbLibRjbRobRoLsbRobRobRhLsb
LcbRobRcbRobRcbLgbRhbLsbRsbRobsbRcbRcbRibRgbLjbLcRsbRibLcbLcRsbLgbRgbL
cbLjbRcbRobRcbRcbRibsbRobRobRibRjbRcbRobRhbRibLibRcRsmbRcbRobRcLsbRcbR
cbLjbLibLcbLcRsbLcbLjbLjbRsbRgbRhbRobLjbRcRsmbLgbRjRsmbsbLsbRhbLsbRsRs
mbLcbRcLsbLhbRhRsmbLhbRsbLsRsbRcbLibsbLcbLhbLhb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 28; Drug: Control Apo 0.5 然
bLibLgbLjRsbLoLsmbLibLjLsmbLjLsmbLibRgbLsbLibRjbLjbLhbRjbRcbLibLhbLibL
obRhbLibLcbLibRibLcbLcbLcbLibLibsbLcbRcbLhbRcLsbRibLgbLibLibLiRsbRjbLi
bRibRhbLhbRhbLiRsbRibsbRgbLgbLebLcbLibLibRcbRoLsbRhbLibLibRebLcbRcbLib
LgLsbRibRibLjbLsbLcbRjbLhLsbRibLhbLcLsmbLibLibRibLgbLobLiLsbLgbRjbLibR
sbRiRsmbLjbLcbsbLibLibRcbLsbLibRcbLhbLhbRcbRobRcbLibRcbLibRibLcbRibLhb
RcbLcbLcbRcbRhbLhbLhbLcbLiLsbLcbRcRsmbRhRsmbLjbLobLiLsbLibLibLibLgbRcb
LjbRhbLibRsbLibLjbRcbRibLibLsbLgbRibsbRgbRgLsbRsRsmbRcbLibRsbRcbLibRob
LhbRgbLgbRsbRibLibRoLsbRjbLibLibRcbLhbLibLibLjbLibRiRsmbRcbLcbLcbLebLi
bRibLcLsLsmmbLcbRcbRhbRgbLibLjbLibLjLsmbLjbLcbLgbRhbRjRsmbRcbRcbRhbLib
LjbRebRoLsbLjbLjbRcbRibRgbLibLcbLibLibLsbLibLiLsbLibLcbLhbLibLsLsmbLsb
LsRsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 29; Drug: Control Apo 0.5 然
bRgLsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 30; Drug: Control Apo 0.5 然
bLsbLgbLibLsbLibLsbLcbRibLgRsbRsbLobRsbRibLobLibLibLsbLgbRsbLobRjLsbRo
LsbRcbRibLcbLiLsbLcbRibRebLjbRcbLibRcbRcbRibLsbLibRibRgbRgbRcbLiLsbLcL
smbLibLiRsbLsbRgbLibLhLsbRgbLcbRsbLjbLcbRgbRgbLsbLibLcbLhbRsbRsbRsLsbL
cbRjbRcbLjbLibLibLibRjRsRsmmbLsRsbLibLgLsbRsRgbRcbRibLgLsbRibRsLsbLsLs
mbRcbLsLgbLjbLgbLoRsbRibLobLibLgbRibLibRiRsmbRobRiLsbRibLiRsbLgbLsbLgb
LibLhbLibLibRcbLgbRsbLibRjbRcbRobRobLhbLibLcbLcRsbRcbLibLobLibLibLhbLs
bLibRgbRsbLhbRgbLibRgbRjbRhLsbLjbRcLsbLsRsbLgbRobLgbLsbRobRibLcbLhbLgb
LsLsmbLgLsbLcbLgbLjbLcbRcbsbLibLjbLcLsmbLcbLibRjbRobLjbLibLiLsbLhbRcbL
cbLgbRibLgbRsbRibLgbLjbLcbLcbLibLjbLjLsmbRjbLjbLjLsmbRcbLsbLcbRgbRgLsb
LjbLjbRcbLibRsbLjbLsLsmbLjbRsbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bRsbLibLcRsbLhbLgbLcbsbLebsbRsLsbsbsbsbsbsbsbsbsbsbsbsbLsbRsLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bLgbLgLsbLsLsmbLgbRsRsmbRebLcbLjbLgbRgLjbRcbRcbRgbLibRhbLibRobLibRobRh
bRcbRcbLibRhbLgbRcbRcbLjbRobRhbRiLsRsbLibRibRhbRgbRcbLibRiRsmbLsbRcbRg
bRoRsLsmbLibLebLgbRobRgRsmbLibLsbRobRgbRcbRsbLibsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bRgbLsbLobRsbLebRibLibRobLibLcbRebLgbLebLobRobLobRobRebRobRebRobLobLob
LsbRobLobRcbLobRgbLcbRcbLcbLobRibLobLibRibRebRibLebLobRobLcbLobRobRobR
gbLobRcbRobLebRsbLjbLcbRobLobRgbRibLhbLobLebLcbRobRibRobRibLebLebRobLo
bRebLobRebLcbLgbLobRobLobLibLsbLobLobRobLgbLobRebLebRobLcbLebRobLibRcb
LibLebRcbRobLgbLobRibRebLobRibRebRcbRibRsbLobRobRgbLebLobRobRcbLibRsbR
cbLebLcbRobRobRobLgbRobLebRibLcbRobLebLgbRcbLcbRobRobRcbLgbRgbRebRcbLg
bLgbRobRobRobRebRgbRebRebRobLgbLebLebLibLebRsbLobRobLebRobRobLebRobRgb
LcbRebLcbLobLobRebLcbRobLobLobRobRgbRsbLcbLobRobRobLobLhbLibRgbLjbRebL
cbLcbRobRobRebLebRobRcbRobLibLobRobLobRebLibLobLcbRebLcbRcbLebLobLobLs
bRhbLobLobRsbLobRobRgbLobRebLebLsbLsbLebRebLobLobLebLibLebLobRobLibLcb
LibLobRcbRobRobRobRcbLobRobRibLibLhbLobLobLebRgbRebRcbRobRobRcbLebRobL
obLibRsbLobRsbRobLgbRebLcbRgbLobRobRobRobRobRjbRgbRobLobRgbLobLobRsbLe
bLibRobRobLobLibRebLgbLebRsbLibLobLhbRebRobLobLobLobRobLebRebRgbRibLob
RobLgbRebLebRgbLjbLebLobLcbLcbLebRebLcbLobRobLebLobRgbRobRobRobLebLhbL
obRibRobRebRobRibLobRobRebRobRsbRcbLobRebRibRsbRcbRebLcbLgbRebLebRcbLo
bRobLobLobLibRebRobLobLobRcbRsbLebRsbRibLgbRcbLebLobRobLsbLsbRobLebReb
RobLobRobLobRobRibRsbLobLobRcbLebRcbLsbRobRebLobLobLobRobLibRebRgbLebR
sbRebLcbRgbRibRsbLcbRibRebLebRhbLobRobRhbRhbLcbLobRebLobLobLcbRebRobLo
bRobRobRgbRobRebLobRobLobLobLebLgbLgbRibRebLobLobLebLobLobRobLobLcbLeb
RgbLobLobLebLobRebRobLebRobRgbLebLibLobLcbRobRobLobRobLebRcbRebRgbRgbR
obLcbRobRgbRobRobRgbLobRibLobLobLobLebRebLsbRcbRobRgbLebLibLibLjbLebLe
bRcbRebRobRobRobRhbRcbLebLebRgbRebRgbLobLsbLhbLcbLgbRobRobLobLebLhbReb
RebRebLcbLobRibRobLhbRcbLebRebRobLibRobRobLobRgbLobLebLibRebLcbRsbRsbL
ebRobLobRhbLobRibRebRibRgbLebRobLobLobLibLsbRobLgbRgbRcbRgbLcbLobRobLo
bLcbLobRcbLobRobRobRcbLobRebRobRobRebLebRgbRebLobRobRobLebRobLcbLebRob
RsbLebRobLebLsbRebLobLebRgbLcbRobRcbRobLobLibRcbRobRgbLobLobLgbLobRobR
obRibLebRobLobRcbLsbRobRobRobLcbLebLobLobLcbLobRjbLobLcbLobLobRobRobLe
bLcbRibLebRcbRcbLobLcbLebLobRobRobRibRobRobLibRobRebRcbRebLebLebLobLcb
RebLobLobLebLebRobLobRcbLobLebLobRhbLobRobRcbLhbRobLobRobLebLebLebRibL
obRcbRcbLcbRebRebRebLobRcbRobLobRibRhbRgbRobLebRebRcbRobLebRebLcbLebRe
bRebLgbRobRsbRcbLobLobLobLebLebLgbLcbRcbLobLgbLobRobRcbRibRgbLobRobLob
LebLobLobLobRobLobRobRibRgbLobLsbLobLhbRobLebRobRibLobRobRcbLcbLobLhbR
sbLobLibRgbRobRcbRobRcbLcbRibRcbRobLebLobRebLebLobRebLgbRcbLcbRobRibRc
bLcbLobRebLcbRobLcbRgbLobLgbLebRcbRobLgbRebRcbLibRobRibRcbLebRobRgbLeb
LebLcbRibLebRobRobLobLebRobRcbRebLcbLobRcbRobLebLibLebRgbRcbLobLjbRcbR
ibRcbRcbRebRobRcbLcbRebLgbRobRobLebRcbRobLebRobRebRebLibRobLobLcbLobRo
bLcbLobLobRebRobRobRibRobLobRobRsbRobLobRobLsbLobRebRcbRobRobLobRobLob
RcbLobRcbRebRcbRcbRibRobRobRcbLsbLebRobRcbLobRobRobRgbLebRcbLcbRsbRcbL
ebLibRobLebLcbLsbLobRebLsbLobLebLebLobRcbRgbRobRobLobRcbLobRgbLobRhbRe
bLebLebRobLgbRobRebRobRsbRsbRobLobLobLobLobLibLsbLebLcbLcbRobLebLibLeb
LebLobRebLebLcbLobLebLobRcbLebLobRhbRobLebLcbLcbRobLibRcbLcbRgbLgbRobR
sbRobRcbRcbLobRobRobRgbLgbLcbLebLcbLebRobLebLibLobLobRebRibLobRobLobLo
bLobLcbRebRobRobRcbLobLebLgbRebLobLibLobRgbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bRcbRcbLjbRcbRsbRsbRhbLjbRcbLjbLobRibRcbRjbRhbLibRcbLsbLjLobRhbRsbRsRs
mbRhbLsbRibLsbsbLebLobRcRsmbRcbRiRsmbLhbRgbRibLjbRcRsRsmmbRoRsLsmbRcbR
cbRibLgbsbRobRhbLhbLsbRgbRiRsmbLjbRcbRibLjbLoRsLsbRgRsmbRcbLsbRgbRsbLs
bRsRsmbRsbLsbsbLsRsRsmbLsRsLsbRgbRsbLsbRsbLsRsbRiLsbRsRsmbRsRobLcbRgbL
jbLhbLobRibLcbRhbRhRsmbLcbRjbRiRsmbRgbsbLobRjbLcbLgbRobLjbLoRsbLhbRjbL
ibRebRcLsLsLsmmbRoRsRsmmbLobRibRcbRobLcbRibsbLobRgbRcbLjbLobRcRsmbLjbR
cbRgbLjbRcbRebLjbLibLgbRcbRebLjbLcbRjbLobReRsmbLsbLgbRcbRhbLcLsmbRibLo
bRgbRjbLcbRobLcbLcRsbRgbRobsbLgbRhRsmbLgbRgbRibLsbRgbRobLgLsbLibRsbLib
RobRcbLibRobLibRibRibLebRcbLgbRcLsbLibRobLhbRjRsmbLcbLsbLgbRsbLjbsbLob
RsbRcbLcRsbLgbLgbLgbRgbLibRsbLjLsmbRibLcbRgbLhLsbRibLibRcbRibLibRcbLgb
RebLibLobLsbLsRsbLsbLjbLobLibLsbLgbLsbLsLjbRgbRcbLgbLgbLgbLgbLgRsbRgbR
gbLibRebLjbLcbRgbRibLhbRcbRjbLjbRjbLoLsmbRibLibLibLsbLgRsbLjbRgbRcbRib
ReLsbLcLsmbRcbRhbRhRsmbLcbRcbLibLsbLibLoRsRsmbLsbRibLcbRibLcbRjbLcbRsb
LibLsbRoRsmbRcRsmbRcbLcLsmbLibRibLjbRiRsLsRsmbLjbRcbRgbLsbLsbLsbLsbRib
LsbRhbLjbRobRhbRhbLhbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bLcbRibRibLsbRibRgbLsbRgbRhbRibLgbLoRsbRhbRgbRibRgbRsbRcbRhbRibRgbRgbL
jbRjbRobLhRsbRibRibRgbLcbLobLcbRibRibRgbRgbLibRgbRsbRjbRobLibRebRcLsbL
sLsmbLhbLobRhbLibRibLoRsbRebRibRiLsbRcbLgbLgbRhLsbLsbLsbRibLsLsLsmmbRi
RsmbRsbRgbLgbRibRgbRgbRgbRgbRgbRsRsmbRsbRcLsbRgbLobRibRibRsbLjbLoRsbRg
RsmbRgRsmbRgbRsbRjbLjbLobRcbRhbLsbRgbRgbRgbLhbLobLibRibRjbRibRsbRibRsb
RgbLjbRibLsbRibRcbRcbRibRobLiLsbRobLibRsLibLjbRjbRobRibRiLsbLgbRibRgbR
gLsbLgbRsbRibRsbRsRsmbRgbLjbRsbRibLsbRibRibLjbRsbRgbsbLsbRgRsmbRgbLsLs
mbRjbRhbRsbRgbRgLsbRgbRhbLgbsbLobLiRsRsmbRgbRsbRjbLobRjbLcbRibRcbLjbLo
bLobRcbLgLsbRibLcbRebRhbRiLsbLsLsmbRibLobLhbRhbRjbLoLsmbLoRsbRgbRibRgb
RibRibLibRibRgbRsbRgbLsbLsbLgbRcbRgRsmbRebLcbRcbRcbRibRhbLcbLibRibRibL
gbRhbLcbRjbRcbLgbRibLobRibLjLsmbLcRsbRibRibLobRhbRibRcbRhbLcbLcbRibLib
RcbLsbRgRsmbRhbRcbLebLgLsbLibLcbLcbLoRsbRhbLibLoLsmbRcbRcLsbRcbRhbRsbR
iLsbLiLsbRgbRgbRibLjLsmbRibLgbLjLsmbRcRsmbRiRsmbRcbReRsRsmmbsbLibRcbRc
bLjbRcbRcbRsbRgbRgbRsbRgbLibRsbRibRgbRsbLgbLjbRjbRcbRhbLjLsmbRcbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bLibRebRsbRcbRgbLibRobReRsmbLibRhbLsRcbLsRsbReRsmbLsbRcbRsbRgbLcbLgbLi
bRsbRgbRobLibRsbLobLobRhbLiLsbLhbRgRsmbRcRsmbLsRsbRsbRcRsmbLibLobRibRe
bRcbRebRibLibRsbLcbLjbRcbRgbRiRsmbReRsmbLgbRibLibRibRgbRgbRgLsbLgbRebR
jRgbRibLibRgbRebLibLjbLobLibLeLsbReRsmbLgbRcbRcRsmbReLsbLsbRiRsmbRibRe
bRsbRsbLsRebRsRsmbRjRsmbRcbRhbRsbRgRsmbLjRsbRibLobLgbRhbsbLjbRibLsbLgb
RhRsmbRjbLjbLgbLgbRsLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bLiRsLsbRsbLcbLibRgRsmbLsLsmbLcbRibLhbLsbLsbLcbLhbRcbLcLsLsmmbRgbLiLsb
LgbLgbsbRjbLhbsbRgbLsRsbLiLsbLiRsbLgbLgLsbRsbRoRsmbRibLjbRibRcLsbRgbLs
bLsbRsRcLsbLgbRobRibRgbLhbRgbRobLcbRgbRibRoLsLsmbLsbRcbLibLsbRcbRgbRgb
LcLsmbLobRgbLcbLiLsbLgbRibLcRsbsbLcbLcbLiLsbLibRsbLsbRhbLgbsbLsbRibLob
LcRsbRgbLcbRgRsmbRsbLobRibLcbRgLsbLiLsbRgbLgbLsbLoLsLsmmbRcbLhbLcbLibR
iRsmbRsbRgbLobRsbLobLcbRgbLcRsbLibLcbRibRsbLibRgbLcLsmbLibLgbLcbRcbLgb
LobLsbLsbLsbLcLsmbLiRsbRsRsmbLibLcbLcbLcLsmbLgLsbLobLibLsbRsRsmbLcbRib
LcbsbLsbLsbLsbLhbLhbLhbLibLsbLoLsmbLhbRibLibLsRsbLcbRiLsbLgLsbLiRsbRgR
smbsbLsLcbRgRsmbLibLibLcbRibLibLibRgRsmbLobLibLgbLsbLcbRsbLgbRsbLiLsbL
hLsbRsbRsbRsbLcbLcbLgRsbRsRsmbLibLibRcbRgbRibRgbRcbLiLsbLsbRsRsmbRibsb
LsbLsLjbLcLsmbLsbLibLsbLsbLsbLibRsbLcbsbLcRsbsbLhbLibLibRsbLibRsbLjRsb
RgbLiLsbLgbRsbLoRsbLibLiRsbLhbLgbRjbLibLobLibRgbRiRsmbRjbRgbLibRsbRoLs
bRsbLsLsmbRgbLcLcbsbLgbLhbLgbLibLcRsbLsbLcLsmbLibLhbLsbLsLsmbRsbLcRsbR
sbLgbLibLcbLiRsbRgLsbLsbLhbLibsbRsbLsbRsbLibRsbLgLsbLgbLibLibRsbLgbLib
LcRsbLcbLibRsRsmbRhbRgbLsbLjbLhLsbLsLsmbLibRsbRobRibLcbLhbsbRgbRjbRcbL
cRsbRcbRhRsmbLibRibRgbLsbRsbRiRsRsmmbRiRsmbRsbRgbRsRsmbRgbRsbsbRobLcLs
mbLhLsRsbRobRcbLsbLibRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bRsbRgbRsbRgbRsbRsRsmbRiLsbLsRsbRgbRgbLsbRibRibLibLsbLhbRebLhbLibLhbRi
bLsbLcbLgbRsRsmbLgbLgbsbsbRgbLgbRgbLcbLhbsbRsbRibRgbLibLsbLgLsbLhRsbRg
bLobLiLsbRsbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bLibRjRcbRsRcbLgbRhRsmbLhbRcbRhRsmbRgbRebRibLcbLiLsbRgbRsbLgbLibRobRib
LsbRhLsbRcLsbLobLoRsbRcbLjbLibRcbsbRcbLibLibLibLcRsLsbReRsmbRcbLebLobR
ibLobLiLsbLgbLibRhbRcbRcLsRsbLhLsbLsbRcbRgbRsRsmbRsbLsbRhRsmbLibRiRsmb
RcbRsbRsbLgbRgbRibRiLsbLgbLcbLcLsmbRebRcbLiLsbLsbLibLoLsmbRcbRgbLebLcb
LoRsbRibLhLsbLibLibRcbLcbRcbRhRsmbLobLcRsbRcbRcbLebLobLcbLibLibRcbLcbL
obLobLcRsbLibRhLsbLhbRjbRcbRibLibRiLsbRcbRcbRhbRgbLcbLhbLjbRcbRcbRjbRg
bRcbLhbRibRjbRiRsmbRcLsbRibLjbLcbLibLjRsbLsbRcbLjbRjbRiRsmbLcbLibRcLsb
LhbRcbRjbRcLsbLcbLcbRiRsmbRiLsbLsbLsbRibLhbLcLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bLobRgbLcbRsbLibRsbRgbRcbRsbLgbLobLibLgbRgbLcbRsRsmbLgbLsbRgbLobLcbRsb
LibLibLgbLgbLibRjbRcbRgRsmbRibLjbRgbRibRgRcbRibLsbRibLgbLibRsbLiLsbRsb
RcbRibLgbRgbRsbLgbRibRgbLsLsmbRgbRibRsLjLcLibRsLsbLgbRgbLgbRsbLgLsbRsb
LibRsbLibRgbLiRsbLoRsbLsbLiLsbRibLsbRibRgbLibRibLobLhbRgbLgbRsbLibRgbL
ibRsbLibRgbLibRgbLgbLsbLgbRsbRhbLibLgbLibRsbLjbRgbRcbRgbLibRgbRjbRsRsm
b

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bRibsbRgbRcbRcbsbLebRobLibLsLjbLiLsbLebLjbLcLsmbsbLcRsbLibLcLsmbLhLsbL
sbLibLjLsmbLebLibLhbLjLgbLhLsbLibLsbLgRsbLibLibLebLsbLjbLsbLibLcLsLsmm
bLibLibRsbLsbLjbLebLgbLibLebLgbLhbLcbRebLsbRsbLcbLibLjbRsbRcbLibLsbReb
LcbLibLcbLibLibLhbLobLcbReRsmbRjbLgRsbLebLgbLiLsbLhb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bLibLgbRjbRjbLjbRjbLcbLgRsbRcRsmbLjbRcbLibRibLcbLcbLibLobLibRsbLgbLsLj
bsbsbRgbLgbLgLsbRjbRjLsbRjbLibRibRsRsmbLgLsbRgbRibLgbsbRibRgbLgbRsbLgb
LgbLsLsmbRsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
bLsLsRsmbLibLibLjLsmbLibRsLsbLgLsbLgbLcRsbLoRsbRgbsbLibLsbLibRgLsbLgbL
ibLgbRibLibLsRsbLibLgbRgbLiRsbRgbLcbRgbRsbLcbRgbLibRgbLiLsbLgbRgbLgbRe
bRiLsbLibLjbLhbRjbRcbLcbsbRibsbRsbRsbRibRcbsbLsbLiLsbLhbLjbRhbRgRsmbLj
bsbsbRibLsRobRibRibRibLgLsbLcbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bLgbLgbLgbRsbLiLsbLsRsbLgbLsbLgbLibRsbLcbRsbLobLsbLhbLgbRibLcbLgLsLsmb
RsRsmbRibLoLsmbRsbLobRsbLobRsbRsbLhRsbRgLsbLsbLsbLhbRjbRcRsmbLhLsbRiLs
bLcbRjbLibLgbLiRsbLgbLsbRjbRcbLebRsbRsbLhbLgRsbRjbRsLcRsbLsLsmbRsbLgbL
gbLsbLibLsLsmbRibLgbLgbLjbLsLsmbLibLsbLcbRsbLibRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bRibRcbRhbLcbLgbRibRoRsmbLobRgbLobRibLcbRjbLibRsbLibRgbRobRgbLjbLjRsbR
sbRcbRibLibRibLgRsbRhbRcRsmbRibRiRsmbRsbRibRibLgbRibRgLsbRgbRgbLsbRsbR
hbRcbRcbRobRibRibRgbRsbLsbRibRibRibRibRgbRgbRiRsmbRibLjLsmbLhbRcbLcbRc
bRcbRiRsmbLgbRibRibRibRibLibRibLobLcbRobRsbRcbRibLibLgbRcRsmbRcLsbRebR
ibLibRgbLjbRhbLebRcbLoLsmbRobRcbLibLibLjRsbLibRibsbRcbRhbLcbLjLsLsmmbL
gLsbRebRjRsmbLebLsbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bsbsbRibLibRhbLcLsmbRsbLibRgRsmbLsbLibRsbLibLgbRgbRobRhbLjbRibRgbLobRh
bRsbRibLgbRibRibRgbRjbLobLiLsLsmbLgLsbRiLsRsbLgbRjRgbsbLjbLibLcbRibRib
RiRsmbRgbLsbLebRgbLobLsbLibRjbRsbLibRgbLgLsbLibRjRsmbLibLsbLgbLsbLibRs
bLgbRsbLsbLgbRcbRcbLgLsbLjbLiLsbLsRsbLobRcRsmbLsbLjbRobLibLibLibRjbLib
RgbLibRgbLibRibLeLsbLsbRcRsmbLobRebLcbRsbLjLsLsmmbLcbLhLsbLcbsbRjbLibR
cRsmbLiLsbRibLjbLjbLjbLhbRcRsmbRibLjbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bLsLsmbLcbLgbRsbRebRibLsbLcbRgRsmbLibRjbLsRsbRjbRibRsbRgbRgbLsbRgbRsbR
ebLibLsbLsbLsbRobLgbLsRoRsmbLgRsRsmbRiRsmbLjbRgbRsRsmbRsbRgbLsbLcbRibR
sbRgbLsbRgbRgbRgbLsbRobLgLsbRgbLgbRibRhLsbLgbRgbRgbRgbRgLsRsbLsbRgbRsb
RjbRgbRsbRsbLsbRjbRsbRsbRsRsmbRgbRgbRsbRgbRsbRsbRsbRsLsbRgbRiRsmbRgbRg
bRgbRgRsmbRsbRsbRgLsbLgLsbRibRcLsbLcbLcbLibLiLsbRgbRgRsmbRibRsLsbRsbRg
bRsbLsbRgbRgbLsbRgRsmbRsbRsbRgbRgbRgbRsbRgbRgbRgLsbRsRgbRgRsmbRgRsLsmb
RgbRgbRgLsbRiRsmbRgLsLsmbRgbRsbRsbRsbRgbRsbRgbRsbRsbRgbRibLibRgbRibLgb
RibLhbLgbRhbLhbRgbRsbRsbsbRsbRibRsbLibLgbLibRgbRsbLsLcbRgbRjbLibLibRgb
LibLgbRsbRgbRsbLgbLobLhLsbRibLgbLgbLiRsRsmbRgbRgbLgbRsbRjbLjbLgbLgbRcb
RoRsLsLsmmbLgbRibRgbLgbsbRgbLsRsbLjbLcLsmbRjbLibLibLgbRgbLsbRsbRjbRcbL
cLsmbRibLcRsbLhRsbRibLgbRgbRjbRibRgbRsRsmbLsbRgbRsbRsbRgRsmbLsbRgbRgbL
sbRsRsmbRgbLsbRgbRsbRsbRsbRgbRsbRgbRgbRobLibLgLgbRibLgbRgbRsbLjbLsbRgb
RsbLjbLgbRsbLcbRibRsbsbLibRjbsbRibLibLibLgbLibLibsbLgbRgbLgbRgbRsbRgbR
gbLhbLsbRjbLjbLjbLiLsRsbLibLgbLjbLgbLsLsmbLsbLjbsbLjbLeRibLibLibRsbLib
LibLibLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 124717; End: 125217;
Recording: 1-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bRhbLsbLhbRebLjbRhbRibLgbRhbLgbRhbRobLjbRcLsbRobLcbLibRobRibLcbRgbLibL
obLcbLcbRebRcLsbRhbLjbRcbLjbRcbRoLsbLjbRiLsbRgbLcbLhbLcRsbRcbRoRsmbRib
RibRsbRcLsbLibLibLcbLobRhbRhbLibLibRgRsmbLibLibRebLibLsbLibRhbRcbRhLsb
LhbLibRjbRhbLibsbLjbRsRcRsmbRhRsmbLgbLsbRcLsbLibRhbLjbRcbLibLhbLgbLgbL
gLsbRjbLibLgbRgbLibRjbLibLibLsbLobRsbLibLcbRiLsRsbLibRsbLcbRcbLjbRhbLo
bLobLcbLcbLcbRcbRcbRcbRoLsbLiRsbLcbLobRcbRibLcbLoRsbLcbLcbLibRcbRcbLob
RobRcbRcbLhbRgbLibRhbRibRjLsbLjbRibRsLsbRgRsmbRgbLsbRsbRgbLsbRibLsbLjb
LhbRcbLcbRoLsbRcbRibLiLsbRibLgbRiLsbRhbLhLsbLgLsbRibRjbLcbLcbLiLsbLcbL
obRcbRjRsmbLgbLjbRhbLjbRcRsmbRsLsbRobRgbLjbRibLsLcbLcbLibRhbLebRobLcRs
bLsbRcRsmbLjbRibRhbLcbLhbRhbRcbLcbLcbRjbLjbRobRcbLhbLcbLibLibRjbRibLib
LibRibLibRcbLcbRcbsbRoLsbRobLibRjbRhLsbRobLibRobLcbLibsbLjbsbRhbLibLib
RibRsLsbLhbsbLiRsbLibRgbLibRsRsmbRibLgLsLsmbLibRhbLibsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 1; Drug: Control Apo 0.5 然
bLsLiLsbLhbRiRsmbRjRsmbLibRgbLibRgbRjbRibRhRsmbLjbLibLcbRgbRsbLcbRjRsR
smmbRobLjbRcbLgbLibLgbLsLiRsbRcbRhbLiLsbLjLsmbLibRcbRcbLcbLibRcbLhbLgb
RjLsbLhbRjbRjbRcbLibLeLsbLiLsbRibLobLcbLebRcLsbLibRcbLgbLgbRcbRibLsRcb
LibLibRhbLgRsbRjbRibsbLeLsbLibRjbRcRsLsmbRgRsmbLiLsbRhbLsbRcbLgbRcbRsb
LjLsmbLcbLibRhbLsbLcbLsbLhbRibRsbRjbRibLsbsbLjbRhbLhbLebLibLjbLsbRcbRc
bRibLibLjbRcbRibLibLgbLsbLibRibLsbLibRgbRcRiRsRsRimmbLgbRcbRcbLgbRibLi
bRcbRsbRcbLcbRjbLcbLjbRcbRibLgbRcbRcbLebRgLsLsmbLsbLgbRjbRhbRibLjbLcbR
oRsmbRhbRcbRgbLcbLibLibLsbLhRsbLibRjbLhLsbLhbLjbLgbRjbLgbRjbLcLsmbRjbR
jLsbLsbRsbRhbRgbRsbLhbRsLibRiRsmbLobLobLhbRibLcLsmbRcbRcbLibLjRsbLiLsR
sbRhRsmbLjbsbRibLhbLjbRcbRsbLjLsmbRcbLsbLjbRcbLjbRhbLjbLjbRhbLsbLjbRhb
RibLcbLibLsbLcbLhbRgRsmbLjbLjbRobRcbRjbLjbLhLsLsmbRgbLjbLibRjbRcbLsbLc
bRjbLcbRjbLgbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 2; Drug: Control Apo 0.5 然
bRibLsbRiLsbRibLebRcbRiRsmbLsRsLsbRebRgbLhbLibRgbRiLsbLibRiRsmbLgbRgbR
ibLgbsbRgRsmbRgbRgRsmbRsbRobRsbRsRjRsRsmmbLjbRibLsbLebLgLsbLsbRsbLcbRg
bsbRsbRgbLjLsLsmmbLjbRibRjbRgbRsRsmbRgbRgbLibsbsbRibRsbRgbRsbRgbLjLsmb
LibLjLgbRgbLjbRgbLsbLoRsbRcbRgRsLsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 3; Drug: Control Apo 0.5 然
bRoRsmbRsbsbRcbRgbLsbLhbLsbLcbRjbRobLsbRiLsbLsRsbLjbLoRsbRsLsbRjbLcbLi
bRjbRcRsmbRhLsbsbLeLsbRiRsmbLsbRgbRhLsbLhbLgbRoRsmbLiRsbLsbLjbLgbsbRcb
sbLgbLgRsbLibRsbRsbRcbLgbLgLsbRsbLibLgbRsRsmbReRsRsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 4; Drug: Control Apo 0.5 然
bLibLgbLgbLibLibRobRhbRcbLhbLebRjbLobRgbRibLibRgbLibRsbRjbLibLibRjbLib
RjbLiRsbRjbLhbRobRobRgbRgbLibRiRsmbLcLsmbLsbLgLsbLsLsmbLsLsmbLgbLibLib
LjbRjRsmbLjbLjbLibLjRsbLjbsbLobLibLibLebLjLsRsmbRsbLiLsbLsbRgbRgbLcbRi
bLcbRibsbRibLgbLsbRjbLsbLibRsbRsbLibLibLjRsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 5; Drug: Control Apo 0.5 然
bRiRsmbLsbRsbRsbRibRsbRiRsmbRgbRsbRsbLgbsbRjbRcRsmbRiRsmbRibRgRsmbRgbL
iRsbRgLsbRibRobRebRsbLsLjbLhLsbRsbLsLsmbLsLgLsbReRsmbRsbRebRsbLsbRibLi
bRhbRsbRsbRgbRgbRgbRgbRgbRgbRgbRsLsbRgbLgbRcbRsbRhbRsbLgLsbRsbRsbRgbLi
LsbLgbLgbLsbRjbLcbLcLsRsmbRsbLoLsmbRsLsbRgbLiLsbRcLsbRibRsbLjbRjRsmbRc
bLsbLgbRobRibLibRsLsbLsbRsbRjbLjbLibLibLibLcLsmbRsbLsbRsbRhbLsRsbRsRsm
bRsbRhbRsbRsbsbLgbRjRsmbLsbRiRsmbRgbRsbRsbRgbLgbRiLsbRibRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 6; Drug: Control Apo 0.5 然
bLjRsbsbLsbLibRjbRcbRgLsbRjLsbRiLsbLgbsbLgLsbLgbLcbLgbLgRsbRibLibLibLg
bLgbLgbLcbLcbRsbLibLhbLibLebRgRsmbLibLjbRsbLhbLgbLibLiRsbLgLsbsbLiRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bRibLjbRjLsbRjbRjbLcbRjbRobRebRjbRibRibRsRsmbLjbLsRsbRsbLsbLsbLgLsbRsb
RgbRjbsbLsRsbLsRsbRsLsbRsbsbRcRsmbLhbRibRhbRcbRhLsbLjbLjbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bRsRjbRjbRjbRcbRibRsbRsbRsbLebRobRsbRsbRsbRsbRsbRibLsbRibRgbLsbRsLsbRi
bRgLsbRsLsbsbLcbLhbRjRsmbLebLcRsbLhbLibsbRjbRjRsmbRjRsmbRcbRibRhRsLsLs
mmbRcRsmbRjbRibRhbRibRsbRibLsbRsbRsbRsbRcbLhbLibRjbRgbLhbLibsbRsbRjbRi
RsmbRsbRhbRhbRcbLsRsbRcbRhbRjbRiLsLsmbLcbLcRsbLjbLhbRjbRibLibLiLsbRjbR
ibRsbRsbRibRgbRjbRjbRhbRhbRjbRjbLjbLjbLcbRobRjRsmbRjbLibRhRsmbRjbRibRh
bRcbRcbRgbLibRcbRhbRhbRgbRibRsbRsbLgbRibLibRhbsbLcbLoRsbRgbRibRsbRibRs
bRibLsbRcbRcbRibLgLsbLibLibLsbLgbLibRjbRjRgbRjbLjLjbLhbLjbRsbLibRsbLsb
RsbRsbLgbLhbRcbRibRebRibLsbLiRsbLcbLebLcbLebRjbLibLsRsbLhbLcbLjLsmbLib
LsLsmbLibRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bLcbRjbRcbRhbLibLjLsmbRhbRjbLobRcbLcLsmbRjbLjbRibLcbRcbRcbLcbRcbLsRhbs
bRebRhbLgbRcbRsbLcRsbLsbLgLsLsmbLcLsmbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bRsbRhbLjbLiRsbRjRsmbLibRsbRibLgbRsLsbLgbsbLhbLgbLcbLibLibLibRiRsmbsbs
bLcbsbsbLjbLcbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bsbRsRsmbRsbRsRsRsmmbsbLsLsmbRsRsmbRgbRgbsbRgbRsbRjbRgbLjbRcbLsbsbLgLs
bRsLsbRsLsRsbRjbsbRsbRsbRiRsmbRgRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bLiRsbLcbsbsbRobRgbRsbRsbRjRsmbLhbLhLsbRcbLcLsmbLsLcbRobLjbLcbLsbLibLi
bLcbLcbLibLibLibRcbLhLsbRhbRsbLibLibRobRsbLibsbLibsbLgbRobsbRgbRsbRcbR
ibsbsbRgbRgbRibsbRsbRgLsbLsLsmbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bRsbRsbRsbLsbRsbRsbRsbRsbRsbRsbRebRsRsmbRjRsmbRsRsmbLsbLsbRsLsbRsRsLsm
bLcbLsbLcbRibRgRsmbLjbsbsbsbsbsbLsbRcbsbRiRsmbLsbLibReLsbLsRsbLsbRsbRs
bLsbLsbRsbRsbRjbRsbLsbLsbsbLgRsbRcbLjLsmbLcbRsbRebLsLsmbRsbLsbRsbRsbLs
bLsbLsbLgbRsRsmbRgLsbsbsbLgRsLsRsbsbsbsbRsRsmbsbRsLsbLsRsbLsRsbRsLsbsb
LsbRsLsRsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bLhbsbLjLsLsLsmmmbLgbLsbRobsbLeLsbLsbLcbRjbLcbLgbLsbRsbLcLsmbLobRsRsmb
RibRobLobLibLcbRgRsmbLhbLsbLoRsbLgbLjbLibRcbLibsbRhRsmbRibLsbsbLobLebL
sbsbLgbRsLsbLsbLgLsbLgbLgbLgLsbLsRsbLiRsbRibRcbRgbRgRsmbLcbRcLsbRjbsbR
ibLsLsmbRsbLobRsRsmbsbLgbLhLsbRcRsmbLobRcRsmbRebLobLobRgbLcbRcbLobLobL
cbRhbLiLsLsmbRjbLcRsbRjbRsbRibRobLsRsbRsLsbLgbLoRsbRgbRgbLcbReLsbRhLsR
sbLibLsbLsbRsRsmbRgbLobLcLsmbRgbLhbRjbLibRsbLcLsmbLhbLsbRibRsbLgbLcbRo
bLobLcbRhRsLsmbLjbLsbLiRsbRibRcbRibLgbLhLsbLcRsbLebLobRgbLsRibLiLsbLiL
sbLsbLjbLcbRgbLsbLiLsbRjbRibRgLsbRsLoRsbRcbLhbRibRobRhLsbLiLsbsbLobRib
LsbLhbRgRsmbLibLsbRcbRoRsRsmmbLgbRjRsRsmmbLjbRobRiRsmbLiRsbLcbRcRsRsmm
bRcbLiLsbRibRibLgLsbRhbRsbRhbLebRsbLjbLobsbLcRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bLsbLobRebLsRsRsmbLsbRsbRibReLsbsbRobRcbLobRjbRjbLcbRobLebRobRjbLsbLob
RjbLebRobRobLebRsbRsbRsbLebLsbLsbLsbRsbRebLjbRsbRsbLobRjLsbLsbRjbRcbLg
bRgbLgRsRsmbRsRsmbsbRsbRsbLsRsbLcLsmbsbLobLebRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bsbLsbLgbRgbRsbsbsbLgbRibRgbLsbRsbRsbRsbLsRsbRsbRsbsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bRsbLsLsmbLsbRsbsbLsbLsLsmbLsbRsbLsbLsbRsLsbLsLsRsmbLsLsRsRsLsLsRsLsLs
mmmmbLsLsmbsbLsbsbsbsbsbsbRsbRsbRgRsmbsbsbsbsbsbsbsbLsbLgbRsbLjbRgbLib
LsbLsbRsbLsRsLsLsmbLiRsRsmbRgbLgbsbLgbRebRsbRebRgbRhbLgbLibLjRsbLobLib
LgLsbRsbRjbLobRjbLcbLeLobRibLsLsRsmbLsbsbRsbLsbsbRobRiLsbRsbsbRibsbRob
LibRibLhbLgbRibRcRsmbLsbLibLgRsbLcbRgbLiLsbLgbLgbLcbRsRsmbLgbRsbLsbLjb
RiLsbLiRsbsbLsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bRibLjbRiRsmbRgRsmbRgbRsLsbRgbRgbLsbRgLsbRsLsbLsbRgbRsbRgbRgLgbRibRgbR
hLsbLiLsbRhbRsbRgbRgLsbRibLsbRgbRsbRgbRsRsmbRiRibLsRsbRgLgbRibRgbRgRsm
bRgbLsRgbRjbRobRiRsmbRibLjLsmbRgLsbLjbLibRjbLhbLgbLsbRobLcbRjbRibRiRsm
bLsbRibLjbLibLgbLsbLiRsbRsbRsRhbRibRjRsmbRgbRgbRibLibLcRsbRjbLcRsLsbRi
bRjbRgbRgbRsbRgbRsbRsbRsbRgbRsRjbRjbRibRsRibLjLsmbRjbLsRhbRiLiLsbRibRg
bRsbLsRsbRsbRgbRsbRibRgbRgbLcbLjbLeRiLsRsbRiLsbRibLiLsbRhbRebRsLsbLjbs
bLibLebLgbLsbRjbLsbLibRsRgbRjbLibLsbsbRgbRgbLsbRgbRgbRgbRsbRgbRgbLsbRc
bRibRgbLsbLcbRcbRcbRjbLsbsbLebLcLsmbRhbRebLsbRibRoLsbRebLhbRibLsbLibLc
bRibRgbLcbLcbLhbLiLsbRgbRgbLcbRjbLobsbLibLibRibLibRibRcbRcbRibsbLjbRhb
RcRsmbRcRsmbRgRsmbRjRsRsmmbsbLibRjbRjbRibRiLsRsbLjbRjbRcbRcbRibLibRcbR
iLsbRsRjbRcbRibRibRibsbRgLsbRgbLibRgbRgbLibRhbLhbLgLsbsbLgLsbLsbLgbLsb
sbLibRgbLgbsbLsbRgRsmbLcbLcbLiLsbRibRcbRcbRiRsmbLgbRcbRibRgbRsbRgbRgbL
sbLjbLhbRgbRsbLcbRgbLibLcRsbLoRsbLebRjRsmbRcbRcbRhbRjRgbRsbRjRsmbsbLsb
RibRibRcbRhRsLsmbLjLsLsmmbLhbLebLcbRjbRjRsmbRcbRibLjbRhbRibRibRsRibRib
RibLjLsmbLsLsmbLsRsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bLcbLobRobLsbRhbRobRibsbLsbsbRsbRgbRsRsmbRsbRsLsbRcbLsbsbRcbLjLgbRsbsb
LcbRsLsbLcbRsLhbRjbRjLsbRjbRjbLjbsbLhbRebLjLsmbRgbLiRsbLsbLsbRgLsbRibR
gbLhLsbLsbRsbLsbRsbRgbRiRsmbRibLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bLsbLsbsbsbRsbRsbRgLsLsmbsbLgbsbsbLsbRsbLsLsmbLgbLgbLsbLgbLsbLsbRsbsbL
sLsmbsbLgbLsbRsbRsbLiLsbRsLsbLsbLsbRsbLcRsbsbsbLgbRobLhbRcbRjbRhbLsbRg
bLibRsRsmbLgLsbRgRsmbRgbsbLibLgbLhbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bRsbsbRsbsbRsbRsbRjbLsRsbsbRebRsbRsbsbLcLsRcmbRcbRcbRcbRiRsmbRsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLcbLibLgbLsRsbRhbLgbLibLcbLgLsbLgbsbLibRibLsbLgLsRsbLiLsbRsbLibLsbLhb
RsbLibRgbsbRjbLcbLgbLibLibLsLibRibLsbRibLgbRcLsbsbLgbLibLhbLjbLibLgbLs
bLgbLibLcbLsbLcLsmbRcRsmbLsbLiRsbLgbLgbRgbRcbLhbLibRsbLgbLsbLsbLsbLibL
sLsmbLgbLsbLcRsRsmbRhbRsLsbLibRcbLgbLibLsbLsbRjbLhbRjbLiLsbLgbLsbLgbLs
LsmbRebsbRibLhbLcLsmbLiRsbLhbLhbLcbRcRcbLjbLcbLiRsbLiRsbsbLibLgbRsbLgL
sbRcbLcbRsbRcbLhbLjbRgbLgbLjbLgbLcbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bRsbLiRsbLsbRibRhbRibRcLsbRcbRcbLjbRobRgbRcbLgbRibRibRgbRibLsbRibRibLs
bRjbRgLsbsbLjbRhbRgbLjbRibLsbRiLsbRgbRgbLsbRibRibRibRcbRgbRsbRgbRibRib
LjbRcbRgRsmbRjbRobRibRibRibRjLsbRibRibLcbLobRjbRcRsmbRiRsmbRibLibLgLsb
LibLgbLibRsRsmbRsbLobRgbRhbLjbRgbRhbLhbRibRcbLjbLoLhbRjbLsLoLsmbRgbLsb
RsRebRhbRcbRibRibRjbRgbRsbLsbLgbLsbRgbRgbRgbRiLsbRibLgbLgbRgbRsbRjbRib
RcbRibRsbRibRgRsmbRibLgbRgbRgLsbRobLgbRhbRibRibRgbLibRibLcbRibRgbLibRh
LsbLcbRhbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bLsLsmbLgbLgLsbRgbsbsbLibRhbLsLsmbLibLsbLsbLsLsmbRjbLcLsmbsbLgbLsRsbRj
bRsRsmbLibsbRgRsmbLgbRsbLsbLsbRgRsmbsbsbsbsbRsbLsbsbLibRjbRebLjbLjbLiL
sbLsLsRsmbRcbRcbLgbRcbLsbLgbRibLsbLsbLsbLsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 25; Drug: Control Apo 0.5 然
bRiLsLsmbRhbLgbsbsbRsbRhbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 26; Drug: Control Apo 0.5 然
bRgbRsRsLsmbRsRsRgRsmmbRgbRiLsbRiRsmbRiRsmbsbsbsbLibRsbRsbLibsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 27; Drug: Control Apo 0.5 然
bLjLsmbRhbLcbRcRsmbLjbReRsmbRcbRcbRobRcbsbRcbRcbRsbRobRiLsbLsbLhbsbLcb
LcbLcbLcbLibLobRobRcRsmbRoRsmbRobRobLibLhbLcbLcbRobRjbRoRsmbLcbRsbLcbL
hbLsbRcbsbLgbLsbRcbLjbRjbRcRsmbRobRobLjLsmbLobLcbLjLsLsmmbLsbLgbRcbRob
RoLsbRcRsmbRobRobRcbLibRsbRjbLjbRcbLcRsbLibRhRsmbLsbLsbLgbLebLob

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 28; Drug: Control Apo 0.5 然
bLibLibRcbsbLsbLcLsmbLibLcbLcbLibLiRsRsmbLgbRibLgbLibRcbRcbLibLsLsmbRc
bRcbRcbLiRsbLjbLcbLibLibLgbRcbsbRhbRsbRcbRcbLiRsbRcbLgbLsbLcbLcbLhRsbR
gbLsbLgbRjRsmbLobRsbRcbLibLoLsmbLjbLibLgbLgbLsbRhbLibRibLsbRjbLgbLibsb
RcbLiLsbLjbLcbLcbLcRsbLgbLiRsLsbRhbRcbRgbLhbLibLsbLsbRcbRebLhbRsbLiLsb
LsLsmbLibLgRsbLibRhRsmbRibLsbRhbLobRiRsmbLibLsbLgbLsLsmbsbLgbLibLibLsb
LsbLhbsbLiRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 29; Drug: Control Apo 0.5 然
bsbRhbLsbLsbRcbLobLsbRibLsbRsRsmbRsbRsLsbRcbsbLcRsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 30; Drug: Control Apo 0.5 然
bLibLcbsbRibLgbRcbsbRjLsbRobLsbRobRgbLjbRsRoLsbLgbLhbLcbLibLibLsLsmbRc
bLibLcbLcbLcbLiLsbLhbLgbLhbLhbLcbRgbLibLobLcbLhLsbLgLsbLjbLcbLjbLgbLeb
LjbLcbsbLjRsbLjRsbLsbLibLibRsbsbRcbLibLibsbLcbsbsbRobLcbsbRgbLcbsbLjbL
cbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bsbRsbRgbsbsbsbLgLsbsbRgRsmbRsbsbRsRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bsbsbRgbLsRsbRjbRsbLsLsRsRsRsmmmbRsLsbLsbLgbsbRsLsRsbLsbsbLsRsbLsbRsbR
sbRsRsmbsbsbsbsbsbsbsbsbsbRsRsmbRsbsbsbRsbsbLsbsbsbRsbLsbsbLsbsbLsbRsb
sbsbRsLsbsbRsbLsbLsbsbLsbsbsbsbsbsbsbsbRsbRobLiRsbRibRjbLsbsbsbsbRsbsb
LsLsmbRsRsmbsbRobsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbRsbLsbsbsbsbL
sbRsbsbsbLsbsbsbRsbRsbLsbRsLsbRsbsbLsbRsbsbsbsbLsLsmbLsRsbsbLsbsbsbsbs
bsbsbsbsbsbLsbsbLsbsbsbLsbRsbsbsbLsLsmbsbRsbLsbsbsbsbRsbRsLsRsLsbsbRsR
smbsbsbsbRsLsRsbsbsbRsRsmbsbsbLsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bLebLsbLibRcbLebRobLibLebRebLebRobLobLobRcbLibLcbRebRebLebRibLebLibLeb
RcbLcbRobLibLcbRcbRgbRcbRebLgbLebLobLobLibRhbLcbLcbRobRcbRebLibLebLcbR
cbRsbRebLcbLibRgbLcbLcbRobRobLsbRebLcbRebLgbLobLobRebLobLibLobLebLobLe
bLsbLcbLobRsbRibLobRebRcbLobLebRcbLebLgbRobLcbRobRibRobRobRsbRibLcbLob
RobLcbRgbLobRcbLjbRobLobRsbRsbRcbRgbRobRebLebRibLobRobRjbRebRebLobLobL
cbLobRebRcbRebRobRobLobLobRobRebLobLobRobRobRobRebLcbRobLobLebLobRibLo
bRibRebLebRibRcbRcbLebRibRobRobRobLcbLsbLcbLgbLebRebRcbRobLebLobLobReb
RebLobLebLobRcbRcbRgbRobRibLobLobLebLobRobLcbLobLobLobRobLobLebRobLebR
cbLebRcbRobRobLhbRcbRobLobRebRebRobLhbLebLobLcbRobRobRebLebRibRobLcbRo
bLobRobRobRobRgbRebLgbRobRgbLobLcbLobLebRobLobLobLebLibLebRcbRhbLibRob
LobLobRobRobLcbRebRgbRobLcbRobLgbLebRcbLobLgbLebLcbRobRobLcbLebRobLsbL
ebRobRobLcbRebRobRobRibLibRobRobLobLcbRobLobRobRobLobLebLobRobRcbRobRe
bLebRebRibRsbLgbLibRobRobRobRcbRebRibLobRobRsbLcbRgbRobRobRobRobRibReb
LibLcbLibLobLcbLcbLibRebRibRebLobLgbLobLobLobRibLobRebRcbLibRhbLcbRobR
obRcbLebRgbRebRobLobLibLobRobLcbLobRebLobRibRebRebRebLcbLebRobRebRibRo
bRebLcbRebLebLsbLobLibLgbRcbLebRebLebRebRhbRibRsbRsbLebRobLcbLibLhbLob
RobRcbLcbLebLebRcbRsbLobRibRobRgbLebLebRebRcbLsbLebLobLibLebLsbLcbLjbL
gbLibLibLcbRcbRobLsbRsbRobLobLhbRobLcbRobLcbLobLobRebRobRcbRcbLcbRebRi
bRgbRcbLobRsbRebLobRobLobRobLgbRobLsbLibLibRcbLgbLebLobRebRgbRebLsbRob
RgbRcbRcbRebRebLibLobRobLobRobLsbLebRebLcbRobLebRgbRobLobLobLobLobRobL
ibLebLebLgbRebLobLhbLobLobRobRsbLcbRebLobRobLcbLsbRgbRhbRebRobLebLebLo
bRcbLebLcbLobLibLobLcbLobRobLobLibRcbRobLebRobLobRobLobRcbLobRebRobRob
LebLcbRebRobRobLobRcbLebRcbLobLebRebLobRobRobLobRcbLcbRcbLibLibLcbRobL
ebLebLcbLobRebLgbLebRcbRgbLgbRobRobRobLobRcbLebLobLibRibLcbLobLobLcbRe
bLcbLebRobLobLcbLcbRobLcbLobLobRebLebLobRebLobRgbRebRobLcbRgbLobRebLob
LibLobRgbRhbRibRebLcbRcbLcbRobLgbLobLcbRcbLebLobLobRcbLobLcbLhbLcbLhbR
gbLgbLcbLobLobLibLobLobRibRobLobRobRebRobLobRobLobLcbRcbLebRcbLebLibLc
bLobRobRhbLobRobLebRebRcbLobLobRibRibLobLgbLibRebRebRobRgbLhbLebLcbLob
RebLcbRebRobLobRebLsbRobRobLibLobRcbRobLcbRebRcbRcbRebLobLsbLobLcbLibR
gbLebRgbLebLobRsbRebRhbLcbRobRibRebLobLibRobLobLibRobRebRobRibRobRcbRe
bLobLgbLebRcbLgbRgbLsbLhbLibRibLobRebLgbRobLobRibLobLebLobLobLobRobRob
RebLcbRgbLobRebLebLebRobLobRebLgbLobLobRhbRobRobRobLibLebRobLebRcbRobR
obLobRcbLobRobLsbLibLobRobRebLebLebRobRcbLebLibLobLcbLibRobRebLsbLcbRe
bLcbLobRgbRebRobLgbRebLobLobRobLcbLebLcbLobRebLobLibRcbLebRobRobLebRob
LibLebRebRcbRobRibRobRebLebLcbLebLobRobRhbLcbLobLobLgbRobRcbRobRibRsbR
cbLhbRobLebRobLobRobRcbRobRgbRobLebRobLcbRsbLcbRobRebRobRobRobLibRebRo
bRobLhbRobRgbRgbRsbLcbRobLobRobRcbLebRobLobLobLebRebLgbRebLibRobRcbLob
LcbLcbLgbLobLgbLobRcbLcbLgbRebRcbRgbLebLgbLobRobRobRcbRebRebLebRibRibR
hbLobRcbRobLibLcbLcbLobRebRcbRebLobLgbRibLebRebLobLobLebRebLsbRgbRgbLo
bLebLobLobLcbLhbLebRgbRebLobLsbLobLebRsbRobLobRobLobRgbLobLibLobLcbLeb
RcbLobRobLobRcbLobRobRibRibLobLibRobLobLibLcbRcbRobLhbLgbLcbRobLobLobL
ebRobLcbRibRobLobLcbRebLgbLebRobRgbRcbRibRgbRebRhbRebLcbLhbLibLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bRibLcbLgbRcbRibRibRibLibLsbRsbRcRsmbRjbRcbLcbRcbLebLsbLsbLhbsbRebRsRh
bLhbRhbLsbLsbRsbRibLsbRjLsbRcbLhbRgbLsbRsbRhbRjbLhbRibsbRibLcbRibLibLs
bLsbRjbLebRgbRcbRhbLiRsbRjbLibLgbRibRibLgbLebLhLsbLobsbLebRibLgbRcRsRs
mmbRcbLjbRibRcbLjbRhbRjRsmbRibLibRjbLobLjLsmbRjRsmbLhbLcbRiRsmbRgbRhbL
ebLcLsmbRjbLcbLobRhbRsRsmbLsbRcbRibLsLsmbRsbRhbRgRsmbLcbLobRhbLcbRibRj
bRcbRsbLsbRjbRhbLsbLgbLgbRsbLsbLgbLgRsbRhbRcbRcbRibRibReLsbLobRsLsbRgb
LibLgbLgLsbLgLsbRibLsbRjbLcbLibRjbRjbLcbLcbLjLsmbRjRsRsmmbLobLjbRjbLsL
smbRjbRcbRhRsmbRcbLsbRjbRcLsbLsLsmbLjbRhbLobLsbLsbLjbRebRgbRsbRsbRibLc
bLibLcbRjbsbRibRcbRhbLsbLibRhbLcbRcbLcbLgbRsbRibRgbLsbLsbLhbRgbRjbLcbL
cb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bLjbLgbLsbRcbRsbLsLsmbRjRcbRibsbRgbRiRsmbRsbLsbLjLsmbRgbRsbsbRgbRibRgR
smbLgLsbsbRjRsmbRsbsbRgbRsbRhbRgRsLsmbLsbLsbLsbRgbLsLsmbLjbLsbsbLsLsmb
LsbRsbRjbRhbsbLsbRebRgbRsbRgbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bsbLsLsmbRsRsmbLsbsbLsbLsbsbRsbRsbRgbRgbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bLsbLibRgbRsbLibLibLibLgRsLsbRoRsmbLcbRcRsmbLjbLcbsbRibLcbLibLcbLebLcb
LjbLhbRcbRibLjbLcbLibLibLsbLcbLsbLibRgLsbLebLcbLhLsbLiLsbLiLsbLgbLcbLc
bRsRibLjbLiLsbLsbLiLsLsmbRsbsbsbsbLsbRsbRobRsbRsbRgbRsbLsbRgbRiRsmbLsR
sbRgbRsRsmbRgbRgbRsbRgbRsbRgbRgbRiRsmbRibRcbLcbLcbRgbLhRsbRibLjbLibLcb
LcbLcRsbRibRgbLcbLcRsbRcbLobLhbLiRsbLsbLibLibLgbRjRsmbRjbLcbRhbLobLcbR
sbLibLsbLhbRjbLhRsbRgbLiLsbLsbLibLsbLcbRsbRcRsLsmbRibLgbRcRsmbLibsbRgb
LibLsRsbRjbRhbLhbLcRsbLcRsLsbLibLibRibRgbRsbRsbRiRsmbRibLjbRebRgbRcbLc
bLgbLcbLibLibLibLsbLibRsbLiLsbLsLsmbRsbLcbLcbLhbLcbRgbLiRsbLcbRobRibLs
bLsbRcRsmbLibRhbLjbsbRcbRjbLcRsRsmbRgbLobLcbLcbRjbLgbLhbLibRjbLcbRcbsb
RiLsbLgbLhbRcbRiLsbRcbLiLsbRsbsbLcbLsbLgbLiLsLsmbLibRgbLcbsbLcbLsbLiLs
bLsbRgbRjRsmbRcbRiLsbRsbLibLsbRibRgbLcbLibRsbLibLoRsbLobLhbLcLsmbLobsb
RjbLcbLibLsLhbsbLobLsLsmbLiRsbRsbLhRsbLsLgbLgbLobLcLsmbLibLhbRsbLibRib
LsRcbRoLsbRcLsbLhLsbLsbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bLibLgbLibLcbLcLsmbRjRsmbLobLgRsbLgbRsbLeRsRsLsmbLhLsbLgbsbLsbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bRcRsmbLibLjbLobLobLgbLgbRsbRcbRjbRcLsbsbRsbRcbLebLoRsbRjbLcbLhbRsbRhb
RsbLcRsbRhbLcLsmbLcbRibLibLjRsbRsbRsbLgLsbRsLsbLcbRcbRibsbLcbLibRjbRjb
LoLsmbsbRebRobRcLsbLhbLgbLhbLcbLoRsbRcbRgbRcbRhbLsbLjRsbRcbRcbRgLsbLib
RjbRjbRcbRcRsLsmbLsbRibLibRibRhbRibRebRebRibRgbLjRsbLjbLiLsbLgbLgbLibL
sbRgbLcbLgbLgbLgLsbRsLsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bRsbLsbRsbRibRibLebLcbLsbRsbRsbRsbLsbRsbLsbRsbRsbRsbRsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bRibRsbRebRsbRgbLobRcbRebRebLebLcbLgbRgRsmbLhLsbLgbRsbLgbLibLibLebRgbL
ibLsbLgbLiLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bLgbRsRsmbRsbRibRsRsmbRgbLsLsLsmmbRsbRgbLsLsmbRsbRgbRgbRgbRgbRsbLsbLsb
RgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
bRgbRgbRgbRibRoLsbsbRibsbsbLibsbLjbLjbRsbLgRsbRcbsbRhLsbRhbRgbRibLsbRj
bRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bRgbLjbLibLcbLgbLcbRcbRcbLobRebRibLgRsbLjbLobsbLhbsbLibLibLcbRgbLcbRsb
LebRiRsmbsbLcbRobRgbRhbLiLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bLgbLoRsbRobRsbRhbLobLobRsbLobLoRsbLhb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bLjbLsLsmbLibRibLibRgbLibsbsbRgRsmbLiLsbLibLhbRibRgRsmbLibLsbLjLsLsmmb
LgbLgbRsbLgbLgbLibLjLsRsRsmmbLiLsbLibRgbLsLsmbLjbsbsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bLsbLibLgbRsLsbsbLgbRsbRsRsmbLgbRsRsLsLsRsmmbsbsbLgbRsRsRsLsLsmmmbLsbL
gbRsRsmbRsLsbLjbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125219; End: 125719;
Recording: 2-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bRibLjLsmbRhbLjRsbLgbsbRsbsbsbsbsbsbsbsbRjbLcbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 1; Drug: Control Apo 0.5 然
bLibLibRibLhbLibLibLibLsbLsLsmbRibLebRjbLsbLibRcbRgbRibRgbLgLsbsbRgbRc
bsbRsLsbLsbRsbLcbLjbLibLibRibLsLsmbsbRibLsbRjLsbRgbRgbRsbLsbRhbsbRcbRs
bRibLcbLcbLgbRcbLjbRcbRgbLjLsmbRibLsbLsLsmbLsLsmbLebRgbLibRgbLibLsLsmb
LhbRibRjbLjbLibLsbsbLiLsbRsRsmbLsbLsLsmbLsbLibLsbRoRsmbLgRsLsbLcLsmbRc
bLsbLsbRsbLsbRcbLiLsbRgbLsLsmbLgbLsbRsbLcbRibsbLibRgbLsLsLsmmbLhbLcbRc
LsbRiLsbLibLcbLobLhbRibLgbLibLsLsRsmbLsLsmbRsbLgbRsbLibRibRsbLhbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 2; Drug: Control Apo 0.5 然
bRgRsmbRgbRsbLcbLsbRgbRibRiLsbRsbsbRgbRsbLcbRgLsbLiLsbLibLgbLgbLsLsmbR
gRsmbLsbsbLsbLgbLsbLsbLibRgbLsbLibLsbLhbLsbLsbLjRsbLibsbsbLgLsbRiRsmbL
gbsbLgLsRsbLsbLibLoLsmbRhRsRsmmbLsbRgbRgbRsbLgLobLsbsbLsRsbsbsbLhbLgbL
jbRibLsbRsbLiLsbLsbLibLibLsbRgbRsRsmbRgRsmbRibRgRsmbLsbLcbRcbLebRsbsbR
sRjRsmbsbLibsbsbLgbLsbLhbRgbLibLsbLgbRjbLibLsbLibsbLhLsbLsbLsbRibLsbRs
bLibLjbRgbLibLsbsbsbsbLsbLcRsbRiRsmbLsbLibRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 3; Drug: Control Apo 0.5 然
bRjRsRsmmbLsLsmbsbRsbsbsbRgbsbLjbRibRsLsbRiRsmbRsRsmbRsRsmbRcbsbsbsbLg
LsbLsbRsLsbRjbLcbRgbRsbLsbRibLgbRgLsbLsbRsbLgbRjbRgbRsRsmbRsbRiRsmbRhb
RibLgbRgbsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 4; Drug: Control Apo 0.5 然
bRibRgbLsbLcbRebLjbsbLsRiRsmbRsbLebRibRgbRgbRgbLsbsbRsRgbLgbLgbLgbLgbs
bLgbRjRsmbRsbRgbRgbLsRgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 5; Drug: Control Apo 0.5 然
bRsbRibRsRsmbLsbRsbRsbLsbRjRsmbRhbRsbRibLibRsbRgRsRsmmbLjbLibRcbRhbRsb
RsbRibLjbsbLsbRebRebRibLiLsbLibLebLibLgbLsbLsbLsLsmbLsbLgRgbLgbsbLibLg
bLibRgbRobRibLibLjbRibRsbLcbRgRsmbLjbRcbRsbRiRsmbRsbLgbRibLsbRsbsbRhbR
sbRsbRibLibRsbRsbRibRgRsmbRsRsmbRsbRsbLgbRsbRgRsmbRgbRibLsbLgbLsbLsbLs
LsLsmmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 6; Drug: Control Apo 0.5 然
bLibLhbLibLibLjLsmbLgRsbRibLgbLgbLgbLcbLcLsmbLgbLiLsbRobRhLsbsbLgbRoLs
bRsbLsbRobLibsbRsbRgbRsbLcbRhRsmbRjbLobLsbRiLsbLebLebLgbLsRsbRsbRsbLjb
RjRsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bLcbLsbLgbLiLsbRsbLibRjbLibRjbLsbRsbLgbLjbLibRjbLjRsbRibRjbLgLsbLgbRgb
LsbRibLjbRibRsbsbLebLsbRsbLsRsbRsbRibRibRgbRsbRsRsmbRgbLgRsbRsbsbsbLcb
RibRibLjbLjbRsLhbLibLjbLsbRgbLibRsbLgbLsRsbLibLiRsbLhbRoLsbRibLgbLjbRj
bLjbsbLjbsbRsRjbRhRsmbLgbLgbRebRjRgLsbRsbLebLsLsmbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bRcbRjRsmbLcLsmbRjbRhbLibRhbRibRebRcbRcbRjbLsRobRjbRjbRjbLobLobsbLobLg
bRsbRibLibRsbRsbRsbRsRsmbLebsbRjRgbLjbsbLebLibLjbLibsbRibRcRsmbLsLsmbR
ebRobRibLjbRjbLibLsRsRsmbRjbLcbRcbRjbLcbLcbLcbLcLsmbLjLsmbLsLgbLebRcRs
mbRjbRibsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bRhLsbLjbRiLsbRcbLibsbRibLobRsbLsbLibRcbLgbRcRsmbLjLsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bLibLhbsbRsbRibRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bRgbLsbsbRgbLcRsRsmbRgbLoLsmbRsbLcLsmbLhbLsbLibLsbsbLibRsLsbLibRsLsbRs
Lib

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bRsbsbLcbsbRibLibsbsbLibRibsbLgbRobRsbRgLsbsbRcbRibRsRsmbRibRgbRsbRcbR
ibRhbRcLsbRsbLibRjbsbRcbRibRcbRobRsbRibRobLhbRcbRsbLiLsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bRobRjRsmbRsRsmbRcbLsLsmbRsbRibRsbRibRgbLgbLgbLsbRibRjRsLsmbRgbsbLgbRc
bLsbRsbsbRiLsbLebRjbRcRsLsmbRjbLsbRgRsmbLjbLcbRjbLsbLsbRsLjbRjbsbsbRgb
LsbRsLsbRsbLsbRsRsmbRsbsbsbsbsbsbsbsbLsbsbLsbsbRsbLsbLgbLsbLsLsmbRsbRg
RsmbLsbRsbRcLsbRgbRsbRsbRsbLoRsbRgRhbRcbsbRhbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bLibRcbRoLsRsbLgbLgbRiRsmbRgLsRsbRibLgbRibLebRcbLjbLibRsbRsbLibRsbLgLs
bLcbLsbLiLsbRcbLoRsbRjbLebRobRgbLhbLobRibRgLsbRebRoRsmbLgbRiRsLsmbLibR
jRsLsRsmbRgbRobLibLsbRgbLsRsbRgbRgbLsbRiRsRsmmbLobRcbRhbLjbLobLibLsbRj
bLhbLibRibLsbRjbRobLjLsLsmmbRgbsbRibRgbLsLsmbRsbRgbLjbRobLibRobRibRgbL
sbsbsbLcbRgRsmbLcbLcbsbRcbLgLsLsmbRjbLcbRibLcbLibRibLgbLhbRibLibRibRgR
smbLsbRiRsmbRgbRgLsbLgRsbLcbRjbRoLsbLibRcbRhbRibRsbRgbsbRibRibLhbRsbRs
bLibLgbLcbRiRsmbLjbLibLibRibRibRjRsmbLgRsbLibLsbRhRsmbLgLsbRsRsmbLsLjL
smbLiLsbRsbsbRsbLjbRgbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLsRsbLgbLsbLoRsbLsbLsbLjbRsbRebRjbLebRsbRsbLsbRgbLobLebLgbLsbLibLc
bsbLiRsbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bLibLsbRsbLgbLgbRcbRcbRsbLsbRsLsbRsbLobLsLsmbLhRsLsbRsRsmbRiLsbLjbLibR
sbsbRsbLsRebLjbsbsbRsRsRsmmbLgRsbLiRsbLobLgbRsbRcbRibRgbLgbRgbLjbLhbLs
bLsbLsLsmbRsRsLsmbLsbLgRsbLgbRgbLsbLsLsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bRgbLobLgRsbLcbLiLsbLjbRgbLgbLibLgbRsbLgbRsbRgbLgbsbLsbLsbRsLsRsLsRsbR
sRsmbRsbsbRsbLsRsbsbRsbRsbsbLsLsLsmmbsbLsbRsLsbRsbRsbsbsbsbsbsbRsbRebL
hbRgbRsbRcbRibsbsbsbsbsbsbsbRgRsRsmmbLsbLsbsbLsRsbLsRsbRsbLsbRsbsbLibR
sbLjbLcbLgbRgbLgLsbLsLsmbLgbRsbLsbLsbLsbRgbRebLiRsbLibLobRsbRgbRibRsbL
jLsLsLsmmmbsbRjbRsbsbLsbRsLsRsbLsbLsbLsbLsbRsbRsLsbRsbRsRsLsmbRsbLsbRs
bLsRsbRsbLsbRsbRgbRsbRsRsmbRsbLsbLsbRsbRsbLsbsbLgLsbRgbLhbRgbLgbLgbRsb
sbsbLsRsbLsbRsbsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bLsRsbRgbRjbRibRibLjbLcbRjbRjRsmbRcbRibRgRsmbLsbLcRsbRsbRiRsmbRsbRibsb
sbsbRsbRsbLsbRgRsmbsbsbRsRgbLhLsbRsRsRsmmbLgbRsbRjbsbRjbRebRibRcbRsLsb
RcbRjRsmbRgRsRsmmbRsRsmbRgbsbRjRjRsmbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bLsbRibLjbLibLjbRiRsmbLobRibLjbRjbsbRsLsbRsbRjbLjbRjbRsbLibRibRgbLcbLo
bLjbRcbLebLgbLgLsbRobLhbLibLsbLgRsbRsbRhLsbLsbLiRsbRsbRsbRsRsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bLsbLsbLsRsbRsbRsbsbLsLsmbRibLgLsbRsRsmbLcbRjbLebsbLsbLsRsRsmbLsLsmbRs
LsbRsbLsRsRsmbRsLsbRsbsbsbLgbRsbLgbLsbRjbRcbRsbLsbLsLsmbLsLsRsRsmmbLsb
LsbLsRsRsmbRsbRsbRsbsbRsbLsRsbsbLsbLsbLsbLsbRsbLsLsmbRsbsbsbsbRsbsbLcb
LebLgLsbLsbLsbLsbLsbRcRsmbLcLsmbLibRsRgRsmbRsRsmbsbsbLsbsbsbsbLsbsbLsb
LsbRsRsmbLibLsbRgRsmbRsbLsLsmbRsRsmbLsbLsRsLsbLsRsLsbsbLgLsbLgbRgbLgbR
sbLoRsbRgbRcbRsbLsbsbLsLsmbRsbLsbLsbLsbLsbsbsbsbRsbsbsbsbLsbsbsbLsRsbs
bsbRsbsbsbRsbLsbsbsbsbRjbRobsbRgbRgbLsRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bRjbLgbLhbRibRcbRhLsbRsbLibsbLebLiLsbLgRsbRsbRsbRobRhbRibLsLsmbLgbRsbL
hRsbLcbLiRsbRsbRhbLgRsbRsbRobRiLsbLibRsRsmbRgbRcLsbRsbRibRiRsmbRsRsmbL
gRsbLsbLjLsmbLibsbLsbRgRsmbRsbLcLsmbLcbLoRsbRsRsmbRjbRibLgRsbsbRsRsRsm
mbRcbRsbLibLcbLiRsbLibRhbRsbRsbLcbRibRjbRcbLjbLibLibRgbLibLgRsbRjbLgRs
bLsLibLibRsbLsbRsbLgbLgbLsRsbLgbLiRsbLcRsbRsbRibLsbLsRsbRibRhLsbLibRcb
RhbLjbLcbRsbRobRcbRibLsbRgbLsbRsbLsLsLsmmbRjbRibRibRibRsbLhLsbRibLcbLs
RjbRcbRobRibLsbRcbRgbRhbRsbLsLsmbRiLsbLsbRsbRgbRsbRgbRsbRgbRgbRgbRsbRs
bRibLsbRgbLobRhbLcbsbLibLhbLibRhbRibLsbLcbRsbLibLgbRsbRgbLibRsbReRsmbR
hbRgbRsbRgbRibRsbRibLgbLsbRibRibRhbRibLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLjLsmbLgbLjbLsbLcbLhbLibLgbRsbRiRsmbsbLsbRibLcRsbLoRgbLibLhRsbLgbLibL
gbLiLsbLgbRibLhbRgbLibLgLsbLgbLgbRsbRibLibLgbRsbLibLsbLgbRsbLgbRibLibL
cbLgbLibLibLgbLsbLibLsbRhbLibsbsbRebRobLiRsbsbLjbLhbRsbLjbLcbLibRsbLjb
LcbLobLibLgRsbLcbLgbRjbRcbLjbRobLgbRsLsbLcbLhbLiRsbLhLsbRsbRgbRsbLgbRs
bRhbLjbLibLgbLhbLibRibRsbLgbLgbLsbRjbRcRsmbRsRcbLsRsbRiRsmbLsbLibRjbRc
bLjbLcbLiRsbRibLgbsbLiRsbLsbRibLgbsbsbLgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bsbLcbLsbsbRibsbRjRsmbsbLibsbRsRsLsmbRsbLobRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bLsbsbsbRsRsmbRsbLsRsbLibLsbsbRsbLsbLsbLiLsbLgbLsRsbRsbLiLsbRsbRsbRgbL
jbRsbRsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 25; Drug: Control Apo 0.5 然
bRoLsbRjbLibRcbRibRcbRsbLsbLgbRsbRobRsRsLsmbRsLsbRibRebLgbRibRsbRjbRhb
RjbRgbLsbLjbLjbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 26; Drug: Control Apo 0.5 然
bLsbRsbsbsbRsbLsRsbRsbLsbLsLsmbLsbRsbRsbLsbRsbLsbRsLsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 27; Drug: Control Apo 0.5 然
bLcbsbLcbLgbLjbLcbLcbLjbLebLjRsbLhRsbRcLsbLibLhLsbLsbLcbLcbLjbLcbLjbRe
bLoLsmbLibLgbRcbLcLsmbLcbLgbLiLsLsmbLgbLgbLgbLgbLsbLgLgbLobsbLoLsmbLib
LibRob

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 28; Drug: Control Apo 0.5 然
bLibLgbRjbLhbLibLibLebLcLsmbLiLsLsmbLsbLiRsbLsLsmbLgbLibLibLgbLiLsbLib
LibLibLsbLgbLgbLebLibLibRjbLjbLjbLiRsbsbLiRsbLibLiRsbLgbLsbLcLsmbLsbLj
RsbLsbLiLsbLibLibLsbLebLhbLcbLjLsmbLibLjbLcbLiLsbLibLibLibLhbRibLjbLib
LhbRcbLjbLjbRoLsbRibsbRebRcbRcbLhbRibLcbsbLiLsLsmbLhbLsLsmbLsbLcLsmbLe
bLibLcbRsRsRsmmbRgbLcbLcRsbRgRsmbRgbLiLsbLsbLibLibRsbLcRsbLiLsbLiRsbLc
bLgbLibLjbRgbRgbLhbLibLgbLhbRcRsmbsbLjbsbLhbRjbLcRsLsLsmbRjbLcbLgLsbLi
bRsbRibLsbLjRsbRsbRsLsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 29; Drug: Control Apo 0.5 然
bsbsbsbLiRsLsbLsbRhbLsbLgbRgLsbsbLsbRgbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 30; Drug: Control Apo 0.5 然
bLibLhbRcbsbRcbLcbRcbLcbRoLsbLcbLgbRcbLcLsmbRcbRgbLcbLcbLhbLsbLjbLibLg
bsbLjbRgbRsbLibLjbLibLjbRsbLcbRsRsmbLhLsbLibLobLibLibLhbLsRsbLjbLjbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bLsbsbsbLcbLjbsbRsbsbsbLsbRgRsmbsbsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bLjbRsRsmbLsbRsbRjbLsRsbLcbRiRsmbRjbRhbRcbRhbLibLgbLgbRsbRgbRoRsmbRiRs
mbLgbLiLsLsmbLibRgbLgbRobLgbRcbRhRsmbRibLgbLibRebRcbLsbRgbRibRcbRhbRcb
LjbRcbLibRcRsmbRcbRibRcbLjLsLsmmbRjbRgRsmbLjbLobRoLsbLiLsbLsbLgbLgRsRs
LsmbRsbLibLsbLgbLsLsmbLibLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bRebLcbLcbRebRhbRcbRebLcbLibLobRibLsbRebLobRebRobLcbRobRjbRibLobLebReb
LobRobLobLgbLobLibRobLsbLebLobRobLibRobLcbRobRobLobRebRobRibLobLobRcbR
cbLcbLobLsbRibRgbLebLcbRobLebLcbRobLsbLobLsbRebLibLebRobRhbRebRhbLcbLo
bLebLebRobRebRebRebRebRobLobRibRebLcbRebRobLebLobLebRobLcbLcbRibLobLeb
RobLibLobRobLobRobLobLebLebRibLebRobRgbRgbLgbRebLebLebRcbLobRibRebRcbR
cbRibRcbLebRobRobLobRobLobLobLebRebRobLcbRebRebRcbLobLobLibLcbLobRobLo
bLebLobRebRhbLobLobLobRgbRcbRobLebLebRobLebRobLobRcbLcbLibRgbLobRebLeb
LgbRebLcbRobLebRebRobRcbLebRcbLcbRobLobLebRobRcbLcbRobRobLibRibRsbRebL
ebRibLobRgbRgbRcbLebLsbRebLsbLobRhbLgbLobLebRsbRobRobRhbRibRibRhbRobLc
bLobRgbLebRebLobLebRgbLobLobRibRibRsbLebRobRcbRebRgbLgbRibRsbRobLobReb
RebLcbRebLobLobLcbLobRgbLebRebLobRobLobLcbLobRebRibRcbLcbLobLhbRebLobR
cbRobLobRobLobLobLobLobRebRibRibLobRibLgbRebLibLobLebLebLsbLobLebLgbLo
bLebLcbRobLebLsbRobLibLcbLobLobRobLhbLibRebLobLcbRsbLobRobLebLibRsbLgb
LibRobRhbLcbLobRsbLcbLcbLebLobLcbLobRobLobLobRobRebLobLebLobRibRobLcbR
obRobRobLobLebRobRgbRebRebRibRobLhbRcbLgbLgbRobRcbRobLhbRcbLobRsbRobLg
bLcbLobLobLhbLsbLobRobRcbRibLebLobLsbLgbRobRobLcbRebRgbLebRobLobRobLcb
RobLibRobRebLobRebRebRobRobRcbRgbLibRcbLsbLobRobLobRebRobLgbLobLebRibL
obLsbRebLobLobLobRibRobLobLebLobRobLsbLobLibLcbRebRibRebLobLobRebRcbRc
bRobRgbLsbLibLebLobLebLobRobLcbRobLobRcbRobLebLcbRsbRobRcbLgbRobRobRob
LobRobLobRibRobRibLebRobRobRibLobLobRobLobRsbRcbRebLebRobLobLebRsbRibL
obRobRsbRobLobLgbRobLcbRcbRobLebLebLhbRebLebRebLebLcbRebLobRobLobRobRc
bLobLsbRobLobRcbRsbLcbLcbLobRsbRobRgbRobRgbRobRhbRobLebRgbLibLobLobLob
LibRebLobLibRebRcbLebLsbLibRcbRsbRobLcbRobRcbLebLobRgbRobRobLobRobLobL
obRobRobLobLobRebLobLebLebLobLcbLobLobLebLgbLobLobLibRcbLebLcbRobLcbLc
bRobRobRcbLobRjbRobRebLsbLebLobRibRcbRobRebLibLobRobLobLobRobLsbLebRhb
LobRebRobLebLebLobRobRobRsbLgbLebLobLobLebRobLibLibRobLobLobLobRobRobL
obRhbRsbLobLcbRobLebRebRobRobLibRobRsbLcbLibLobLcbRibLjbRobRobRobRebLe
bRobRcbRobLobLgbRcbRhbLcbLebLobLebLebLjbLebRobLcbLebLobLibLcbRcbLobRsb
RobLobLcbLsbLcbRsbRebLobRobRobRibRcbLebLobRibRobLebLobRebRgbRcbRobRcbL
obRobLibLobRsbLhbLobLebRebRebLobLobRobLgbRebLobRcbRgbLobLebRebRcbLcbLo
bRebLibLobRebRcbRobLebRobRgbLgbRobRobRobLcbRebRobRhbRebRebLebLhbRibLob
LsbLgbRgbRobLobLobRcbRcbRobRebLjbRcbLsbLobLgbRobRobRebLcbLsbRcbRgbLcbL
obLobLebLgbLcbRgbRobRobLebLebRcbRgbLibLobRjbLobRcbLobLobRobRcbLobRobLo
bRibLcbRebLcbLobLcbLobLobLobRebLobLobLcbRebLebLsbLcbLobLebRebLobRhbLeb
RebLcbLobRsbLibRgbLobRsbLebLobLebRobRobRebRgbRobLebLobLcbLobLobLcbRobR
obLobLebLsbRobRobRebRebLobLcbRobLibRobRgbRobRobLebRibRcbLobLobRsbLobRo
bRsbLobRobLobRobLcbRcbLobLobRobRobRebLobRobLhbLobLebRebLgbRhbLobRobLgb
LobRcbRebRebRebLibRcbRibLobRebLobLibRibRobLibLibLebLcbRebRobLsbLobRobR
obLcbRobLcbRebLgbLobRobRobRcbRebRsbRebRebLobRgbLobRcbRcbLsbRobRcbRobRo
bRebLcbRsbLcbLgbLobLcbRcbLobLibRobLcbRibRebRibLebRebLibRebLebRibRobLob
LgbLebRobLobLebLibRsbRobLcbRobLgbLobRobRcbRebRibRebLobLobLebLcbLebLobL
ibLgbRebRobRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bRsRsmbRibLiLsbRsbRjLsLsmbLcbRibLjbLcLsmbRcbRibLsbLjLcbRhRsmbsbRhbRcbR
ibRcbRhbLjbRhbLgLsbRsRsmbsbLcbLgLsbLsLsmbRcbRibLsbRsbLgbRhbsbsbLjbRcbR
iLsbLiRsbRsbRsbsbRjRsmbLsLsmbLgbRhbRcbRgbLibLsbLjbLjbRjbRsbRsbRsbLsbRg
bLcbsbLgbLibLsbRibRsbLjLsmbsbLsbLgbLgbLgbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bRgbsbsbsbRjRgbRsbRgbRibsbLsbRsbsbRgbRgbRgbRsbLsbLsbLsbRibLsbLgbRcRsLs
mbRibRsbRgbRgbRiRsmbRgbRibRsbsbLsbRcbRsbRibRcLsbRsRsmbRsbRibsbRgRsmbLs
bRgbRsbLsbRgbLsbRgRsmbRgbRsbRcbsbRsRsmbRgbRgbRsRhbRsbRibRsbRibRgbLsbRs
bRsbRsbRgbRgbsbRgLsbLsbRgbRsbLsbRsLsbRibLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bRsLsbLsbRsbLsbLsbLsbLsbLcbLsbRgbRibLsLsmbRsbRsbLsbRsRsmbLsbRsbRsbsbsb
RsbRobLibRobLgRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bRibLibRsRhRsmbLhbLjbLhLsbRjRgbRcbLjbLibLgbLsbLibLsbLibLsbLibLibLcbLcb
LjbLsbLibRsLsbLibLjRsbLgbLibLsbLsbRgbRgbRgbRgRsmbLsLsmbRsRsmbLhbLhbLob
LhbLiLsbLhbRgbLibLgbLgbRsbLgbLsLsmbLiRsbRgbLgbRsbLiLsbRsbLiLsbLsLsLsmm
bLsbsbLsLsmbLgLsbLsbLcbLcbLibLibLgbLgbRcbLiLsbLiLsbLibRgbLsbLibLsbLibL
gbLsbLsbLgbLcRsbLcbsbLjLsLsmmbLsbLhbLcbLobLhbLcbLcRsbLhbLibLgbLsbRsbLh
LsbLibLibLibRgRsmbLibLgbRsbLibLgbsbLhRsbLgbLcbLgbLibLiLsbLiRsbRjRsmbRg
bRsbLibRhbsbLjbLcbLgbLjbLibLjbLibLgbRibLibLgbLsbLibRsbRcbLiLsLsmbRobLs
bRhLsbLgbLgbRcbsbRgbLibLhbLgLsbRgbsbLibLsRsbLgbLgbLgbLsbLcRsbLibLibLsb
LgbRcbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLibLgbLgbLsbsbRibLibsbsbRsbLjLsmbRgbRsbLiLsbLibLgbsbLcRsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bLibLjLsmbLsRsbRibRebLibLgbLgbLibRjLsbRcbsbLibLjbLjbRgbLibLgbRsbLjRsbL
gbLgLsbsbLcRsbLjbRhbLsbLiRsbsbRibsbLcbRsbRebRjbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bsbLobsbRjRsmbsbRjLsbsbLiLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bLgbRgbLibsbLibsbLibRsbLibLibRsbRhbLjbLgbRsbRsbLibLcbRoLsbLgbLsbsbLjbR
iLsbLgbRibLibLjbLhbLobLgbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bRgbRsbsbRgbLgbRgbLobRobRsbRebRgRsmbRsbRsRsmbRgbRgbRsbLgbRgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bLiLsbsbLcRsLsbLhbLibLsbLjbRcRsmbRebRobLebLcbLgbRiRsRsmmbLsRsLsbRsRjbR
sRsmbLcbLcbRgbLibLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bsbRjLsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bLsRsbRsbLgbRsbLsbsbLgbLsRsbLsLsmbLsRsbRsbLjbsbsbLjbsbsbsbLibLiLsbLibL
sLsmbLeLsbLgbLjLsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bRiRgLsbRsRsmbsbLsbRibRsbRsbRsbRsbRsRsmbLsLsmbRsbRsLsbLebLsRsbRjbLsbRs
bRgbLsbRsbRsLsLsmbLsbLjbLsbLsbLjbRsbRjbLsLsmbRjbRsbRsbRsbLsRsbLsRsbLsb
RsbLsbLjbRsbRsbLsbLsbRsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 125721; End: 130221;
Recording: 3-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bsbRhbRhbLibRgbLgbRjRsmbRsbsbsbsbsbsbsbRsbRsLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 1; Drug: Control Apo 0.5 然
bRibLgbRsbRibRsLsbLjbsbLhLsLsmbRgbLjbLgbLgbLjbLcbLjbLcLsmbRjbLiRsbLsLj
bRcbRhRsmbLibLibsbRgRsmbLgbsbLibLjbLcbLsbLibLsbRjbLibRsbLcbLcbLeRsbRib
sbLibRjbRsLsLgbRgbLgbRcbLsbsbLgbRsbLgbRebLiLsbLsLsmbLibRgbLjLsmbRibRib
RcbRibLjbLibRsbRhbRgRsmbLibLibRgbRebRibLjbRsLsbLjbLibLgbLsbLibRsbRgbLs
bLgRsbRgbRsbsbsbRobLoLsmbLibRcbLjbRebRcbLgbLjbRsbsbLjLsmbLgbRcbRcbLgbR
ibLsbsbRsbsbRsRsmbLsbRiRsmbRsbLsbRsbRgbRsbsbsbsbRsbsbRsbsbsbsbRsbRsbLs
bsbsbLsbsbsbLibLgbLsLsRsmbLgLsRsRsmbLgbLibRjbLjRsbLiLsbLsbRobLhbLebLcb
LibLsbLsbRjbRibRibLsbRcLsbLjbRcRsmbLibsbReRsmbRiLsRsbLgbRcbLjbLjLsmbLs
LsmbLsLsmbRjbRcRsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 2; Drug: Control Apo 0.5 然
bLibRjbLgbRibRiRsmbLgbRhbLjbsbsbLibLgRsbRjbRjbLibRgRsmbLibLibRgbLibRib
RjbLebLsLsmbLibLgLcLsmbRgbLsRsbLgbLsLsmbRibRsbRsRsmbRjRsRsmmbsbLgbsbLj
bRibLebRhbRiRsmbLgLsbRsbRsbRgbRibLibRgbsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 3; Drug: Control Apo 0.5 然
bLsRsbRobRibRibRibsbRobRcbRsRsmbRibsbRhLsbLobsbRgbRcbLgbRjbsbLobReLsRs
bRibRjbRoRsmbRcRsmbLsbRebLcbLcbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 4; Drug: Control Apo 0.5 然
bRsbLsLsmbRgbRibRsbLsLsLsmmbLsbLsbLiRsbRcbRjbRibLsbsbRiRsmbLsbRgbRgbRg
bRsbLsbLsbRibLsbRibRgbLsbLsbRgbRsRsmbRiRsmbRibRibRsbRiRsmbLibRsRsmbRcb
LjLsmbRsbRsbRiRsmbLjLcbRhbRiRsmbRibLibRibRibRsbRsLsbLgbLgbRibRibRgbLib
RgbRgbLsLsmbRibLsbRsbRgbRsbRgbRgbLsLsmbsbsbRsbLsbRibRsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 5; Drug: Control Apo 0.5 然
bRgbRsbLgbLgbRibRgbRebLsbLsbLgbsbRhbLgbsbLjbLhbLgbLsRjbRcbRiRsmbRjRsmb
RcbLsRsbLibLcRsbRjbLibRgbRhbRsbRcbLgbRcLsbLsRsbLjLsmbLjLsmbLibLgbRjbLi
bLcbLibRcbRibLibLgLsbLsLsLsLsmmmbLsbLsbRsbRhbLibRibRibLgbsbRcbRsbLibLs
bRsbLibLsbLsbLcbLibRgbLcbRsbLibRsbRsbLiRsbRsbRgbLgbLsbLgLsLsmbLgLsbRsR
sRsmmbRjRsRsmmbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 6; Drug: Control Apo 0.5 然
bLjbLjbLgbLsbLobLsbRebRobLjbLebLobLjbRsbRsbRsbRsbLsbLsbRjbRcbRobLsbReb
LsbLsbRobLobLjbRsbRebLsbRebLebRcbLsbRsbRsbLjbRobLobLebRsbLsbRsbRobRjbR
sbRobRjbLjbLjbRobLibsbRiLsRsbLgbLgRsbLobLiRsbsbLiLsbLjbRibLcbRhLsbsbLg
b

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bLeRsLsbRibLsbLibLobRibRibRsbRoLsbsbLcLsmbsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bRjbRobRjbsbsbsbLjbLcbRsLsbRgbsbsbLiLsbRibRobLibsbLhbRjbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bsbsbsbsbsbsbsbsbLsRsbLsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bsbsbRsbRgbLobsbRgRsRsmmbLcbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bLgbLibRibRibLsbsbLcbLibRibRjbLsLsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bRobRgbRibRoLsbsbRcbRgbsbRjbRcbRcbRgbsbLcbRibRibRcbRsbRjRsmbRhbRibRhbR
ibRibsbRebRibRsbRsbRebRibRibLibRebReb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bRsbRibLibsbLobRcRsmbLsbRsRsmbLcRsbLhbRibLsbRsbRsRsRsmmbLgbLsRsbRcbsbR
sbLsbRsbLsbRsLsbRsbRsbLgLsLsmbLgbRgbLjbLiRsbRgbLsLibRcbRobLsbsbLgbRsbR
sbRsbRsbRsbRsbRgRsmbRgbRsbLsbRsbsbRsbLoLsLsLsmmmbLhbLgbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bLibLgbRgbsbRsbLhbRsLsbLhbLcbsbRsbsbsbReLsLsmbRsbRibRgbsbsbsbLeLsbRgRe
bRsLcbLhbLibRsRsmbRcbLibRibRoRsLsmbRsbRibsbsbLjLsLgmbLsLsmbsbRgRsmbRsR
smbsbRjRsmbLibRjRsmbLjbRgbLebLsbRcbLgbRsbRgbRjRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bLcbLgbsbRsbLsbLibLsbLsbRsRsmbRsbLjbLgbLibRsRsmbLsbRsbRsbRgRsmbLobLgbL
sbLjbLsLsmbLgbRsbRibLibRgbRsbRiLgbLibLibLsLsmbLibLgRsbRgbRibLgbRsbRsbR
sLsbLsbLsbLgLsRsbLgbLjbRjbRsbLjbLcbLsRsbRibLgbRgbRibLjbRgbRsLsbRgbRgLs
bLgbLgbRsbLsbLsbRsRsmbLibLgRsbRsbRebLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bRgbLsRsRsmbLsbRsbsbRsbRsRsRsRsRgmmmbLsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bLsbRsbLsbLcbLsbRibLobRibLjbLibLhRsbRgbLgbLgLsbLjbRsbLsbsbLsbLsbLgbLgb
sbLsbLjbLgRsbLsbLiRsbsbRgLsbRobLgLsLsmbLgbRgbRgbLjLsmbsbLsbRgbRgRsmbLg
bLibRgRsmbLgbLsbLsbLgbRsbLsbLgbRjbLibLsLobLjbRgbLcbLibRgbLgbLsLsmbsbLs
RsbsbsbRsbsbRsbsbsbsbRsbLhRsbLibRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bLsRsLsbRjbRibRcbLgRsbsbsbLsbRsbRiRsmbsbsbsbRgbRsbRjRgbRgbLsbLcbLsbsbL
hbRibRiRsmbLsbRsbRjRsRgmbRibRcbLjbLcbRsbLjLsRsmbsbRebsbRebRsbRjbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bRsbRsbLsbLsbRsRsRsmmbLsbRsbRsbRsbLsbsbRsRsmbsbRsbLsbLsbsbRsbLsbLsbLsb
RiRsmbRibLsbsbRebRjLsbRsbLsbLsbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bsbRgRsmbLsbRsbsbRsbLsbsbRsLgRsbRgRsmbLcbLhbRoRsmbLsbLsbRsbRgRsmbsbRsb
sbLhbLibRcbsbLsLsLsmmbLsbLsbRgbRgbLsbLsbRjRsmbRgbsbLsbLjLgbLgbRgbLcbLs
bRgRsmbLibLsbLsbRsbLgbsbLgLsbLibLsbLsLsmbLsLsmbRsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bLgLsbLsLsmbRsbRjbRibLsbLsRobLibRibRcbLibRjbLibRsLsbLibRjbLhbRjbLibRjb
RcLsLsmbRsLsbRibRsbLgLsbRibLebLsbRjbLibRsbLibRcbRobLjbLjbLgbRgbRsbLibR
jbRebLsLjLsmbLhbLibsbRibLhbRjbLibRjbRibLcbLobRsRsmbRgLsbLsbLcbLgbLgbLi
bLgbLsbsbRibLcbRjbRobRcbRiRsmbLhbRiRsmbsbRsbsbsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLgbLgRsbLgbLgbLibRibLgbLgbLgbsbRsbLsRsbRsbRibLgbRgbLgbLgbRgbLgbLgbsbR
jbLibLibsbRgLsbLgbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bLgbLgbLoLsRsmbRibLobLoLsmbRhbRoRsLsmbLobRgbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bRgbRsLsbRobLjbRsLjbLsLsmbRsbRjbLgbLsbLiLsbRiRsmbRsLsbRsbLsbRsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 25; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 26; Drug: Control Apo 0.5 然
bLcbLjbRsRsmbLcbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 27; Drug: Control Apo 0.5 然
bLibLcLobRobRobLibRjbsbLjbLiLsbRcbLcbLibLcbRiLsbLsbRobRcbRcbLsbsbsbRsR
smbRsLsbLsLsmbsbLiLsbLgRsbLsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 28; Drug: Control Apo 0.5 然
bLcbLibLsbLsbLibRcbRcbLjbLjbLibLibLgbRsbLiLsbLjLsmbLsLsmbLsbLsbLibLibL
jbLibRibLibRsReRsmbLibLibLgbLcbLobLibLibRcRsmbRhbLsbsbLjLsmbLibLcbLcbR
jbRibRcbLhLsbLhbLcLsmbRsbRsRcbRhbLibLgbRibLjbLibLjbRcbRgRgRsmbLcbRjbLh
LsbRsbLgbLgbLcbRebLhRsbLibRibRcbLibLgbLgbLgbLibLibLibLsbLibLibLjLsmbLi
RsbRsbRsbLsbLgbLgbRjbLjbLjbLsLgbsbLgRsbRhbRhbLibLjLsmbLhbsbsbsbLibLiLs
LsmbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 29; Drug: Control Apo 0.5 然
bLcbsbRsbRsLsbsbRhbRsbRjbRgbsbsbsbsbLsbLgbLgLsbLsRsbRsbLsbsbsbRsbRjbLs
LsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 30; Drug: Control Apo 0.5 然
bLgbLjbLcbLjbLibLibLgbRcRsmbLhLsbLjLsmbRjbRobLibLiLsbRsbRsLjbLjbLibLib
LgbLibRjbLibLsbRsbRsRsLsLsmmbLsRsbRsLsbRjRsmbLgbLobLsbLsbLgbLgbRsbsbsb
sbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bsbLgbsbsbsbLgbRsbRsbLgRsbsbLebsbLibsbLsLsmbLcRsbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bLcbRgbLobLsbLgbRcRsmbLsbLobLibLgbRhbRsbRcbRcbRhbRsbRgbLcbRgbRgbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bRobLsbRobRobLebRobRebRobRcbLebLebRobLsbRgbRebLobRcbRobRebLcbRebLhbRsb
RobRobRobRcbLebRcbRgbLgbRcbRsbRebRobRobRobRebRebLibRobLobLjbRcbRobRibL
obLobRgbRobLobRibRobRobRobRobLobRobRobRhbLobRcbRobLobLsbLobRebLobLobRo
bRsbRcbLjbRobRobLcbRcbRobLobRobLobRgbLcbLibRobRobLobRibRgbRebRcbLgbLeb
LibLebLsbLsbLebLobLebLcbRebRobLobLobRcbLobRcbRebRobRcbLsbRobRobLgbRebR
obLobRobRobRobRibRebRsbLebRgbLobLcbLcbLobRibRcbRobLibLobRcbRobLobLcbLo
bRobLobRobLobLebRobLebLobRobLobRcbRobLobRobRebRobRgbLebLobLcbRcbRsbRob
RsbRebRebRebRhbRsbLcbRcbRgbLebRebLobRobLobLibRsbLibRobRcbLobRobLcbLebL
cbRsbRobRcbLcbLcbLobRobLebLobRcbLobLobRobRobRcbLobLcbLobLobLebLobLobLg
bLhbRhbLhbLcbRgbRobRhbLebRebRsbRobLcbRobLobRjbLobRcbRobLgbLebLcbLgbRob
LobRcbLobRobRobLobLobRibLobLsbLgbLobRsbLobLcbLebRobRibLobLobRobRobLsbR
cbRcbRgbLebRcbRobRobRgbRebRgbLebRobRsbRebRsbLebRebRhbLcbLebLobLebRcbRe
bRobLibLcbLobRobRobRobLobLebRobLebLobRibRobRebLobLobRsbRebLobLcbLobLcb
LebRgbLebRobLebRobLobLhbRobRgbLgbRhbRgbLobRobRhbLobRcbLcbLobRobLobLobR
sbRcbLhbLebRobRobLobRobRhbLibRcbLsbLobRebRebLobLebRobLobLibRebLobLgbLo
bRebRcbRcbRebRcbRobRsbLebLobRobRcbRcbRcbLcbRsbRebLobRibRsbRcbLibRobReb
LebRsbRebLobRebLobRibLobRibLebLsbLobRibLobRebRgbRebRobRebRibLcbLobRebL
obLobLobLebLobLobLibLebRcbRobLobLebRobRobLibLcbRgbLhbRobLibLobRebLobRi
bRebLobRebLibRgbRobLgbLcbRobLcbLobLsbLebLcbRebRcbLebLebLhbLgbLobLebReb
RcbRebLcbLcbRebLobRgbRcbRibLgbLobLebRobLobLebRebRobLebLhbRobRebRgbLobR
gbRebLcbLebRobRsbRgbRsbRobRobRobLobRcbRgbRebLobRcbLobLebLobRobRsbLobRo
bLcbLcbRebLibRebRebLobLsbRibRobLobRebLgbLebLobLcbRcbRcbLobRobLobRobRcb
LobRgbLibLsbLobRobRsbRobRobLibLobLcbLebRcbRcbLobLobRjbLcbRsbRcbLobLebL
hbRobRibRebLebLobRibRobRobLebLgbLebRobLobLobRebLobRobRgbRebLobLebRsbLo
bLcbRsbLebRobLebRcbRibLobRcbRibLobLebRobRcbRobLsbLobLgbRobRobLobLcbLeb
RibLcbRcbLobLobRibRebLobRcbRsbRebRobLgbLebRobRebLibRibRebRobRgbLobRcbL
cbLebRobLsbRebLebLobLobRobRobRgbRobLobLhbLobLobRobRebLcbRobLobLobLebLg
bRebLebLcbRobLobLebLgbLobRobRobRgbRobLebLobRebLsbRebLibRibRcbLibRobRsb
RgbRebLsbRsbLebRobLebLcbRobRcbRibLobRebLobLcbLcbLobRobRebRcbRobRebRibL
sbLsbLebLebRcbLobLhbLebLobRebLgbRcbLebRcbLsbLgbLcbRobRobRobRobRobRcbRj
bLobRsbRebLobLcbRobRobLobLobRgbRobLcbLsbLobRobLebLcbLobRgbLobRebLobRob
LibLibRcbRgbRobLobLobRobRobRibLsbRjbLsbLcbRobRibRebLobLobLobLobRobRebL
obLcbLobLobLebLebRebLobRobRobLobRobLobRcbLcbRcbRgbRobRobLcbRebRobLibRo
bLcbRobRobRcbLobLobRobRebLobLobRobRgbRebRebLcbLobLebLobLobLobRcbRebReb
RcbRobRebLobRcbRsbLibRibRobRibLebLhbRobLcbRobLobRobLcbRobRebLobRobLebL
sbRcbRobLobRcbRcbLobLebLcbLobLcbLibLobRebLobLobRgbLcbRobLsbLibLobRcbRi
bRcbRobLobLcbRjbLcbRibLcbRobLebRobRcbRibLhbRcbRobLobLebRobRcbRibLobLeb
RcbLobLebRobLibRebLebLobLobLgbRsbLhbLebLebRobLibRebLebLgbLibRcbRsbRobR
obLebLcbLobLcbRebRobLebLobRebRobRobRobLobLgbLobLebLobLobRobRobRebLobRi
bLebRhbRobLobRobLobLebLgbLebLcbLcbLebRobRobLebLobRcbLobRobLcbRcbLgbRob
LebLhbLobLobLibLebRobLobLebRsbLebRobRobRobLibLobLobLobRebRcbRobRibLebL
gbLibRcbLibRsbRcbLebRcbRobRebRebLobRobRcbLcbLcbLobRebLobRgbRsbLcbRhbLo
bLcbRobLhbRobRibLobLcbRibRcbRebLhbLebRsbLibLobLobLobRobRcbLebLebRebReb
RebLobRibRsbLibLibRobLob

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bLgbLjbLobLgbRsbLgbsbLsbLsbRobLjbRgRsmbRsbRgbsbRsRsmbRsbsbsbRsbRsbLgbL
ibRibLibRjbsbRhbLgbRcbRcbLibLsbLgbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bRsbsbRibRsbRsbRsbRgbRgbsbsbsbsbsbRsbRjbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bLsbsbRibLsbLgbsbRibLsbLsbsbsbRgbLibLsLsmbsbsbLsbLsbRsbRgbRgbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLgbRibRiRsmbRgbRibLgRsbRjRsmbRibRgbRcbLsbRhLsbLsLsmbRiRsmbRibsbLib
RibRibLsbLsbLibRjbRiRsmbLebLgbLibLsLsmbLsLsmbLgbLhbLgbLgbLhbLibRsbLibL
ibLgLsbRibLibsbLibLsbLibLibLsbLsbLgbLsbLgLsbLgbRcbLgbRiRsmbLhbLhbRhbsb
RsbLobLcbLsbLibLgbLjLsmbRcbLcRsbLibLgbRgbLibLgbLibLcbLsLsmbLcbLhbLibRg
LsbLgbLsbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLgbLgbLiRsbsbRgbsbLibLsbLsbLebLgLsbRsbLsRgbRgbLgbLsbRsbLhbLibLgbsb
LgbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bRhLsbLiRsbRsLsbRjbLgRsbLsbRsbLibLsbLsLsmbRsLsbLgbsbLgLsbRgLsbLcbLsLsm
bLibRibLjLsmbRjbRibLebRiLsbLcLsmbLobRhRsmbLgLsbRiRsmbLgbLsbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bLcbRoRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bRsbLiRsbLgbRjbLsbLiLsbRibLibLsRsbLibLibLibLsbRgbLgbLibLgbLsbLibLgbLib
LgbLgbLsbLsLgbLgbLgbRgbRsRsmbLibLgbRsbLibsbRsbLgbLhbLgbLsbLsRsbLibRsbL
ibLiLsbsbLjRsbRjRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bRobRsbLgbLgbRsbLeLsbLgbsbRibRebRiRsmbLcbLsbsbsbLsbRgbRibLcbLcRsbLgbLg
RsbLjbRsbLobLobLebRgbRcbLgbsbLgbLgbLsbLgbLgbRsbRsbsbLsbRibRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bRgbRsRsmbLiLsLsmbLibLcRsbRibRsbLgbLibLgRsbLgbRjbRgbLsbLibRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bRoRsmbLobLsLsmbRcbRibsbRibRgbLsbsbLibsbLsbLcRsbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bsbLsbRgRsmbLsbRsbLjbRsbsbsbLjLsmbsbLsbLsLgbLsbsbLgbLsbsbsbsbsbRjRsRsm
mbLjbLsLsmbLgbLsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bLsbLsbRobLjbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 130223; End: 130723;
Recording: 4-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bLcbRibLsbRiLsbsbLsbLhb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 1; Drug: Control Apo 0.5 然
bRobLsbsbsbsbRsbsbLibRgRsmbRhRsmbRibLsLsmbRibRsbLsRsbRsbLjbRebLsbLgbLs
bLsbLgbRsbLsLsLsmmbLsbLiLsbLsbLiLsbLsbRsbRoLsbLsLsmbLsRsbLebRiLsbLsbLs
bRsbLcbRsbLibLsbLhbRcbLiLsbLsbLgLsbLibLgbLsLsmbLgbsbLsbLgLsbRsbRgbLsRs
bRsbLgbLibRsbLsLsmbRsLsbLiLsbRjbRcbRgbRsbLsbRgbRibRsbRgbsbRsbLsbLgbRsb
RibLsRsbsbsbsbLsLsRsmbsbsbRsbLgbRgbRsbsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 2; Drug: Control Apo 0.5 然
bLsbRcbRsbLibsbsbsbRjbLgLsbsbLsbLsbLsbLgbLsbLsbLibRcbRsbLebRibLjbLobRo
bRhbLibLsbRsRsmbLgbRsbRgbLgbLsbRsbRsbRiRsmbLebLsbsbLsbLgLsbRhbLsbRsLsR
sbRsbLsbRibRgRsmbRcRsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 3; Drug: Control Apo 0.5 然
bRjbLsbLgLsbsbLcbRobLhRsbRiRsmbRibsbLjbLgbReRsmbRibLobLsbRjbLobLsbLsRs
bRibRibRoRsmbLsLsmbLsbRsbLobRibLgbRibLcbRiRsmbLhbRcbLcbLsbLjbLgbLsbLcL
sLsLsmmmbRgbRibsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 4; Drug: Control Apo 0.5 然
bRsbRobLsbLgbLsbLibRsRsmbLgbLsbRoRsmbRjLjLsmbLibRsbRsbLhRsbRgRsmbLiLsb
LgbLsbsbLsbLsbLsRsbsbLgLsbLsbLgbLgLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 5; Drug: Control Apo 0.5 然
bLsbLsbRsRsmbRcbLibLsbRcbRgbRhbRsbLcbLibLcbRjbRcbRsbLhbRgbLibRibRsbRsR
smbRsbRgbLsbRgbsbLjbRibRsLsbRhbLsbRsbRsbRcbRiRsmbLsbLibLgLsbLeLsLsmbLg
LsbLsLsmbLsbLsbLsbLsbLgbLibLibLsbRsbLgLsLsmbLgbLcbLibLhLsbLcbRcbRsbRib
LcbRsbLgLsbRsLsbLsbRsbRsbLsbRsbRsbsbLgbRsbLsbLiLsbRjbRiLsLsmbRsbLjbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 6; Drug: Control Apo 0.5 然
bLgbLibRcbLsbRsbLcbLibLgbLgbRcbLgbRobLiRsbRiRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bLsbRsRsmbsbsbsbRsLsLgLsbRsbRsbsbLibRsLsbRiLsbsbRjbLgbsbRibLibLjbLcbRc
bRcbLjbLcRsbRsbLobRsbLhbRibLgbRgLsbRsbLgbLjbRjRsmbLjbRibRgbLgbRgbRgRsR
smmbRgbRsbRsbRsbRgLsLsmbRibLgbRoLiLsbLsbLjbLibLiLsbLiLsbLsLsmbRjbLcbRg
bLsbLhbLsbLgbLgbRgbRsbLsbRsLsbRobLgbRibLgbRgbRhbLsLgRsbRsbRgbRgbRsRsmb
RgbRiRsRgRgmbRgbRgRgRibRibRsbRjbLhbLibLibLibLgbLjbLgbRsbRsbLsbLjbRibLj
bRgbLhbLsbLibRgbLcbLgbsbsbLhbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bLebsbsbRsRsmbsbRjLsbRgbRjRsRgmbLjbLiLsbLsbRjbLcbRcbLibRsbsbsbsbsbsbsb
LsbRobLhbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bLjRsLsbLoLsmbRsbLcbRsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bRsRsmbRebRsbsbLebsbRgbLgbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bsbsbsbRsRsmbLsbsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bRiLsbLibLsbRgbsbRsbRoLsbLgbLobRibsbsbLsbsbsbLsRcRsmbRjbLsbLcbLsbRsbLe
bLhbRsbLjbLsbRobRhbRsLsbLhbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bLsbLsbRobRjbLiRiReLsbRobRoLsbRsbLjLsmbRibRsbRcbRibLgbLsLsmbRsbRibLibs
bLoLsmbLjLsmbRsbLibsbRibLsbLsbsbsbRhLsbsbLibsbsbLsLsmbsbsbLcbRiRsmbRsR
cbLsbRsbLsbRobsbLgbRgbRiLsbLsRsbLsRsRsmbsbLgbLobLsRsRsLsmbRsbLibLibsbR
gbLsbLcbsbsbLibRsbLsbRiRsLsmbRcbRibRsRsmbRsbLjbRibRsbRiRsmbRiRsmbsbsbL
hbsbRsbRgbRobLibRgbLibLsbLsbRsbsbsbsbRjbRsbLsRsbLsbLsRsbRsbsbRsbRsbLsb
LsbRsLsRsbLsbLsLsRsmbRsLsLsLsmmbLsRsbLsbRsbLsLsmbRsLsbsbRsbsbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bLsbRcRsmbLhbLjbLibsbLcbRsbLcbLsbLsbLgbLobLebLibLgbsbRsbRsbLibLcLsmbLi
RsbLibsbLsbLhbRjRgbRcbRhbLcRsbLcbRjbRobLsbsbRjLsbRsRsmbLjbRiLsbLgbRcbL
ibsbsbLsbRsbLsbLsbLsbLsbsbLsbLibLsbsbsbRsbRsbLsRsRsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bLsbLibRcLsbLibLgLsbLhbLibLgbLjbsbsbLibsbsbRebLhRsbLsbRsbLgbLobLobLjbL
gbLsbRsbRcLsbLcbLsbRgbRsbRgbsbRgbLsbLgbRsbsbLibRsRsmbRgbRgRsmbLibLsbLs
LsmbLiLsbRjbsbLgbRebRobLcbLsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bLgbRgbRiRsmbLjbLobLgRsbLsbLgbLsbLsbsbLsRsbLsbRsbRsbRsbsbsbsbLsbsbRgbR
obRjbLsbRjbRsbsbsbLjbRiLsLsmbRgbRibRsbLjbRjbRgLsbRebLcLsmbRibRsbRjbLob
LsbLsLsLsmmbsbLgbLsbLsbLsbRsRsmbsbLsbLsbsbRsRsmbsbsbsbsbLsbsbRsbsbRiRs
mbLsRsbsbLibsbLsbLgbRgRsmbRebRiRsmbLibRgbLsRsLsbLgbLibLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bsbsbRibRsbsbRibsbsbLhLsbRjbReRsmbRgbLgbsbRsbRgbLjbRsRsRsmmbRsbsbLsRsb
RsbLsbRsRsmbLsbRsRgbsbsbsbLsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bRebRobLobRobRebRobLebLjbLsbLsbLobLsbLgbRcbRibRhbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bLjLjLsmbRjRsmbRgbLsRsbLsbsbRsLsbLsbLsRsbsbLsRsbRsLsbRjRsmbsbsbsbRsbsb
LsbsbRgbsbLjbLsRsbRgLsRsbRsbRiRsmbRibRibRsbRsbRsbLjbRcbRgbsbRcbRgbRcbR
sbLsbsbLsbsbsbsbLsbsbLsbsbsbsbsbsbsbRsbLsbLsbsbsbRsbsbLibRsbsbsbLsbsbs
bRsbRsLsbRgRsmbLobLjbRibLsbLcbLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bRoLsRsbLhbRcbLiRsbLsRsbLsbsbRcbLibLgbLgbRcbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLsbRsLibLsbLgbLsbRcbRobRcbLgbsbRsbLibsbLibLjbsbLebsbLibLjbLsbRsRsmbLi
bLhbLgbLibLsRsbsbsbsbLibRiLsbLibsbRcbLiRsbLsLsmbLjbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bLobLibRcbsbRcbRsbLsbRibsbRcbRobRsbLobRhbRsRibRjRsRsmmbLobRibsbRgbLibR
iLsbLjbLsbRjbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bLsbLsbRsRsmbLsbRjbLsbRgbLsRsbLsbRibLjbLhLsbsbRobRsLsbRhbRsLsbRiLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 25; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 26; Drug: Control Apo 0.5 然
bRsLsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 27; Drug: Control Apo 0.5 然
bRobsbsbRoLsbLcbLsbLcRgbLhbLhRsbRsbLoRsbLobRjRsmbRjRsmbRjbLgbLibRcRsmb
LibRcbRhbRiRsRsmmbLcLsmbLibsbLibLibsbsbRjLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 28; Drug: Control Apo 0.5 然
bLgbRobsbLsLsmbLsbRhbsbsbRibRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 29; Drug: Control Apo 0.5 然
bRibLgbLcbRsbRsbLsbsbRsbsbLsbsbRsbRsLsbsbLsbRsLsbRgbRsLsbLobLjbLibRsbL
hbsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 30; Drug: Control Apo 0.5 然
bLiRsbsbsbsbsbLcbLiLsbsbRsRsmbLobLjbLjbLiLsbRjbRobRcbLibRhbRibLgbLgbLo
bLibLjbLhbLibLsbLgbRsLsbLjbLjbLhbLibLibLibsbsbLsLsmbsbLibRcbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bLobLebRiLsbLcbsbLsbLgbsbLsbsbRgRsRsmmbsbRsbLsbLgLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bLsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bRobRobRibRobLobRgbRibLobRebLcbRibLgbLcbLibLobRobLobLebLebRobRebLibRgb
RobRcbRgbRobRcbRebRgbLcbLcbLobRobRobLebLibRebRobLobRobRcbRobLobRobRibL
obRobRobLebLgbRebRobRebLcbRebRobLobRebLebRibLobRobLebLcbRobRobRebLobRc
bLcbLebRibRhbLgbRobLibLebLobLebRobRebLebLgbRobRobLobRebLebLobRebLhbReb
RibLobRobLobRsbRobRebRcbRebLobRobRobLcbRobLebRcbRebLobLobRebLcbRibRcbR
cbRsbLebLebLsbLgbRgbLebLebLobRebRobLcbRobRobLibLibLebRibRcbRebLebLibRe
bRebLhbLibRebRebRcbLobLebLobRhbRobRobLobLebRobRobRebLebLibRobRcbLobRgb
RebLebRebRobRobLcbRobLcbLibRobLsbLcbRibRibLebRcbLcbRobRobLebLhbLcbLgbL
ibRobLcbRebLobRjbLobRobRobRcbLebLobLgbLebRobRsbLobRebRobLcbLobLcbLibLe
bLibRobRebRebLibLgbRebRgbRibRobLobRebRobLobRgbLcbRobLebLobLobLobRobReb
LebLebLibRobLgbRcbLebRobLebLibLibLebRibLgbLcbLebRobRcbRobLcbLebLebRcbL
jbLibRcbLebRsbLcbLobLcbRcbRcbRobLcbRcbLobRcbRebRobLobRobLobRebRobLsbLo
bLgbRobLobRgbLcbRobRhbLebRobLibRobRobLcbRebRobRebLobRgbRobRobRcbRobRob
LebLgbRobLobLobLobLobRcbRebRebLobLgbRobLobRhbRcbRhbRobLobRobLhbLsbLobL
cbRcbLobRebRcbLobRobRgbLgbLobRsbRcbLgbLobRcbRgbRebRebLgbLobLibLobLebLg
bRobLobLobRebRcbLobLobRebLhbRcbRebRobRobRcbRobRobLobLebLebRobRcbRebLib
LobLsbRebLgbLobLibLcbRebRobLobRobRobRcbLobRcbLibLobRibRgbLibRgbRobLgbL
obRsbRobLobLgbRhbRobLobLobRcbRebRobRebRobRgbRsbRobRgbLobLcbLcbRebLcbLc
bLobLcbLebLgbRgbLobLobLobLgbRobRobRobLebLebRebLebLobLcbLibRobLebRsbLob
LcbRobLcbRcbLcbRobRobLobRhbRobLhbLobRobRobLobLhbLobLibRhbLcbLcbRebRebL
obRcbLebLobRobRobLebRobLobRobLobRobLibRobLobRcbRebRobRobLobRobRebLsbRo
bRibRebRcbLebRcbLobRobLcbLcbLobLebLebLsbRebRobRobRgbLebLobLcbLgbRobRib
LsbRibRcbRcbRcbRobRhbLebRibLebLebLobLobRebLobLobLobRcbLibRobRsbLgbRobR
ebRebLebLcbRebRcbLobRobLobRhbRebLcbRobLcbLsbRebRebRebRebLebRobRebLobLg
bLobLobLebLebLcbLcbRebLebLcbRobRobRobLcbLobRsbRibLebRcbLebRcbLebLobLhb
RcbLsbRibLobRcbLibRobRobRobLebRobLhbLcbLobLobLgbRsbLobLgbLibLobLobRobR
ibRobLcbLcbLobRebLobRcbLobRjbRhbLebRcbRebLebLibLgbLibLobLobRobLobRgbRo
bRobRobRobLhbRsbRcbRgbRcbLebRebLobLcbLobRhbLcbRgbLsbRobLobLobRobLobLob
RobRobLobRgbRcbRobLobRobLebLhbRobLgbLobLcbRobLebLobLebLcbLebRebRhbLibR
obLibLebLobRobLebLobLobLgbRobRebLebLobRcbRebLsbLgbRobRcbRgbRobRobRobLe
bRcbLcbLobRcbLcbLebLgbLcbLgbRobRobLobRcbLebRobLobRebLobLibLebRgbLebRgb
RcbLebRibRobRobRgbRgbRobLebLebLobLcbRobLcbRobLebLebLgbLcbLobLsbLsbRobR
cbLobLobRhbLhbRebRsbLcbRobLobLebLobRobRobRobRobLebRobRcbRebLobLcbRcbLo
bRebRobLobLcbLcbRcbRobRobLebRcbLobLobRebRgbLgbRebLebLcbRobRobLobLcbLob
LobLsbLobRcbRobRebLcbLibRhbRhbLobRcbLsbRobLobRjbRcbLobLebLebLcbLobRobR
gbLcbRobLibRobRebLsbLcbRebLobLobLebRobLhbRobLobRobLobLobRobRgbLgbRibRo
bRcbLgbLibLobLibLebRobLobLobLebRibLibLcbRgbRobRobLobRgbLobRobLobLcbLob
RobRibRobLebLobRebRcbRibRobLobLobRobLobRobRobRibLobRobLobRibRobRcbRobR
ebLobRebLobLsbLibLgbLsbLobRcbRobLebRebRebRsbLebLobRibRcbRebRebRobLobRg
bLibLobLsbRcbLcbLebLcbRobLobRcbLobLobLcbLgbLgbRgbLobRebRebRgbLcbLobRgb
RobRobRcbRibRebLebRgbLebLobRebLibLobRobRebRebRobLobLsbRobRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bsbLjbRsbLsLsmbLcbLsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbLsbsbLi
bLgbLsbLibLcbRibLiLsbsbRsbLjbLgbLsbLjbsbLibLsbLhbLibLgLsbRoRsmbRcbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bLgLsbLsbLgbRsbLsbRjbRibRibRsbsbRsbsbLsRsbRsbRsbsbRsbLsbRsbRsRsmbsbsbs
bsbsbRibRgbLsbRibsbLsbLsbRjbRsbsbsbsbsbsbsbsbLsbsbsbsbsbsbRcbRobRgbRiL
sbRsbRsbRsRsmbRgbRiLsbRsbLsbsbsbsbLsbRsLsLsRsmbRsbsbRibLsbRibRhbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bsbsbLsbRsbRsbRsbRsbRibLhbLhbRobRsLsbRsbRebLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bLibLibLgbLgLgbLhLsbLoRsbLsbLsbLibLcRsLsbLhbLhbLibLibsbLjbLhRsbLcbLgbL
ibLjRsbsbRjbLibLsbRsRsRsmmbRsbLhLsLsLsmmbLibLibLiRsbRgbLsLsmbLsRsbLcbR
jbRibsbLcbRjRiRsmbLsLsmbLibLcbRebLibRjRgbsbLhbsbLhbLcbLibLibLsLsmbLsRs
bRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bRiLsbLgbLgbRibLgbsbsbsbsbsbLhbLcbLjbLjLsmbRsbRsbLsbRcRsRsLsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bRobRgbLcbLiLsbRsbLobLibRsbLcRsbLsbLgbLibLibRgLsbLsbRsbLsbLsbRiRsmbRgb
LcbRibRgbLsRsLsbLhbLgbRsbLibLsbLhbRjLsbLibRgbLgLsbRsLsbLcRsbLibLibRsbL
ibLibLgLsbsbRgbRsbLcbRibRibRsbsbLcbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bLoRsbLsbRcbsbLgbsbsbsbRsbRsbRsLsbLsRsbRsbLsbsbLcbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLsbLsbLgLsbLgbRcRsmbRsbRsbRgbLjRsbLjbLiLsbLgbLibLibLibLsbLgLsLsmbR
gbRibLjLsmbsbsbsbLsbLgbLgbRsbLiRsbLhbLsbsbLibLgbLebLibRibRsbRobLiLsbLe
b

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bLgbRgbRsbLgbLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
bLsbRsbLsbRsbLsbLsbLsbRsRsmbLsLsmbLsbLsbLsbLsbLsbRsRsmbLsbRsbLsbLsbRsb
RsbRsbLsbRsbRsLsbLsbLsbRsbsbRsbRsLsbLsbLsbLsLsmbLsLsmbLsRsbLsRsRsLsmbL
sbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bLibLiLsbRhbRebLgLsbLsbRgbsbLibRjbLcbLobRgbLhbRcbLcbLibRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bRgbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bLeLsbLiLsbRsbLjbLsbRgbRsbLgbsbRiRsRsmmbLsRsbLgbLebLgLsLsmbsbLgbRsbRgR
smbRgbLgbLjbLsLjbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 130725; End: 131225;
Recording: 5-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bsbsbsbsbRgbsbRsbLcRsbRsbRobLgLsbRsbLcLsmbLobRhbLjLsmbRoLsbRcbLjbLcbLi
bRobRibLgbLsRsbLibLgbsbRjbRhbLibLibRcbRibLhLsbLibRcbRcbLibLibRsbLibRiR
smbRibRsbRibRgRsmbLjbRhLsbRobRcbLgbLhbRobRibRibRsbRsbRcbLibRcbRibRcbRi
LsbLgLsbRhbsbRjbsbRjbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 1; Drug: Control Apo 0.5 然
bRgbLsRibRibRgbLgbRibRcbRsLsbRoLsRsLsbRcbRibLjbLcbLcLsmbLibRsbLibRcbsb
LsbLsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 2; Drug: Control Apo 0.5 然
bsbsbsbLsLsmbRsbsbLsbLsbsbLsbLsbLjbLjLsmbRoRsmbRsbRjbsbsbLjbsbsbRibRsb
LsbRsbRibRcbsbLebLibLsbLgRsbLibLjbRibsbRibLibRibLsbLibRsRsmbRjbLiLsbLs
bRcbLsbRsbRgbLjbLsbLsbRibRsbLibLhbLsbLsbLsbLgbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 3; Drug: Control Apo 0.5 然
bRibRebsbsbLhbLcbLibRebLcbRjbRsRsRsRsRsmmmmbLjLsmbRibLcbRobsbsbsbRcRsm
bRsRsmbLcbLcbLoLsRsmbLsbsbLcLsmbRsRsmbLibRjbLhLsLsmbRibsbsbLhLsRsbRhbL
obLsbRcbRsbRsLsbRcLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 4; Drug: Control Apo 0.5 然
bsbsbsbLjLsmbRgbLjLsmbLiLsbLsLsmbLiRsLsbLsbRgRsmbRsbRjbLhbRsbRibRiRsmb
RibRebLibLgbRgbRibRgRsmbsbRsbsbRibLcbLjbRsbRsLsRjbRgbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 5; Drug: Control Apo 0.5 然
bRhRsmbRibLgbLjLsLsmmbRsRsmbRcbRhRsmbLibLcbRsbLibRgbRibsbRibLgLsbLsbRi
bLibRibRhbLcLsmbLgbRcbLobLhLsbRcbsbsbLjbLibLibLsbLibRsbRcbRiRsRsmmbLsb
RhbRibRsbRjLsbRcbRjbLibLsbLibRsbRibLsbLiLsbLsLsmbLsbsbRsLsbLgbRsbLgbRs
bLibLgbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 6; Drug: Control Apo 0.5 然
bLobRoLsbLibRcbRcLsbLsbLibsbRsbRsRsmbLibRgbLgbRsbLgbRcLsbLibsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bRgbRibLgbRgbRgbsbRhbLsbLsbRsbRibRibLsLsmbsbRjbLgbRgbRsRsmbRgbRsbRsLsb
RsbRsbRgbRgbRgRgRgRibRsbRjbRibLhbLjLsmbLibLjbRgLsbLjbsbRibLcbLgbLgbRsR
smbLiLsbRjbLibRsbLsRhbLgbRgbLgLsbRgbRgbLgbRibRsLsbRgbLsbLjbRibRgbLsbRg
bRibRhRsmbRhbLjbLibLsbRgbRgbRsbRibRgbRgbRsbsbRgbLsRsbLsLsmbRsbLjLsmbRg
bLibLgbRgbLjbLhbLibLibsbLiLsbRsbsbsbsbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bsbsbLsbLsbRsbLsbRsLsbLsbsbLsbRsbLhLsbLoRsbLobRgbRsbsbsbsbLobLsLgbRsbR
sbLcbLobRcbLobLcRsbLibRsRsmbRcRsmbRsbRobRibRgbRhbsbRoLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bLebRgbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bRsbsbRsLsbLsLsmbLsbRsbsbRsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bLsbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bLsRsbRsbLsbsbLsLsmbLsbLobRsbRebLsLsmbLibRibRsbRjbRoLsbRsbRsbRcbRobLib

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bLoRsLsLsRsmbsbLgbsbLgLibRcbsbsbsbRsRsmbLsbsbLsbRcbsbsbsbsbsbsbRgbsbLs
LsmbLcLsmbLsbRsLsbLsbRsLsbRsbLoLsmbsbRoRsmbRjbRhbsbRibRgbLhLsbRcbRibRg
bRgRsmbLibRcRsmbRiLsbLgbRiRsRsmmbRsbRsbRibRibLibRsbRgbRiLsbLsLsmbRsbRs
bLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bLhbRsbLsRsbLhLsbLebLsbLsbLibRebLgLsbsbsbLsLsmbLebLsbLhLsbLobRsRsmbRsb
LibRcbLebLebLibLibRebLgRsbLhbRsbRibLib

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bsbRsbLsbRsbRsbLsbLhbLsbLsbLiLsbRgbsbsbRgbLsbLsbLgbRgbLsbRgbLgbRsbRsbL
sbLgbRsbLiRsbRgRsmbLsbsbLebLibLibLsbLibRjbRgbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bRsbRgLibLsbRjbRoLsbLgLsbRgbLibLgbLibRiLsbRiLsLsLsRsmmbLobLsbLgbLgbLgb
RsbLsbLhbLsbRsbLsbLgbLgLsbLgLsbLgbRsRsmbLsbLgRsbLsbLgbLobRebLibLibLsbL
gbRgbLsLsmbLgbLsbLsbLjbLgRsbLgbsbRgLcbRibRobLsbLibsbLcbRsbRjbLcbLebLsb
RsbRgbRhbRibsbLjbLoRsbLibRiRsmbLsbLcbLobRsLibsbRgLsbRobRcbRsbsbsbsbRsR
sRsRsmmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLsRsbLgbRgbRsbLcLsmbLgbLsbRsbRsRsmbRsbLgbLsbLsLsmbRsLsbRsRsmbRsLsb
sbsbLsLsLsmmbLsbsbRgLsbRiRsmbRoRsmbRgbRgLsbRsRsmbLgLsbLibLgbLgRsbRjLsb
LsLsmbRibRiRsmbRcbLsRsbLsbRsbLcbLobRcbLjbRcbLgbLiRsbRhbRiRsmbLsbLsbRcb
RjbRibRsRsmbLsLsmbRibRsRibLsbRgLsbLjbRiLsbLibRcbsbLjbRgbLsbLjLsmbLoRsb
LoRsbRsbLibLsLsmbLsbLsbLgLsbLsbLsbLgbLgbsbLsLsLsmmbsbLsRsbLsbLsbLcRsbR
jRibRiRsmbRibRibLibRgbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bsbsbRsRsmbRsbRsbLsbLsLsmbLhbRsRgbLhRsbRsbsbRibRsRsmbLsRsbRgRsmbsbRhbs
bRcbRhbsbRjRsRsRsmmmbRgRsmbLgbRibRsRsRsmmbLgbRgbRgRsmbRsbRsRsmbRibLsbs
bRiRsmbRsRsmbRjbRjbRsRsRsmmbRsLsbLibLhbRgbRcbLobLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bLhbRgbLebLiLsbRiRsmbRibLcbLsbRibLsRsbLsbRsbLsRsbLsbLsbLsbRsbLjbLcRsbR
sbsbsbLcbRibLsLgbLibLibLsLsmbsbLgbLsbLsbRsbRsLsRsbLgLsRsbLobLgRsbLgbLg
bLibRsRsmbLsbLgbLsbsbLsbLsbsbsbsbLhbRsbRsRsRsRsmmmbRgbRsLsbRsbLsbsbRsR
smbRgbRgRsRsmmbLsRsbLiLsbLsbLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bRjbRjRsmbLsLcbRibsbRibRcbRibRcbRhbRsbRhLsbRcbRhbRsRcbLgbRjbRcbLcbLibR
gbRebRibRcbRibRcbRsbRobRgbRibRibRsbRjbRibLjbRjbRobRhbRsbRibRibRibRibRi
LsbRcbLgLsbLsbRgbRibRcRsmbRcbRgbLhbRjbRjRsmbRibRibRibRibRsbLsbRhLsbRgR
smbRsbRcbLsRsbRsbRcLsbRiRsmbLgbLsbRibLibLsbRobLgbRhbLgbsbLgRsbLibLsLsm
bLgbLiRsbRsbRcRsmbRsbRjbLsbLjLcbLgbLiRsbRgbLibRebRsLsbLsbRobRibRibRsbR
ibLsbRibRsbReRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLgRsbLgbLsbLgbLgbRsLsbLgbLsRsbLgbLibLibsbsbRhLsLsmbsbRsbRgbRebsbLsbsb
LgbRsbRcbLcbLibsbLsbLobLiLsRsbRhLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bsbLsLsLsLsmmmbsbLjbLcbLobRsRibsbsbRibLsbLgbLsbLibRsbRgbRibLeLsRsbRsbL
hbLobRibLsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bRjbRhbRiLsbLgbLsbLgbLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 25; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 26; Drug: Control Apo 0.5 然
bLsbLsbRsRgbLobLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 27; Drug: Control Apo 0.5 然
bRobLobLcbLcbLobsbLiRsbLhbRhbLibRgLsbLcbRjbRsbRjbRibLhRsLsbLiLsbLhbLsL
smbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 28; Drug: Control Apo 0.5 然
bRgbRcRsmbLeLsbsbRsbLcbRsbsbRgbRgbLjbLhbLsbRsbRsbLebLsbsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 29; Drug: Control Apo 0.5 然
bsbRjbsbLoLsmbRsRsmbsbsbRsbRebsbsbLsbRhbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 30; Drug: Control Apo 0.5 然
bRgbLibRsbRjbLjbLcbLibLibLsbLgbLibLgLsbLgbLibLsbLsbsbLsbLcRsbLobsbLjLg
bsbLsbLhbLebLsbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bRibsbLcRsbLebLgbsbLobRsbsbRsbsbsbsbsbsbRsLsbsbsbLsbRsLsbsbsbsbRsRsmbs
bsbsbRsLsbRsbRsbLsLsmbsbsbsbsbLsRsRsLsmbRsbRsLsbRsbLsbsbsbsbRhRsmbLhbR
obRobLcbsbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bLcbLiLsbRcbLcbLcbLsbsbLcbRibRhbRsbRgbRhRsmbRhRsmbLebLgRsbRsbRgbRsRobL
jbRobLebLibsbRcbRiRsLsmbLibRcRsmbRgbRibRibLsLsmbLibRobLjbRibRibRiRsmbL
sbLsRsbLjbRhRsmbRoLhbRibRib

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bRgbLebRobRobRobLcbRebRgbRebRibLhbLobRobLibRebLgbLebRcbLobRobLobRcbLeb
RgbRebRobRibLobRcbRebRcbRcbLebLhbRsbRobRobLjbRcbLobRebRibLibLebLsbLobL
cbRibRobLebRsbLgbRebRjbRibLobLebLsbLhbLibLibLebLibLobRgbRebLgbLobLebLo
bRcbLcbRobLobLcbRibLebLcbRibLsbRgbLobLebRcbRcbRobLobLibLobLobLobLgbRcb
LgbRgbRebLgbRebLsbLebRgbRebLobRobRobRebRgbRobRobLobRobLebLcbRcbRobLibL
ebRobLobLobLebRcbRobLobRobRobLibRobLobLobRebRobRobLobRobRebRebRcbRebRi
bLebRobLobRcbLobLibRobLobLobLcbLibRobLgbRobLebLhbRobLebLobLobRcbRcbLob
LebLsbLobLobRebRgbLobLcbLobLibLebLjbRibLobLebRebRhbLcbRobLhbRcbRcbLcbR
ebLobLobRcbRibRibLobLcbLibRobRebLobRcbRcbRobRobLibRsbLhbLebRobRobLcbRo
bRobRcbRcbLobRobLobRebLobLebLcbRobLebRebLebRcbLcbLebLhbLebRebRobRobLhb
LhbRcbRobRebRgbLebLebLibRobLibRebLebRgbRobLobLobLebRobLobLobRobRebLibR
obLebLsbRibLobRobRebRgbRebLobLcbRobLobLobLobRobLsbRebLebRobLobLebRcbLi
bLibRebRibRebRebRobRgbRebRebLcbLebRgbRobRcbLcbLibLgbLsbLgbLobLobRebRob
RcbLcbRgbRobLsbRcbLcbLgbLsbRebRebLebRobRcbRcbRcbLobLobRobRobLcbLsbRebL
gbLobLcbLebLebLcbRobLobRobLobRgbRobRobRcbRcbLibRebRcbLcbRobLibRobRebLi
bLibLsbLobLebLebRobRobLobLhbRcbRibRobRebRcbRgbLebRsbRcbRobLebLibLcbRob
RobRobLobLebLibLgbRcbLobRhbLobLebLcbLebRebLgbRobLsbRgbLibLobRebLobLobL
ebLebRobRebLobRebLcbLobLebLibRibRcbRebLobLibLobRobLobLobRcbLcbRobRcbRo
bRgbLibLcbRcbRebRibLobLibLebRgbLcbRgbRebLobLebRgbRebLcbRobLebRebLgbRob
LebRebRibLjbRibLobLhbRobLobRcbRebRobLobRgbLcbLobRebRcbRcbRebLibRobRibL
obRhbRsbLobRobRcbLobLsbRgbRibRobRobRebRcbLebLobRebLjbLibLebLebRibLibLo
bLobRcbLobRebLgbRebRobLcbRibRibLobLobRcbRgbRobRobRobLebLobRebRcbRobLob
LobLcbLebRobLgbRcbRibLobRobLobLobRebLobRibLobRobRsbLobLcbLgbLobLebRobL
obLobLcbLcbLebLcbRibRibLobRsbLsbRcbLobLsbRobLobRcbLobLcbRgbLobRebRobLe
bLjbLcbLebRcbLobLhbRcbLcbLobLibRebRgbRobLcbLobLebRebLobLebLebRobRobLob
RcbLebLobRsbLcbLebRibLcbLsbRobLobLebLgbLcbRebRebLcbRobRcbRebLobLobRobL
ebRcbLebRobRobLcbLibLobRebLebRobLebLebRobLebLobRobRebLcbLebRebLgbRgbLc
bRobLibRobRibRobRobRibRobLsbRobRebLsbLcbLobLebLebRobLsbLgbRobRobLebLeb
RsbLobRcbLgbLobLobLobLebRcbRobLebRcbRobLcbRebRcbLobRibLobLibLibRobRcbR
obLobLsbLobLcbLcbLebLebRcbRobRcbRebRsbLsbRcbRobRsbRobLebLibLobLobLebRc
bRsbRebRebRobLobLobLobRibLgbRcbLobRgbLgbLobLobLebRobRhbLebLobLcbRebRob
LgbLgbRcbLebLebRobRebRobLebLobRebRsbLcbLibRebRhbRebLebRgbLobRobRgbLebR
obRebRebRebRibLobLcbRobRobRobRcbRgbRsbLobLobRgbRobLebLobLsbLobRobLebLo
bRibRibRebLcbLobRobLebRsbLibLibRobRobLobLebLsbRobRebRibRhbLibRibRobLcb
RcbRibRibLibLobRebLebLebLobRebLhbRobLobLcbRobRcbLibRebLobLcbRebRebLebR
ebRibLobLobRobLibRobLebLcbRobLobRobRcbRobLhbLobLobRcbLobLgbRebRcbLobRo
bLgbLsbRobLebLcbLebLibRsbRebLhbLobLobRobLcbLobLcbLgbRobLcbRobRebRobLsb
RobRobLobLibRobRsbLcbLebLgbRobRcbLebRsbRobLobRcbLibLsbLobRobRobRobLibL
hbRcbLebRibRcbRebLcbRobLgbRebLobRobRcbLebRobRhbLobRibLcbLebRebRobRobRc
bLsbRgbLobLgbRobLobLhbRsbRobRebRcbLobRobRobRebRibLcbRobRobRobLibRebRob
RobLcbLsbRebLgbRibLibRcbLobRobLobLobLobRibRcbRebLebRobLobRhbRibRobRsbR
obRobLobRobRobRibLcbRobLcbLgbLebRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bLcbLsbLibLcLsmbRsbRsbLsbsbsbLsRsLsLsLsmmbLsLsmbsbsbLsLsmbLsLsmbsbRsbs
bsbsbsbLjLsmbsbLgbLebRcbRsbLgLsbLibRibRsRsmbRsbLgbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bRsRsmbsbLsbRjbRsbRsbRsbLsbLsbsbRsbsbRsLsbLsbRgbRsbRibRibsbLsRsbRhLsbR
sbLsbRsbRhbsbLsbsbsbRsbLsbRgRsmbsbRsbsbRiLsbLsbsbsbsbLsLsmbRgbsbsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bsbLsLsmbLgRsbRsLsbLgbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bLsLgbLjbLeLsLsmbLibLsbLgbLibLgbLcbLhbLcLsmbLjLsmbLgbLgbLobLhbLhbsbsbL
gRsbLcLsmbRjbsbRhbLhbRibLibLibRsbLcbLcLsmbLibLgRsbLsbLsbRjbRobLhbLhbLc
bRoRsmbLibLiRsbLgbLsbRjbLhbRcLsLsmbLgbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bRsLsbLsbLibLgbsbLgbLsbLgbLibLgLsRsRsLsmbRobsbsbLsLsmbsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLgRsbLsbLgLsbLsbLsbLsbRobReLsbLgbLsLsLsmmbLsLsmbLsbLgbLsbRsbLgRsbL
sbRsbsbLgbLgRgbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bLcbsbRjRsmbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bLgLgRsbLibsbsbLgbLobLjbLsbRhLsbRsbRsbLhbsbLcbLibLsbRgLsbLsbRcbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bLsbLhbRobRobsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bRsRsmbLsbLcbLiRsbLcbLgbRibLiLsbLebLgbsbRsLsbRsRsmbRsbRsbsbLsbLsRsbLsL
ebLgbLcbLhbLcbRiLob

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bsbsbRgbLsbLjbsbRsbRsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bRsbLgbLsLsmbsbLgbLgbLsbLsbLgbRsbRsbLgLsbRsbLgbRgbLcRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bLsbsbsbsbsbsbRsLsbLsbRsRsmbLsbLsbRsbLsbsbLsbsbLsbsbsbsbsbsbsbsbsbsbsb
RsLsbRsbLsRsbRiLsbRjRsmbLgLsbRibLsRsRsmbRsbsbsbRgbRsbRsbLgbLsbLiLsbRjb
Reb

>ZF Recording 2016-08-17; tW: 300s; Start: 131227; End: 131727;
Recording: 6-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bLjbRibLsbsbsbRobRgbLjLsmbLjLsRsmbRsbRibLjbsbsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 1; Drug: Control Apo 0.5 然
bLsbRsbRsbLsbRsRsmbRsbsbLsbLsRsbLsbLsLsmbRsbLsbsbLsbLsLsmbLsbRsbLsbRsb
LsbsbLsLsmbLsbLsbRsbRsbLsbLsbRsbRsbLsbLsbRsbRsbRsLsbRsbRsbsbRsbRsbRsbR
sbLsbRsbLsbLsbRobLcLsmbLsbLsbRhbRcbLobLhbRibLibLcbRjbLobRcbRcbLjbRcRsm
bRgbRcbLjbRibRibRibLibLcbRebLgbLjbRoLsbRjbRsbRcbLjLsmbLibRebLgLsbRgbLj
bLibLobLgbRjbLsbRcbRsLsbLgbRsLsbLsbsbsbLebLsLsmbLobLsbLsbRgbLgbRcRsmbL
jbRcbRsbRhbRgbLsbLiLsbRcbLgLsbRiRsmbLgbsbRgbRsRgbLgbRibRiRsmbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 2; Drug: Control Apo 0.5 然
bRsbsbRjbLjbLgLsbRgbRgbRjbLgbRibLibRsbLjbLiLsbLobLibRcbRiRsmbRhbLgbsbs
bLsbRsbRibLhLsbLsbRgbLebLsbsbLhbLsLsmbRibLjbLsbLjbRibRsbRgbRsRsmbRsbRg
bRjRsmbLobLibLgbLibLsRsbLjbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 3; Drug: Control Apo 0.5 然
bLibLsbRibsbLjLsmbRgbLobsbRcbRebLsbRcbRjRsmbsbReRsmbLjbsbLibRgRsmbRebR
oLsLsmbLsbRcRsmbRjbLjbRcbsbRcbLgbRjRsmbsbsbRcRsmbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 4; Drug: Control Apo 0.5 然
bLibsbLibRsbLibsbRgbRgbRiRsmbLgbLsbLjbRgbRsbRsbLsbLgbsbLsbRiRsmbRobLsL
smbLsbLgbLsbLsbLsbRsbLibRgbLjbsbsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 5; Drug: Control Apo 0.5 然
bLjbLobLcbRjbRibLobLibLgbsbLeRsbLcLsmbRsbRsbLcbLobLibLsbRhRsmbRibRsbRi
bRiRsmbLsbRobRgbLibRjRhbRgbRcbsbLibRebRsbLgbRsbsbLsbLgbRobRsRsmbLgbLsb
LibRjbsbLibLjbsbLhbRoRsmbRibLgbRcRsLsmbLiRsbRgLsbLgbRibLsRsbRsbLsbLibL
sLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 6; Drug: Control Apo 0.5 然
bLsRsLsbRgbLibRjbLhbLhbsbLobLibLsbRgbRgbRgbRsRsRsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bLibLibRibLjbLsRsbRsbRsbLibsbRgbLgRsbRjRsmbLibLobRibRibRgbLsbRjRsmbRiR
smbRsbLgbsbsbsbsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bRsLsbLhbRsbRsbsbLgbRsbRsbLsLsmbLhbRobLoRsbLobLsRsbsbsbRsbLcbsbRhbLsbL
gbRgbRsbLsbRobRebRgbRgbRcRsmbRgbLoRsRsmbRjbRhLsbLsRsbLhbRsbLsbsbRcbLjb
Ljb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bLsbLgLsbLgbsbRjbRsLsbLhbLsLsmbRsbRsRsmbRgbLibRjbLsbLgbLgbRibRibRjRsmb
RsbLcbRgbsbsbsbRsbsbLsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bRsLsbLibLhbsbLsbLsbsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bRsbLsbRibsbRcbLcbRgRsmbRibRobLsLsmbLsLsmbReRsmbsbLsbLhbLcbsbsbsbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bRcLsbLiRsbLgbRsbLgbRebRibRsbLcbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bLsRsbRsLsbLsbLjbRsbLiLsbLcLsLsmmbLibRsbRgRsmbRjbRiRsmbRsbLgbRoLsbLgbs
bRiRsmbRcbRgLsbRgbRcbsbLsbRsbLsbRsbRsbRsbLsbsbsbsbLsRsbRsbRsRsmbsbLsLs
RsRsmmbLsbRsbLsRsLsbRsbRsRsmbLsRsbRsLsRsRsmbLsbLsLsmbRsbRsbLsbLsLsRsmb
LsbLsbRsLsbRsRsmbLsbLsbRsLsbRsbRsbLsLsLsmmbsbsbLiRsbRcRsmbRhbLcbLcbsbR
sbLiRsbLhRsbRsRsmbLibRsbRcbRsbsbsbsbLiLsbLsbLibRcLsbRsRsmbRibsbLibRibR
cbRebRsbRsRsLsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bRcRsmbLsbLjLsmbLgbLibRsbRsbsbsbLsbsbsbLjbLsbsbsbsbsbsbsbsbRsbLsbLsRsL
sRsbLsbLsbRsbsbsbLsbsbsbsbRsbsbsbRsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbR
sbsbRsLsbLsbRsbsbLsRsbsbsbRsbLsRsbsbsbRsbsbsbsbsbsbsbsbRsbRsbsbLsbRsbs
bsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bRsLsbRsbsbRiRsmbRsRsmbRgbLhbLsbRiLsbLsRsbRsRibLcbLhbLgLsbRsbRjbLgbLib
RibRsLsbLsbRsRsmbsbLsbLsbLsLsmbLcLgLsbRiLsbLgbsbRsbRibLjbsbLsbRsbLgbLo
bLcbsbLibLibRsbRcbLjbLsbLibRsbLcbLsbLgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bsbRsbRsRsmbRsbRsbLsbsbRsbsbRsbRsbRsRsmbRsRsRsLsmmbRsbLsRsbRsbLsbRsbRs
bsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bLjbLsbsbRsbLoRsbRjbLsbLsbLsLsmbsbRsLsRsbLsRsbLsbLsbRsbRsbLsbLsbRsbRsb
LsbLjbRsbRsbRsbRsbLsbLsbLsbRgbLhbRsbLcbLsLsRsmbsbRsRsmbRsRsmbRsRsmbsbL
sbRsbLsbLsRsbRsLsbsbsbsbsbsbsbLsbsbsbRcbRhRsLsmbRsbRsbRiRsmbLibRhbLsbR
gbLibLebRsbLiLsbRjbLgbRsRsmbRobLgRsbRsRsRsmmbRgbRsbsbRsbRoRsmbRgbLsbLs
bLibLjbRibLjLsmbRsRjbLsLsmbRsLsLsRsRsLsLsmmmbRsbLsbLsLsLsmmbRsbRsbsbLs
bRsbLsbsbRgbLiRsbRgRsLsmbLsLgbLgRsbLibRjbLcbRgbLsLgLsbLgLsbLgbLsbLibRi
bRiRsmbRjbLcbLsbLsbLsbRibRgbLgbLgbRgbLsbLgbsbRsbRsbRsRsmbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bRgbsbRsbsbsbRsbsbsbLsbRoRsLsmbLsbRjRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bRebRiLsbRgbRsbRsLsbRsRsmbLcLsmbLiLsLsmbsbLhbRsRsmbRsbRibRoRsmbRsbRobR
sbRgbRsbRsbsbsbLcbLsLsmbRjbLibsbsbLsRsbLsbRsbRsbRgRsmbRgRsmbRsbRgRsLsm
bRsbLobRobRibRiRsRsmmbLsbRsbLsbRsbLiLsLsmbRsbLcbRgbLsbsbsbLsbsbLsbLsbL
sLsmbLibLsbRsbRsbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bRsbRsRgbRsbsbLgbsbsbRjRsmbRgbLibLsbRgbsbRgbLgbLsRsbsbRsbsbsbsbsbRgbLs
bLsbRsbsbLsRsbsbRsbLsbLsLsLsmmbsbLsRsbsbRiRsmbLcbLobLibLib

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bRsbRibLsbRsbLsRcLsbRsbRibRsbRibRsbLhbRsRsmbRjbRcbLsbRoLsbsbLibLsRsbLg
LsbRebLjbLcbRibRsbRibsbRibsbLgbLgbLsLsmbLhRsbRjbRjbRsbRhbLcbLcbLsRsbLg
bLgbRsLgbLsbLcRsbLibRsbsbLsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bsbLgbsbLibLjbRcbLgbRhbLibLjbRsbLjbLibLjbLgbRgRsmbRjbRhbLjbLobRobLgRsb
sbsbLgbsbLjbRsbLgbsbLjbLiLsbRgbLiLsbLgbLgRsbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bRjbLhbsbRcbRsbLsbLcbLhLsbRgbLebLsbLsbRjRjbsbLjbRcRsmbLoLsmbLgbRcbRgRs
mbRobsbRibLgbRcbRibRsbLgbRibLsbLebLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bRobLsbLiLsbLgbLsbLiRsbLsbLiRsbLgbLgRsbLhLsbLsbLgbLebLgbLgbLsLsmbsbsbL
sbsbsbRsbsbLsbsbsbLgRsbRibRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 25; Drug: Control Apo 0.5 然
bLsbLsbRsbLsLsmbRsbLsbRsLjbLsbRsbRsLsbLsbRsbRsbLsRsbLsbLobRsLebRsbRsbR
sbRsbLsbLobRsbLsbRsRsmbLsbRsRsmbRobRsbRsbLsbRsbRsbLebRobLsRsbLsbRsLsbR
oRsmbLsbRsRobLsbLsbsbLoLsmbLsbsbLsbLsbRsbRcbRsbRsbLsbsbsbsbsbRsbRjbLsb
LsRsbRsRsmbLsbRsbLsRsLsbLsRsbRsbRsbRsbRsLibLsbRsbRjbRsbLebRobRobLsbRsb
RsbLobRobLsbRjbRsbLsbRobLsbLsbLsbLsbRsbRsbLsbLsbRsbRsbLsbLsbRsRsmbLsbR
sbRsbRjbLsbLjbRsbLsRsbRsbLjbLsRsbRjbLobLsbRsbLsbLsbLsbRsbLsRsbLsbLsbLj
bRjbLsRsbLsbLjbLebLsbLebRjbRsbRsbLebRjbLjbLebRjbLsbLjbLobLjbLjbRjbRjbL
sbLjbLcbLcLjbLcbLobLsbRsbLebRobRsbRebLcbRobRebRcbRebRcbLcbRjbLjbRcbRsb
LsbRsbLebLebRjbRebLebLobRsbLobRobLcbLjbLjbRcbLcbRebLebLebLjbRjbLcbRcbR
ebLobRobRsbLobLjbLobRobLjbLobRebRjbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 26; Drug: Control Apo 0.5 然
bLsLsmbLsbLsRsbRcRsmbRsbRibRgbRgbRibRsbRibRsbRiRsmbRsbRiRsmbRgLsbLsbsb
RsbRibRibRibRsbRsbRcbRibRsRsmbRsbRiRsmbRgbRibRsRsmbRsbLiLsbsbRiRsmbRsb
sbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 27; Drug: Control Apo 0.5 然
bRcLcbLiRsbLcbsbLibRobsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 28; Drug: Control Apo 0.5 然
bsbLibLsbRcbRsbLsbLsRsbRsLsbRsbRsbsbLsbLsbLsbLsbRsbsbLsbsbLsbRsRsmbsbR
sRsmbRsLsbLsbLgbRibsbRsbLsbsbsbLsbLsbRsbsbsbRsbsbRsbRsRsmbsbLsbRsbsbsb
LsbRsbsbRsbLsLsmbRsLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 29; Drug: Control Apo 0.5 然
bRsLsbsbsbRsbRgbLjLsmbRgbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 30; Drug: Control Apo 0.5 然
bLjbLgbLgLsbLgbLibsbLjbLgbsbLibLcbLcRsbLsbRsLsbLsbRsbLsbsbsbsbsbRsbsbs
bLsbRsbRsLsbLsRsbLsbsbRsRsmbsbLsbLsbRsbRsbsbLsbRsbLgbsbsbsbLibRgRsmbLi
LsbRjRsmbLibLsbsbLjbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bRibRibLjbLhbRebRhbRsbRiRsmbRibLgbLsLsLsmmbLsbRibRjbRcbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bRebRobLobRsbLebLebLobLcbLcbLobLobRibRcbRgbLcbLgbLobRibLobRebRcbLobLob
RebRcbLcbLobLebRobLcbLcbLobRebLobRgbRcbLebLhbLebLgbLobLcbRebLobLobRebL
ebLcbRobLcbLcbRcbRobRebLebLobLobRebRobLgbRobLgbRobRobLibLobLebRgbLcbRg
bLcbRcbRsbLebRobLobLobLcbRcbRobLcbLobRgbRobRobLebRhbLebRcbRobRobLebReb
LibRebLobLcbRsbRobRobLobRobLobLebRgbLobLebLobRcbLobLcbLcbLebRibRobLebR
ibLobRobRcbRobRcbRhbLobLcbLebLebLobLobLebRebLcbRcbLobLobLjbLcbLobRobLc
bRobRobRebRobRgbRobLobLgbRibLebLcbLibLcbLobLsbLebRebRobLcbRobRobLobLob
LsbLebRebLebLobRobLcbLibLibRobRobRebLcbRcbLobRobRsbRsbLebLebRibRobLebL
cbRjbLobLobRibLebLobRobRibRcbRobLobRebLcbLebLhbRobLobLsbRjbLsbRcbRobLo
bLcbRgbLgbRebRebLobRebRebLobRebRobLobRobRobLobRebLobLobRcbLobLibRhbLib
LobRcbRcbRobRebRobRcbRobLobRobLobRobLgbLhbRobLcbRgbLobRgbRcbRobLobRibL
ebLobLcbRobLcbLobLobRebLobLcbRhbLcbLobLsbRobLobRobRgbRgbLcbRobRebLcbRo
bRobRcbRebRibLobRibLebRobRobRcbRobLcbRibRebLobRobRobLcbLobRibLobRobLob
LebLjbRebRjbRebLcbRibRebLebRcbLobRibRobLebLobLcbLjbLgbLgbRebLhbLcbLibL
ibRebRebRhbRcbLobRebLobLobRjbRobLobLebRobRobRobLobLobRcbLobLobRsbRcbRo
bRcbLebLobLobRcbRobLibRobLebRobRcbLebLebRebRcbRcbRobRobRebLobLsbRebLeb
LobLcbLobLobLgbRebLcbRobRobLebRebRobRebLebRobLobLcbLcbRebRobRobRobLebL
ebLebLebLsbLsbRcbLobLcbRebRebLobLebRobRgbRcbRsbRebLobRobLcbLobLsbRebRe
bLsbLobLobRobRebLebRcbLebLebLobRobLobLebLebLobRebLebRebLhbRobRsbRebLob
LobRibRsbRibRobLsbLibLobRibLcbRobLobLcbRobRebRobRobRebLobLebRebLgbLobR
sbLcbLebLobLcbRcbRcbRobRobRobRobRobRcbLsbLgbRobRibRebRcbLcbRobLcbRebRo
bRcbLcbRobRebRibLobRobRobLebLobLobLobLgbLibLebRcbRobRebLcbLobRcbRobLob
RibLsbLibRcbRcbRobLobLebLobRibRobRobLibRebRobLobRebRebRcbLebLebLcbLcbL
cbLibLobLcbRobLobRsbRobRobRobRebLsbRobLgbRcbRobRebRobRobLobLobRibLgbLj
bRsbLobRsbLobLcbLibLobLebLcbLobRcbRebLjbRcbLobLcbLgbLcbLobLsbLobLebLcb
RgbRsbRcbRobLcbRebLgbRebRcbRebRebLibLobRobLobRgbLebRobLibLcbRebRcbRhbR
obLcbLobLebRebRobRgbRobLebRibRebLobRobRebLebRcbRcbRobRhbLebRibRsbRhbRo
bRebRsbRobLcbLcbRobLobLhbLobRobRebRobLcbRobRcbRobLobRibLebLcbRebLobRob
LcbRebRcbLcbLcbRgbLobLgbRobRebLebLobLcbLcbRobRcbRebRobLcbRobLobRebLobR
cbRebRobLebRobLebLibRcbRsbLobLebLobRgbLobLebLebRsbLebRcbLibLcbRobLhbRe
bRcbRsbLobRcbLcbRobLobRcbLobLcbLebRcbRgbRsbLebRibRobRgbLobLgbLobLhbLgb
RobLebRobRebRobLcbLsbLebRobLobRobLebLcbLebRsbRibRobRebLcbRcbLcbLebLgbL
obLobLcbRgbLobLebRobRgbRcbLobRobLgbRobRhbLebLobRebLobLebLobRobLobLobRg
bRobRebRobRibLobRobRibRobLobLebLebRebRebRebLebLobRobRibLgbRobLcbLebRcb
LcbLcbRobRobRobLobRsbLsbLobRebLobLgbLhbRcbLcbRebLcbRobLebLobLobRobRebL
ebRobRcbLebLcbLcbRobLobLebLobLebRgbRobLhbRobRcbRibRebRobRsbLobLobLcbLo
bLibLebRobRobLcbLibRobRcbRebLcbRebLcbRobRhbLcbLobRobLobLgbRebLobRobLob
LcbLobRobRebLcbRobLcbLebLobLobLcbLebRibRebLobRobLebLibLobRobRebRobRobR
ebLibRobRobLobLibRobRobLcbRobRebLcbRobLobRsbRsbRebRebLsbLebLcbRibRebLo
bRebRebRsbLebRobRcbRsbRcbRobRebRobRsbRcbRhbLibLgbRhbLebRibRjbRcbRcbRob
RgbLebRobRsbRebLibRgbLobLhbLibRobLsbRobRobLobLebLebLobLebLcbRibLebLobR
obRobRobLibLsbRobRcbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bRibLjbLiLsbsbLiLsbLgLsbLibLgbLibsbRsbLibLibsbLibLsbLjbLcbLibLgbRsbRoR
smbRcbRcbLgbLibRoLsbLjbRsbsbLsbsbRcLsRsbLcbRsbLjbRobLcbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bsbRibRsbsbRsLsbRsLsbLibRsRsLsmbRcbLsbRcbLsRsbRsbsbRgbRsbRgbRsbLsbLsbL
gLsbRobRsRsmbRibRibRcRsmbRibRgbRiLsbsbsbRgRsmbsbLsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bLgbRjRcbRcbRcbRjRsmbLsbLsbsbsbLsbsbRhbLcbRsbLsLsmbLgbRsRsmbRsRgbRcbRe
bLobRgRsmbsbRsbsbReRsmbsbReRsmbRgbLiRsbRgRsRsmmbRjRsmbRsbRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bLgbRsRgbRgbLibLobRebRiRsmbRsbsbRjRsRsLsmmbRibLsbRsbRibRsbRsbLsLsLsmmb
RcbLcbRgbLhRsbLgbLcbLsbLcbLgbLgbLcLsmbLgRsRsRsmmbRhRsmbRgRgbsbRibLsbsb
LsLgbLsLsmbRsRgbLsLsmbRsbLiLsbRiRsmbLsLsmbRgbLsLsmbLgLsbRgRsmbLhbRjRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bsbsbLsbLhbLsbRsbsbRcLsbLcbLsbLgbRsbLibLibLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bLoLsmbLcbRgbLhbsbRhbRjbRobLobLjbRjbLjbLjbLcbLjbRobRebLebRobLsbLsbLjbR
obLjbLjbLsbRobLebRobRsbLsbLobRjbRobLebLobLjbLjbLsbRjbRsbLobRjbLobRsbLs
bLobLjbLobLobRjbLjbRobLebRobLsbLsLgbRgbLsbRcbLsbRgbRcRsRsmmbRoLsbsbRsR
gbLgRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bsbLcbRgbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLgLsbRsbLibLebRsbLgbLgbLsbLcbLhbLibRebRsRsmbLhLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bsbLsbLsbsbsbLsbLsbLsbLibsbRgRsmbRsRsmbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bLcbLcbLobLgbLsLsLsLsLsLsLsLsLsmmmmmmmmbsbsbRoRsmbRgbLcbsbLsRebRsbRsbL
ibLsbLibLcbRebRibLgbRgbRhbRsbLgbRjRsmbLhbsbRsbLibRcbRsbRiRsmbLcbRobLgb
LibLibRobsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bRcbRsbRsbLjbRcbsbRsLsbsbsbsbLjbRibRgbLgbRgRsmbLgLsbsbRcbRiRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bLgbsbLsbLgLsbRsbLgbLsbsbLsbLgbLibRhbLsLsmbLgbRsbsbsbsbRsbLgRsRsRsmmbR
sRsRsmmbsbRgbRhbLobLcbLcbRjbRjbLsbLhbRgbLcbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bRsLsbRsRsRsRsmmmbLsbLgbLsRsbRsbRsbLsLsLsmmbLsbRcLsbLobLjbLobLiLsbLgLs
bLsLgbLsLsmbLiRsbRsRsmbsbLibLgbLsbRsbLgbLgbRcbRsbLsLsLsmmbRiRgbsbRsbsb
RsbRiLsbLsbLsRsbRsRsRsRsRsLsmmmmbLsbsbsbRiRgRsmbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 131729; End: 132229;
Recording: 7-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bsbsbsbRjRsmbsbLsbRgbRsLsRhbLjbLsbLibLjbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 1; Drug: Control Apo 0.5 然
bsbRcbLsbLibRebRiLsbRsbRcLsbRsbRhbLgbRiRsmbRsbLsbLgbRgbRhbLsbRsbRgRsmb
RsbLsbRgbRsbsbsbsbRsbsbRsbLsbRsbsbsbsbsbLsLsmbsbsbLsbRsbLobLcbRibLsbLs
RsbRjbLcbRsbLsbLsbLgbRiLsbLsbLibRsLsbLcRsbLhbLibRebLgbLjbRcbRgbLgbRsbL
sRsbsbsbLsbLsbRsbLsLsmbLsbsbRsLsbRsLsbsbRsRsmbsbsbLsbRsbRibRsbsbLsbsbR
gbRgbsbLsbsbRsbLsbRgbRgbLsbLibLcLsRsmbLcbRcbRhbRgbLibRjbRcbsbsbLsbLsLs
mbLsRsbLsLsRsmbsbsbLjbRobRcbLhbRjRsmbRcbLgbRsbRsbRcLsbLsRsbRcbRsLsbLhb
LcLsmbsbRsbRibsbLcLsmbLgLsbLibRsbLiLsbLibRgbRsbsbLebRobRhbRgbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 2; Drug: Control Apo 0.5 然
bRiRsmbLgLsbLsLsmbLsbLsbRsRsmbLcbLcLsmbLgbRibsbsbLibLcbLjbRobLjbsbLcbL
ibRsbLsbLgbLgbRsRsRsmmbLsbLjLsmbLhbLebLcbRsbLgbLsbLsbLhRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 3; Drug: Control Apo 0.5 然
bReRsmbLgRsLsbRjRgbRgbLjLsmbLsbRjbRjbLobRjbRibRibRsbRsbLcbRibLgLsbRjbR
jbsbRibLobsbRjbRcbRsbsbRhbsbsbRcbRsbsbRjLsRsbRgbLgbRgbLsbRibRgbLcbRsRs
RsmmbsbRibLsbLhLsLsmbRgbLibRgbRsbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 4; Drug: Control Apo 0.5 然
bLhbLibRgRsmbRsbRsRsRsmmbLcbRsbRsbRcbRsbRsbRgbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 5; Drug: Control Apo 0.5 然
bLibRsbRcRsmbRsLsbLibRsbRgbRsbLibLgbLsbLcLsmbRsbLsbRsbLsLsmbLibRsbLcbs
bRibLibRjRsLsmbLsbLiRsbRgbRgbLgbLsbLsbRgRsmbsbLsbLsbRsbRgbLgbLgbLibRcb
sbLiLgbRobRsbRcRsmbRsbRsbLcLsmbLjbLibLgbsbRsbLibsbRhbRsbRcRsmbRibRcRsm
bRhbLgbRibLsbsbRjRsmbLhbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 6; Drug: Control Apo 0.5 然
bRebRibLgbLsLgRsLsbRibLibLjRsbLgbRjbLgbLsbRsbRsbRibsbsbsbLsbRsbLsbLsbs
bRsbRibLibRibLgbRhLsbRgLsRcLsbRsLsbRibRiLsLsmbRgbRhbRhbRjbRobRib

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bsbLcbLsbLibsbLsLsLsmmbLoLsmbLibLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bsbLsLsmbRsbRsbLsbLsbLsbRsLsRsLsbRoLsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bLgbsbsbsbLiLsLsmbRgbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bRsbLsbRsbLsRsbLsbLsbsbsbLobLsLoRgbRgbRsRsmbLcbLibLobLobRoRsmbRiLsbRsb
RsbRgbLcbLgLsbLcbRgbLcbRibRhbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bRobRjbLibLsRsLsbRcbsbRoLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bLsbsbsbRgRsmbsbRibRgbRibRsbRebLsbRcbLsbLjbsbLibLgbRsbRsbLsLsLsRsmmbRs
bLsbRgRsmbLcLsmbLcbRjbRsbRgbLhbLhbRsbsbRibsbLcbsbRjRsmbRibLcLsmbsbRjbR
hbRcbLsLsmbLibLcbLgbLiRsbsbRsbLhbsbLgbLsbLsbRsbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bLsRsbRsbLsbRsbRsbRsRsmbRsbLsbRsRsmbRsbLsbLsbLsRsbLsbLsRsbRsbLsLsmbRsb
LsLsmbRsbLsbLsbRsbsbsbLsbsbRsbLcbLcbLjLgbLcbsbLhbRibRobLgLsbRsbRsbLobR
sbLcbLgRsbRsRsmbRcbRiRsmbLsLsmbLobLibLhbLcRsbLibLhbLiLsbRsbLgbLsbRobLs
bLgLsbRsLsbLhbRibLcbLibLobRgbLobLcbLiRsbRsbRsLhLsbRibLcbRgRsmbLibsbLjL
smbLsLsmbLsbLsbRjRsmbLcbLobsbRgbLhbRjbLcbLcbRjbRcLsbLcbLjbRoLsbRsbLibL
ebLhbLcbRgRsmbLcbsbRibLhbLibRhbLebLebsbRcbsbLobLibRgbLcbRsLsbLiLsbRgbL
jbLgbLibLibLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bLgbRjbRgbRsbLsbsbLgbRsbLsLcbLibRsbRgbRsRsmbLsbLsRsbLsLsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bRgbRgbRsRsmbRsbRsbRsLsRsLsbsbLsbRsRsmbsbLsbRgRsmbLsbLsbLsbsbLjRsbRebR
ibLcbLiLsbLgLsbLsbLcbRsbLibRibsbLsLgbLsbLsRsbRsbsbRsbRsbRsbRsbRsbRsbLs
RsbLsLsmbLsbLsbRsbLsbRsbLsRsbLsbRsLsLsLsRsmmbLsLsmbRsRsmbRsRsmbsbLsbRs
bRsRsRsmmbRhbRsbsbRsbRjbRcbLcLsmbLgbLgbLibLgbRgRsmbRcLsbRsbRcRsmbRgRsm
bRsbRsbRsRsmbRgbLsbRgbRsbRobLgbRgbRebLjbRgbLhbRiLsbLsbLsbRibRibRiRsmbR
sbRjRsmbRhRsmbLgbRcbRgRsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bLiLsbRjbsbRsbsbsbRgbRgbLsbLjbLhbRibRibLibsbLsRsLsbsbRsLsbRibRhbLibRib
RsbRibRiRsmbLjbRiRsmbRsbsbLsbRsbLsbRgbRgbLsbRiRsmbLgbRsbRibRsRsmbRsbRi
bRibRgbLibRibRsLsbLsbRsbsbsbLgLsbLgbLsRsbLsLsmbLsLsmbRsbsbLgRsbLgbRhbR
jRsmbLiRsLsbRsbLsLsmbRsbsbsbRsRsmbLsbLsbLsbRsbRsbRgbLsLcLsmbLsbRebRebR
gLsbLiLsbRibLgbLsbRgbRobLgbLhRsbRjbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bLsbLsRsbLgLsbRsLsbRgbRibRcbRjbRsRsmbLibLsbRjbLsbReRsmbLhbLibRsbLsbRsR
smbRsRsmbLsRsbLsbsbsbRsbLsLsmbLibRgbRcbRsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bRhLsbLibLcbsbLsbsbsbsbRsbsbsbsbsbsbsbRsLsbsbsbLsbsbLsbsbLsbsbsbRsbLgb
RsbLsbLsbRsRsmbLgbRsbLsbLjbRsbLsbsbRsbLcbLsbLsbLiLsbRsRsmbLoLsRsmbLgLs
bRsRsmbLgbLsbRsbLiLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bLsbsbLibRebRgbRibLcbLjLsmbLgbLgbRgbRebLibsbRsbsbRibRgbRsbRgRsRsmmbsbR
gbLgRsbLhLsbRibRcbRjbRgbLcLsmbLeLsLsmbRebLsbRsbRibRgbLgbRsLsbLsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bLsbRsRcbLibRsbsbLcbRcbsbLjbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLsbLibRibLsbsbLiRsbRibRsbLibLgbLgbLibLibLibLobLibsbRcbLgbLjbLjbLibLhb
LgRsbLgbsbLsbRsbRsbLgbLibLgbsbLibLibRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bRcbLjbLjbRgLsbLiLjbRibLobLibLibRsbLsbLobRiLsbRsbRsLsbRgLsbsbLjbRcLsbR
sbRgbLjbLjbLhbsbLiLsbRiRsmbRibLsbRgbRsbLibsbsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bLibLgbLsbLibLgbLsbLsbLjbRgbRebRhbsbsbRgRsRsmmbRhbLibLgbLjLgbLgbRibLsR
sbLsbRhbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 25; Drug: Control Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 26; Drug: Control Apo 0.5 然
bRebRiRsmbsbsbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 27; Drug: Control Apo 0.5 然
bLjRsbLsbRcbRhbRobLibLjbRsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 28; Drug: Control Apo 0.5 然
bsbsbLsbLsbLsbsbLsbRsLcbLibsbRibsbsbsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 29; Drug: Control Apo 0.5 然
bLjbRjbLsRsbRebRsbLcbRsRsmbRibsbLsbLobRsbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 30; Drug: Control Apo 0.5 然
bLibRiRsmbRsbLibLsbLcbsbRjbLsbLobLgbLibLgbLgbLiLsbLgbLgbLiLsbLgbRobRjb
RsbLjLsmbsbLsbLsLsmbLobRoLsbLjbLiRsbLhbLjbLsbLibRgbLgbLgbsbLibLsLcbLib
LsbLgLsbLibLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bRhbLsbRobLibRibLsbLjbRhbLsbRibRgbLcbRibRcbRhbLgbRibRsRsRsmmbRsbRsbLib
RcbLsbLgbRobRgbRiRsLsmbRebLebRhbRhbRcLsbLjbLhbLsbRobRgbLsbRcbRsbRcbRsb
RhbRhRsmbLsbRcbRhbLjLgbLgbRcbRgRsmbRjbRibRsbsbRjRsmbsbRiRsmbRgbLjbRcbR
hbLibsbRjRgbsbLoLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bLebLcbRebLobLcbLobLobRobRgbRcbRobLobLobLobLcbLcbRcbRobRebRobRgbRibLob
RobLibLcbLobRibLebLobLobRobRsbLcbRibLcbLebLjbLgbRcbRobRsbRgbRobRebLobR
obRobLcbLobRobLcbLebRobRcbRcbLobRibRobLibLgbRgbLebRsbRgbRebRgbLgbRcbLc
bLobLobLebRobLebRcbLobLobRibRobLebRcbRcbRobLcbRcbLibLibLcbRebRcbLobRob
RobLebLebRobLebRgbLsbLebRcbRcbRcbLcbLebRobRobLobLgbLobRebRgbRobLebRibR
obRobLcbRobRsbLobLobRebRcbLgbRhbLcbRcbLebLobRobRhbLibRhbLgbLobLcbRebRo
bRobLobLobLcbLobRcbLgbRobLcbRcbLcbLibRebLobLibRobRibRibLobRebLobRebRcb
RebLobLhbRobLobRibLebRobLebRobRobRobRcbRebRobRgbRcbLebRobLebLobLobRobR
ebRibLobLobLebLobLobRobRcbLcbLsbLgbLobLsbLgbLcbRgbRcbLobLcbLobRobRobRe
bRjbLobRcbRobRcbRibLebRibLcbRcbRsbRobRgbRobRibRobRobRcbRgbLobRjbRobRob
LcbLobRibLcbLobLobLgbRobLibRgbLobLibRcbRebRcbLgbLobLobRobRebRebRobRobR
cbLobRibRcbRobLibLsbLcbLebRobRsbLgbRebLobLobLobRobLgbLcbLobRcbLobRgbRe
bLgbLebRobRibLebLibLibLibRcbRobRobRobLcbRobLobLcbRebRibLebLcbLobLcbLcb
LebRibRcbLibLebLibLobLebRebRibRobRebLebLgbRibRobLobLobLobLobLibLgbLobL
obRobLcbRcbRobLebLobLobLobLobRobRibLsbRibRobLgbLebLebLebRobLobLebRcbRo
bRcbLgbRhbRobLobLobRobLobRcbLibRebRebRebLobRibLebLsbLcbLibLebLsbRhbLgb
LibLebLebLibLobRobRobRobLibRobLgbRobRcbLcbRebRobRgbRobLsbRcbRebRcbLgbL
sbRcbRobRobRcbLebRobRobRobLebRcbRgbLobRsbLobRobLibLcbRgbLobLgbLobLibRo
bLobLebLhbLebRsbRgbRibRebLobLcbLibLebRobRsbLebRebRebRibLebRebLcbRcbRob
LebRebLebLobRcbRobLobLcbLibRobLhbLcbRebRgbRebRcbLcbRobLobLebLobLebRobL
ibRebLebLsbLgbRcbLibLobRhbRobLcbRobRobRobLgbRobLgbLobRcbRgbLebRebRobLi
bRibLibRebRcbRebLebLobLobRobRobRebLsbRobRobRcbRebLebRebLobLobLgbRobRib
RebRibLobLhbRcbRebLcbLobLobLgbLebLsbLcbLhbRebLibLcbLgbRcbRobLobRobRobL
obRcbLobLobRgbRobLobRebRobRibLobRebLobLebRobLgbLobRobLobLebLcbLcbLibLi
bLebRibRebLobLobRsbRcbRibRibLobLobLobRebLobLibRibLibRobLobLobRebRebLob
RebRobRobRibLsbRobLcbRsbLobLobLobRgbRobLobLebRcbRebRebLobLibRebRebRobL
ebLobRgbRobRobRcbLebRobRcbLebRebLhbLhbLcbLobRibRobLcbLebRcbLgbLebRobLo
bRebRebRebRebLcbLobLebRsbRobRebRobLebLobRcbRebLobLebRobRobRcbLcbLobLsb
RebLobRsbRobRgbLcbLcbLebLobRobLcbLebLebRobRobLibRebRebRobLebLcbLobLgbR
ebRobLobRibRobLsbRobRobLcbLebLsbRobLobRcbLobLcbRobRobLgbLobRcbLibLsbLg
bRobLebLibLobLebRobLhbLhbLibLcbRobRebLebRebRcbRcbLobRobRjbRobRobRebRib
LobRibLobRebLebLebLcbLhbLobRobLobRobLgbLcbRibLobLobRebLebLobLebRobRobL
ebLobRibLebRobLobRebRobRobLobRebLobLebRebLebLebLgbRobRebRcbRibRebLibLo
bLobLgbRobLebLebRebRobRobLebLibRgbRebLebLgbLebLebRebLhbLobLcbLobRobLob
LobLsbRebLobLebLobLobLobRcbRcbRebRgbRebRibRebRibLebLsbRobRcbLobLcbRcbR
obRhbRobRhbLgbLobLebRobLebRcbRebLgbLebLebRebRobRebLobLibRobLobRobRobLe
bRobLibRhbLcbRgbRcbRebRebLebRebLsbRsbLobRobRebRsbRgbLobLcbRobLobLcbRcb
RobRsbRebLibRobRebLobLebLebRobLobLobRibLibRobLcbLobLebRobRobRebLebLcbR
ebLobLebRebRebLebRibLebLcbLobRobLgbLsbRsbRobLobLgbRebLebLebRobLobRebLe
bLobRebLobLobLobLebRcbLobRebLsbRobRobLcbLcbRebRcbRsbLobRebRebLebRobLob
LobLobLobRobLebLebRibRobRcbRibRebLobLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bLjbLcbLhRsbRibLgbLsbLjLsmbRobRiLsbLsbsbRgRsmbLhbsbLibLcLsmbsbLjbLebRg
bLsbRoRsLsmbRsbLsbLjbLibLgRsbLgLsbLgbRobRiLsbLsbRcbRsbRibLgbRibRgbRsbR
gbRibLsbRsLsbRibRsbRibsbRcbLibRibRsbRibRgbRsbRibLsbLsbRiRsmbLsLobLcLsm
bRjbRibRjRsmbRgbLsbRsbRobLibRsbRsbRsbRsbRibRcbLibRsbLsRcLsbLsbRgbRsLsb
RsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bsbRsbsbRcRsmbRsRsmbsbRsbLibRsbRcbLobLobRiRsmbLhbLcbLhbRsbLcbLibLcbRsb
LibLcbLsbRobRibLsbRhbLsbLsbRgbRcbLsbRibRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bRsRsmbRsbsbsbRcRsmbLgbRibRibRibRsbRsbRibLgbRebLsbRsbRcbLcbRcbRcRsmbLh
bRibLcbLobRhbLgbRsReRsmbRcbRcbLsLsmbRibRobLibLcbRebRebRsLsbRibLiRsbReR
smbRsbRibRebLjbLsbLobReRsmbLsbRgbRoRsmbRsbLsbRcRsmbRjRsmbRibRsbRhbLgbL
sbRibRibRsRsmbRibLgbRgbRgbRsbLsbRibLsbLsbRibLsbRgRsmbRsbRgbLsRsbRgRsmb
RgbRsbRcRsmbLibReRsmbRgRsmbLgbRgbRcbLhbLjbLibRjRcLsbLsbRibLhbLhRsbLibL
sRsbLjbRobRgbLsLcbRobRhbLgbRiLsbRsRsmbRcbRsRsmbRgbRibRgbRgbRsLib

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bLjbRjbRcRsRsmmbLgbRgbRgbRiLsRsbRsbRobLoLsmbRsRgbRgbLiLsbRhLsbsbsbLjLs
mbLibRgRsRsmmbLgLsbLsbRgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bsbLhbLibRsbLjLsRsmbLgRsbRgbLgbRgbsbsbLiRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bLeLsLoRsRsmbRcRsmbLsLsmbsbRsbRsbRsbRsbsbRsbLgbLsbRobLeLsbLgLsbRjbRebR
ibRsbLebLibLsLsmbLgbLgbLcbLibLsbLhbLibLgbRsbRsbLcbLgbLibRsbRsbsbRhbLgL
sbRsbRgbLjLsmbLjbRsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLobLhbsbRobsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLibLibLeLsLsmbRibLgbRhbLsRgRsmbRgLsLsmbRgbLsbRsbLebRcbRibRsLsbRsbR
sbRsbRsbLgbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLsbRjbLcbLgbLibLobRsbLhbLhbLgbLibRsRcbRgbRibLsbLsbLsbLgbRsbLgbLhbR
sbRsbRsbLsbLibRsbLgbLgbRsbLgbRsbLobRsbRibRsbRgbLcbLibLgbLsbLgbLsbRgbRs
bLgbLjbLgLsbLgbRsbRcbRgbRgbRsbRgbLsbRibRsbRibRibRsbRsbRgRsmbLobRcbRgbR
gbLhbRsbRgRsmbLobRgbRobRsbLgbLibRsbRsbRiRsmbRsRsmbRsbRibRsbRsbLgbLsRsb
RsLsbRsLsbLsbRhbLsbLjbLibLgbLgbRgbLgbLgbRjbLibRibRibRsbRsbRgLsbLibLgbR
ibRsbLsbLcbLsLsmbRjbLgbLsbLsbRsbLgbRsbLgRsbLsbLgbRsbLsbLgbRsbLsbLgbRgb
LcbRsbRgbLibRsbRgbLgRsbLgbRsbRgbRsbLhbLsLsmbLgbLsbRsLsbRsbRsbLgRsbLiRs
bRgbLgbRobLgRsbRibRgbRsbRsRsmbRgbRsRsmbLgbRibRgbRsbRcbLibLsbLgbLgbRgbR
ibRsbRibRibRsbRsbsbLibLsbRsbLgbLsbRsRsmbRsRsmbRgLsbRjRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
bLiRobRibRgbRibRibLgbRgLsbRgbRibRibRgbRibLsbRoLsbRibRibLgRsbRibRsbRgbL
sbRsbRibRibRobRibLibRhbLjLjbsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bLsbRoRebsbLiRsbRsbLebRsbRsLsbRibLibLsbRibRobLibLcbLsLjbRoLsbLebRgbLcb
RobLjbLgbLebRhRsRsmmbRcbRcLsbRobRibRgbLcbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bsbsbsbLsLsmbsbLsbRcLsbRoRsmbLobRsbRjRgbLsbLibRgbLsLsmbLgbRibsbRcbLobR
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bLgbsbRsRsmbRibLgRsbsbReRsmbRgLsbLgbRibRsLsbRjRsmbLiLsbLsbLjLsmbLsbRcb
LgbLgRsbRsbLgbRsRsmbRsbLgRsLsbsbRgRsmbLibLgbLgbLsRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bRsbRebRsRgbRgbRsbLsLsmbRjbLebRgLsbRsbLsbLgbLobRibLhbsbsbLgLsLsmbRsbLs
bsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132231; End: 132731;
Recording: 8-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bsbLjbsbLjbLhbRibLsLsmbsbRibsbRsRsmbLsbRsbLsbLsLsmbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 1; Drug: Control Apo 0.5 然
bLsbRsbLsbRsbLsbLsRsbLsbsbLsbLsRsbRsbRsbRsbLsbLsbRsbRsbLsbRsbRsbLsbRsb
RsbLsbLsbRsbLsbLsbLsbRsbRsbLsLsmbsbRsbLsbRsbLsbRsbRsbRsbRgRsmbLsbLgbsb
LcbLsbLhbRibRiRsmbRsbRibLgbRcbRhbRgRgRsRhRsmmbLsbRiLsbsbLcbRebRgLsbLsb
sbLcbLibRcRsLsmbLjbLcbRcRsmbLsbRiLsbLcbLsbsbLibRobRhRsmbLjbLcbsbLibRsb
RsbRgLsbLcbRiLsRsbRjbRibRoLsbLibsbLibRibLibLibLibRsRsmbRcbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 2; Drug: Control Apo 0.5 然
bLsbLebRsRsmbLsbRibLeLsbRsbLgbRhbRcbLjLsmbLjbLjbLsRsbRcRsmbLsbRsbLsLsm
bsbsbRsRsmbLjLsmbRibLsLsmbLobLgbLibsbRgbLgbLjbLgbLgbRhbsbRgbLsbLjLsLsm
mbRhRsmbLibLjLsmbRiLsbRgbRgRsRsmmbLebsbRibLhbRibLsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 3; Drug: Control Apo 0.5 然
bsbRsbRcRsRsmmbLoRsbsbRsbRjbRsbLsbsbsbsbLhbRgbsbsbLhbRcbsbLjbsbRibLcbR
cbsbsbRcbRoLsRsbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 4; Drug: Control Apo 0.5 然
bLsbRgRsmbRjLsbLibLibLibLgbRobRsbRobLsbRjbLgbRsbRgbLgbLsbRgbLgbRsbLgRs
bLcbLebRjbRibLobRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 5; Drug: Control Apo 0.5 然
bLjbLsbLsLsLsmmbsbLgLsbRibRcbLobRjbRhbRcbLobRhRsmbLgbRgbRsbRsbLcbRibRi
bRgRsmbRsbLjbRcbLoRsbLhbRebRcbLgbRhbRsbRsbRibLsbRsbRibLgLsbRibRgbLsbLs
bRgbRsbLjLsmbsbLsbLjLsmbRjRsRsRsmmmbLgRsbsbRibRsbLsbLcLsmbRebRobLsLsmb
LobLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 6; Drug: Control Apo 0.5 然
bRhbsbRgRsmbRgbLgbRjLsbRsRcLsLsLsmmbRhLsbRgbRgbRgbRsRsRsmmbLobRiRsRsRs
mmmbsbsbsbLsRsbLcbRgLsbRcbRoLsbRibsbRsbLobRgbLcbLibLjbsbRibLcbsbsbRsRs
mbRsbLibRsLsbRobsbLjbLcbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bLebRsLobLjbLiRsbRcbRiRsRsmmbRsbLcbLiRsbRibLjbLibLhbLgLsbRobRibRjbRgLs
bRsbLsbRgbLsbRsbRgbRibLsbRobRsbRcbLibLgbLgbLibRgbRsbRsbLibLcRgbRgbLjbR
obRgRsmbLsbLjbRhbLgbLsbRobLsbRsRsmbLsbRsLsbRsbRibLgbRgbRgbLgLsbRgbRsRs
mbRibLgbRsbRgbRibLiRsbRsRsmbRjbRcLsbRsbLsbLsbLsbLgLsbLsbLgbLgbLoRsbLib
LsbRsbLsbLhbRebLcbRsbRhbLcRsbRgbLsbRcbRgLsbLsRsbLhLsbLgbLgbLhbLhbRgRsm
bLhRsbLcbRjbLoRsbLgbLsbLibRsbRsbRsRsmbLsbRgbRgbRcRsmbLgLsLsmbLsbLsLgbL
sbRjbLsbRsbRhbLhbLcLsmbRsbLcbRgRsmbsbLcbRgbLibRsbRjbLsbRibLsLsmbsbRgRs
mbLsbRgbLgbRsbRgRsmbRsbRgbRsRsRsRsmmmbRgbRgRgRgRiRibRgbRiRgRgbRgbRgRsR
smmbRgRsRgRsmmbRgbRsbLjbLibLhLsbLgbLhbLiLsbRgbLsbsbLsbsbRiRsmbLibRsbRj
bLjbsbRhbLibLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bsbsbLcRsbLgbsbLgbsbsbLsRsbRsLsbLsbLhbLibLoLsmbLibsbsbLiRsbLgLsbLsbsbL
sbLobsbLibLcLsmbRsbRibLib

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bLsLsmbLgbRobRobRibsbLsbsbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bLcbLobLobLcbLcbLcbLoLsmbsbLcLsmbLibLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
b

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bLsLobRgbLgbsbsbRcbLhbLsbsbsbsbsbsbRjbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bRsLsbLibRoRsRsRsmmmbRcRsmbRsbRibLcLsRsmbLibLsbRsbLcbLsbLibRsbLibReLsR
sbRibLibLgbLcbLsbLsbRsLsRsbLsbLsRsbLsRsbsbsbRcbRgbRgbRsbLhLsRsbLsbLsLs
mbLobsbRsRsmbLeRsbRobRobsbsbRgbRsRsmbLsRsbRgRsRsmmbRgbLoRsLsbLibLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bRjbLibsbLsRsbRibRgbRjbsbRoRsmbsbLibRibLgbLibRsRsRgmbLsbRcbLsbLjLsmbLc
bRsbLsbLibLgbRibRibLhbRcbLibLiLsbRgbRjbLibRsbReRsmbLsLgbRsbLjbLebLibLe
bLcbRsbRibsbLgbLobLobLsbLcbLibLsbLsbRsbLsbLcbRgbLibLcbRsbRsbLibRsbRgbR
sbLcbLiLsbLgbLobLiLsbsbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bLgRsbLhLsLsmbLiRsbLjbRsbLhRsLsbLcbLsLsmbsbLibLgbsbLibLsbRsbLebLobRsbL
cbRoRsmbLsbLhbLsRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bRsbRsbLsbRsRsRsRsmmmbRsbRsbLobLiRsbRjbRibRibRiLsbRsRsRsmmbRgbsbLsbRsR
sRsRsmmmbsbsbRsRsmbRsbLsbLsRsbsbLsbRsbRsbsbRsbRsbRsRsRsmmbRsRsRsmmbRsR
sRsRsRsmmmmbRsbRsbRsLsbRsbRsbRsRsRsRsRsmmmmbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bLgbRsbsbRsbLsRsbsbsbRsbLsRsLsbRsbsbLsLsmbRgbRgbLgbRgLsbRsbRgLsbRsbRgb
RsbRgbRsbRsLsbsbLsRsbRsRsRsmmbRgbRjbLsbRibLibLgbRgRsmbLgbLsbsbRgbLsbsb
RsLsbLsbRsLsLsLsmmbLsRjbLgbRsbsbsbRsRibLsbLjbLgbRsbRjbLsbLjRsbRgbRgRsm
bRsbLcbRsbLsRsbLibLsRsbLsbLgLsbLsbLcbLsRsbLgRsbLgbLjbRsbRgRsRsmmbLsRsb
LibLsbLibLsLgbRsbLgLsbLsbLgRsbRgbLiRsbLgRsbRgbLibLsRgbLsbRsbRsLsbRsLsb
RsLsbLsbsbLgRsbLibRsbRsbRsbsbLsbsbLsbLsbLgbRibLsbsbsbLhbRjbRcbRsbLgbLg
bLgLsbRsbRibLgbLgbLgbLgbRsbsbsbsbLsbRsbRsbLsRgbRobLjbLgbsbRsbLobLsbRgb
RsRsmbLsbLjbLgLsbRsbRsbsbLsRjbRsRsmbsbRsRsmbRsbRobLsbLsRsbRibRcbLsbRsb
LgRsbLgbLsbRsbLgbRsbRsRsmbRsbRsbsbRsbLsbLsLsmbsbRsRsmbLsLsmbRsbRgbRgbL
gRsbLgbLsbRsRsLsRsRsLsLsmmmbsbsbRsbsbsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bsbRgLsLsmbsbRgbLgbLibLiRsbLsLsmbLgbsbLsbLsbsbRsRsRsmmbRsbsbsbRsRsmbRs
RsRsmmbRcbsbRsbsbsbRgRsmbRgRsRsmmbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bLibRgbRsLsbsbLsbRsbLsbRsbRsRsmbLjbLobLjbsbLsbLsbLsbLsbRsbLsRsbRsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bRsbRsbsbRsbLsbLsbsbLsbLsbsbRsbsbLsbLsbLsbsbLsRsbLgbRsbRgbsbLgbLsLsmbR
sbLsLsmbsbsbLsbLsRsbLsbsbsbsbLsLsmbRsbLsbsbsbRsbLsRsbsbLsbRsbRsRsLsmbL
gLsLsmbRsbLibRgRsmbsbsbsbsbLgLsbsbsbsbRjbLgbLjRsRsmbsbRgLsbRibLgLsbLsb
RgLsbReRsmbLibRoRsmbLibLcLsmbRebLsbLsLoLsmbRsbLsbLsbRsLsbRgbLsbLsbRebR
ibsbRcRgLsbLcbLiRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bRcbLgbLjLsmbRsbRibLsbLgbLcbRcRsmbLibRsLsbLsbLsbLcbRcbRsRcRiLsbLjbRsbL
hbLgLsbLsLsmbRcRsmbRsbLibsbsbLhb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLjbsbRsLsbLibLgbsbLgLsbRsbLsbRgRsmbLgbRjbLgbLsLsmbLsRsbsbLsLsmbLsbLgb
LgbLsbRjbRsbLgbLibLibLebLibLsbLsbLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bLibLsbLsbRgRsRsmmbsbsbLjbLjbRcRsmbLibRsbsbsbLcbLcbLobRibLebRibRhbRhLs
bRcbLsLsmbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bRsbLsbRsbLsbLgbLgRsLsbLsRsbRjbLjbRibsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 25; Drug: Control Apo 0.5 然
bRsbRobLsbRsbRebRebLebLobLsLsmbLjbRsbLjLsmbLebRjbLcbRsbLebRebRebRobLsb
RsbRobLobRsbRobLsbRjbLebRobLcbRcbRobRebLobRcbLobLobLgbLcbRebRcbLobRobL
gbLgbLjbLobLcbRcbRjbRobLobLcbLebRsbRebRobLjbLjbLobRcbRobLobRobLebLebRj
bRobRebLebLcbRebLobLebRsbRcbRobLjbRjbRebRobLobRobRcbRcbRebLsbLobLebRob
RcbLobLjbLobLobRobRobLebLobLebRsbLobLobRobRjbRobLjbRobRebRebRcbLcbLebL
obLobLjbRcbLsbRobLobLobLebRcbRsbRjbLcbLsbRebRebRobRjbLobRobLobRebLobLo
bLobLobLebRcbLobLjbLebRobRebLjbRcbLebLebLobLebLobLobRebRobRjbRobLsbRob
RebRebRhbLjbLebRebRsbRjbLobLcbLebLjbLobLobRebRebLebLobLobRebLjbRobLcbR
jbRobLobLjbRobRjbRobRobLobLcbLsbRebLcbRcbLsbRobRobRjbLobRobRibLebLobLe
bRobLjbLebLebRebLjbRobRobRcbRsbLjbRebLjbLobRebLjbRobLcbLobRcbLcbLjbRob
LobLjbLcbLobRobLjbRobRcbRebLsbRobRobRebLobLjbLobRcbLobLobRobRobRebLobL
ebLobRebRcbRebLebLsbLcbLobLebRobLobLjbLobRobRobLobLobRsRjbLobLebRobRob
RobLobRebRebLjbLobLobRsbLebRebLsbRobRcbRebRobRcbRcbRsbRsbRjbLobLobRjbR
sbLobRsbRobRhbRebRsbRobLsbRsbLcbRobRebRebRjbRebRobLebLobLjbRobRcbRobRe
bRcbRebLebLobRebLebLobLsbLjbLobLjbLjbLobRobRobRjbRsbRobLsbLobRobLobRob
RebLobRobLebLjbLsbLsbRebRobLcbRobRsbRcbRcbRjbLjbRjbLobLjbLebLjbRobRjbL
jbRebRcbRobLcbLebRobLsbLebRsbRebLebRobRebRsbRibRobRobLcbRebRcbRebLebRe
bLcbLobLjbRjbLjbRobRjbLobLobLjbLobRebLebRebLjbLjbRobRobLobLobLjbRjbRjb
RcbLebRobLjbLsbRebRjbRcbRobLobLcbLobLebRcbLcbRebLsbRebRobRobRebLjbRjbR
cbLjbRjbRsbLcbLobRebLobLebRebLcbLcbLcbRobLobRcbRebRjbRjbLobRjbRobRobRj
bRebLebLobLebRcbRobLebRobRibRcbLcbLjbLobRobLobLcbLobRgbRcbRgbLcbLsbLob
LobRebRobRsbLebRgbRobRgbLobLobLobRgbRebLobRobLobLobLgbLebLebLobLobRobL
obLsbRobRobLebLcbLsbLobRebLobRcbRsbRobRibLcbRobLobRebLobLobLobLobRobRc
bRcbRobRsbLsbLcbRobRobRebRebRebLgbRibRibRebRgbLcbLibRcbRibLobRebLobLob
LcbLobRsbRgbRobRibLobLobRobLobLobLobLgbRcbRsbLobLobRebLobLebLibLhbRobR
hbRobRibRobLobRsbRcbRobLobRgbLebLibRobRobRcbRebRobRcbRobRobLobRibRobLi
bLobRcbLobLebLjbLhbRobRsbRebLibLhbLibRebLebLobLebRobLcbLobLobLobRgbLeb
LibRobRobRobRebLobRebLgbLobLibLobRgbRobLgbRcbRobRibLgbRebRgbLebRobLgbR
obLgbRibRebRcbLcbRebLobRebRebRibLobLobLjbRgbLibLcbRobRobRsbLobLobLebLo
bLobLobLsbRcbRobRobLebLcbLobLebRibRobLgbRobLibRobRibLcbLgbLibRebRobLcb
LobRobRsbLcbLobLgbLebLobRebRcbLobRibRibRobRgbRebRobRobRebRcbLgbLobRobR
ebRobLhbRobLhbLobRhbLsbLgbLobLebRibRgbLobLcbRobLobLebLibRibLibLcbLobLc
bRobLobRcbLobLobRebLobLobRobLobRobLebRebLebRebLhbLsbLebRgbLobLobLebLob
LebLebLibLebRobLobLebRobRebRebRobLobLgbRobRebLobLcbRebRobLebRobRobLobL
obRobRsbLgbRcbLebRgbRcbRobLsbRibLcbRsbRibLebLobLcbRobLobLobRcbLibLcbRg
bLebLobLebRgbLobLobLebRobRebLhbLsbRcbLgbLobLhbRobRcbLobLgbLobRsbRebLib
RebLobLobRjbLebLobRcbRgbLobRobRobRibLobRobRgbRobLebRcbLibRcbLcbLebLobR
obRobRebLgbLgbLebRobRibRebLibRebLcbLobRebRhbLebRobRhbLcbLebLcbLgbLibLe
bLobRobRebRcbLcbRcbRgbLobLcbRebRobLobRebLcbLcbRebRobRcbLhbRobLobLobLeb
RcbLobRebRobRebLgbLobRobLobLobRobLobRobRobLobLobLjbRobLobLebLcbLobRobL
obRjbRebRjbLobRhbLgbRebLebLobLcbLobLobRhbLebLcbLcbRobRgbRobRcbLobRobLo
bRobLobLebRobLebLobLebLcbRobRsbLebRhbLcbRobLgbRobRebLebRebRcbLsbLcbRcb
LebLobLobLebRobLcbLobRobRgbLobLobRobLobLobRgbLobLcbRebRebLcbRebRobRsbL
obLebRibLibLcbRobLobRobLsbLobRobLobRebRcbRobLebLcbRebRgbRgbRcbLgbRobRo
bRebLsbRcbRobRebRobLobLcbLobRobLcbLebLobLobLebLebRobLebRobLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 26; Drug: Control Apo 0.5 然
bLoLsmbRebRsbLsbLsRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 27; Drug: Control Apo 0.5 然
bRsbLgbLsRsbLcbLcbLgbLgbLsbLgbLsLsmbsbLgbLibRcLsbLgbLgbLsbRjbLibRsLsRs
bRobLoLcbLibLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 28; Drug: Control Apo 0.5 然
bRibLgbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 29; Drug: Control Apo 0.5 然
bsbsbRsbRsbRsbRgbRgbsbRoRsmbLcbLgbsbRsbRgbRsbRsRgRsmbLgbLsLsmbLhbRcbsb
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 30; Drug: Control Apo 0.5 然
bLjbLiLsbLsbRibLiRsbRsbRoLsbLhbLgbLobLibRgLsbRjbLsbLibLgbLibLgRsbLsLsm
bLsLsmbLsbRsRsmbRsbLiLsbsbRgbLjbLsbRhbLibLgbLsLsmbRobLgbLgbsbRobRsRsmb
LsbLsbLibLgLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bRsbLoLsmbLjbLgLsbRhLsbLebLibLcbLibRsbLcbRcbLsLsmbLjbRjbRhRsLsmbsbLibs
bLibLcbLhbRobRibsbRsbLjLsmbRcbRhbLibLgLsbRcRsmbLgbLeLib

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bLgbRgRsmbsbLgbLgLsbRibRcbRobsbRebRgbRhbRibRcbRobRoRsmbRgbRsbRcbsbRiRs
mbRibRgRsmbsbsbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bRobRebRcbRgbLobRhbRsbLobLobLebRibLobRgbLibRgbLebLobRgbLobLebLebLebLob
RebLobLhbLobRebRobLcbRsbLobLobLobLobRobLobRebLebRcbRcbLebRcbLgbRibLobL
ebLgbRibRebLcbRjbLobLobLebRobLobLebRobLgbLobLjbLcbRobLebLobRobLebLobLo
bRobRgbRebLibRobRcbLobRibLcbRobLjbLhbRebRgbLgbLobLjbLcbRebLhbRobLebLob
RhbRobLcbRobRobRobLibLsbLgbRobLobRobRcbRebLobRebRebRebRgbRobRebLcbLobL
cbLsbRobLcbRcbLobRcbLobRobRebLibRebRebRobRebRcbRobLobRibRebLobRsbLobLe
bRcbRsbRebLebRebRobLcbRebRcbLibLebRebRebLgbLgbLebLcbLgbLibLhbLobRobReb
LobLobLobRibRobLobLcbLobRobRobRebLibLobRobLobRobRcbRebRebRebRobRobRcbL
obRibLobRobRibLobRcbLibRebRobLebRebRebLsbRibLobRobRjbLsbRcbRobRobLobRo
bRobRobLgbRebRobLobLebRebRibRobLcbRebLibLcbRsbRebRobRebRcbLebRhbRibLcb
LsbLobRibRobRebRobRobRcbRebRcbRebLobLcbLobRebRebRebRebRobRobLebLgbLobL
obRebLebLcbLobRebRobLebLobRobRobLebRobLobRcbLobLcbRobRebRcbLobLibLibRo
bLobRjbRobLhbRobRobRebLobRobLcbLsbRhbRebRobLobRobLobLgbLibLobLobLobLib
LebLobLebLcbLobRhbLcbRobLhbRgbRsbLgbLobLcbRebRgbRgbRobRcbLebRobRcbLobL
ebLobLjbRobLcbLobLhbLobLibLobRgbLebRebRobLebRcbRebRebRibLsbRcbLobRobLc
bLebLebRibLebRobLibRhbRobLgbLobLobLobRobLebRibRjbRebRebLebRebRibLebReb
LebRcbLcbLobLebRobLobLebRobLgbRibRobLebLgbLobLobRobRobLgbRcbLobRgbRgbL
obLobLibRebRcbLobRobRgbRcbRibRobLcbLebLebLobLobRobRobRcbRebLebRobLcbLo
bLobLobRcbLobRobLhbLcbRgbRcbLobLobRibRobRobLobLsbLobRhbLobLhbRcbRebLeb
LgbLebLebRcbRsbLibLobRebLcbLobRgbRobLcbLebRcbRcbLobLcbRobRcbLobLobLobR
ebRsbRcbRgbLobLgbLsbRobRobRebRebLcbLsbLsbLcbRhbRobRcbRobRobRgbRebLobLe
bLgbRgbRebRgbLobRobLobLebLebRobRobRobRsbRobRcbRsbLebRibRsbLobLobLobLgb
LobLobRhbLibLcbLobRobLgbRcbLebLobRobRebLobRibLobRobRebRobRibRhbLcbLebR
obRebLebLebLobRcbLobLcbLgbLibRobLobLibLebRibLebLebLebLibLobRobRgbRcbLc
bLobLobLobLgbRobRebRcbLobLobRgbRcbRebLobLobLcbLebRjbLebLobLsbRhbRebLob
LobRobRobLebLebLebRcbLebLebRobRobLobRibLobLobLcbLibRobRebLebRebRgbRobR
obRobRobRebLhbRsbLcbLobLebRibRebRgbRebLibRobLobLcbRebRobLcbRjbRgbRcbRs
bLhbLobRobLsbRgbRobLobRibLgbRcbLobLobLobRobRobRcbRebRebLobLebLebRcbRcb
LgbRcbLobRobRobLobLobRebRcbRibRebRobLobLebRgbRsbRebLobRebRgbLebLcbLobL
ebLobLobLhbRcbLgbRobLobRcbRibRobLobRgbLgbLobLcbRcbRobRebRsbLobRebRebLc
bLobLebLobLcbLibLcbRgbLhbRibLebRobRobRobRcbRobRibLebRobLgbLobRobLobLob
LhbLobLcbRebLobRibLobLcbRcbLcbRebRgbRebRebRcbRcbLobRebLebRobRcbLgbRobR
obRcbLsbLebLebRobLobRcbLcbRebRobLebRgbLcbLcbLsbLsbRobRobLobRgbLebRebRi
bLsbRobLhbRcbRhbRobRebLobLobLobLobRebLobRobRebRobLobLibLobLsbLobLebLeb
LcbRcbLsbLebRobRgbRcbRcbLobLebRobRobRobRobRcbRibRgbLobLjbLibLobRcbRobR
cbLobRobRebRebLibRibLcbLibRobRibLcbLobRebRobLobRobRibRebRgbRcbRcbRebLc
bLobLobLgbLobLgbLobRobLobLcbLebLcbLebLobRibLcbLebLibLebLhbRcbLhbRobLcb
RobRebRobRcbRobRobRibLebLibLobRhbRobLobLebLobLebLobRobLobLobRsbRebLebR
cbRobLcbRebRcbRsbLobRibRsbRobRobRebLcbRebLobLcbRebRcbLibRebLobRebLobRg
bRhbLcbLebRibRebLhbRobLobRobRobRgbLobRcbRcbLcbRibLibLobRebRebLobLobReb
LebLsbLobRobLcbRebLobRcbRobLcbRebLobLob

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bRsbRgRsmbRsbRsbRgbRsLsbRsRsmbRsbsbRgbRsbRgbRsbRsbLcbLgbRobRgbLsbLjbLh
bRgbLhbRgbRhbLsbRjbLgbRgRsmbRsbRsbRsbRsRsmbsbRsbLgbRsbLsbLsbsbsbsbRsLs
LsmbLsbLobLsbLsLgbLgbRjbRhbRibRsRsmbLibRibRsbRsbRsbRibRsRsmbsbsbRibsbL
sbRibLsbLgbRibRgRsmbRsbLobLgbRcbRhbLsbRibLcbRcbRibLibRibRibRibLhbRgbRi
bLsbRjbRgbLsbRibRgbLsbsbRibLjbRibLgbsbLjbLcbLhbLhbRibRsRsRsmmbsbRcbRcb
RcbRhbLsbRibLibRcRsmbLsbLcbRsLsbRcRsmbRsLsbRcbLebsbRobRibRsLsbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bRsRsmbLiLsbLgbRsbsbRibRibLsbLsbsbRgbRsbRiLsbRsRsmbLsbLsbRsbRhbsbRcbLh
RsbRgbRiLsbRjRsmbLsbRgRsmbsbRibRsbRsbRgbLsbRgRsmbRgbLsbRgbRsRsmbsbsbRi
bRgRsmbRsbLsLsmbRsLsbRgbLsbLgbRgbRsbRiRsmbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bRsbsbLibRibLgbRcbLcLsmbRebRibRobsbsbRibRcRsmbRgbLibLoRsbRsbLcbRgbsbRc
bLsbLgbLcbLjLsmbLsbLgbRgbLsbLsbRgRsmbRsbLgbLibRoRsmbLsbsbsbLsbLsbRsbsb
sb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bLjLgbRjRsRgmbLjLsmbLsbRcLsbLoLsmbRgbLibLcbRhRsmbLcbRibRcbLsbLobRibRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLsbLsLsLsmmbLsbRcbLsbRsRsmbRsLsbRjbLjbsbLsRsbsbRsbLebLgbLsbLsbsbLo
bRob

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bRgbLsLsmbsbLjbRgRsmbsbRsbRsbLgbLcbLhbLgbRgbRibsbLsLsmbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bsbsbRsbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bsbLsRsbsbLiRsbRsbsbLibRsbRibRsbRsRjbLiLsbRsbLgbRcbLgbRebLobRsbRgbsbsb
LibLsbRibsbLsbLhbLebLsRsbsbLiRsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bRsbLibRjLsLsmbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
bLcbLibRsbLibLsbLibLebsbLsRgLsbLgLsbRsbsbsbLsRsbsbsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bsbRsbLjbRobLsbLsbLcbLjbRibRcbLgbRgbRibLsbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bRiRsmbRsbLobsbLgbLiLsRsbLsbLibsbRsbsbLgbsbLibRsbsbsbLoRsRsmbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bLsLibLgbsbLsRsbLgbLsbLgRsbLgbLgLsbLgbRsbRsbRsLsbRibRsbLibLeLsbLhbLsbR
sbLgbRhRsmbsbsbLsRsbRgbLgbLsRsbRsLibRsbLgbLibLsbLgLsbLgbRsRsmbLcLsmbLg
bLsRsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bLsbLgbRsRhbsbLsbLjbLsbLsLsLgmbLsbLjLsmbRsLsbRsbRsLsbLsRsbLsLsmbLgbRsb
LsbLsLsmbLsRsbRibLobLsbRsbLsbLjbRgbLsbRgRsRsLsmmbRobRebLsbLebsb

>ZF Recording 2016-08-17; tW: 300s; Start: 132733; End: 133234;
Recording: 9-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bLcbRcbRibsbLjLsmbLsbRgLsbLsLsmbRsbLsbLjbRibRcbRcbLjbLcbRcbRobRcLsbRib
LjbRjRsRsRsmmmbLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 1; Drug: Control Apo 0.5 然
bsbLgbRibLhbRgRsmbLjbRsbRoLsbLsbLgbLcbRjbRibRiRsmbLsbRsbsbLsbRsLsLsmbs
bsbsbsbsbLsbLsLsLsmmbsbsbsbsbsbsbLibRcbRsbRcLsbRcbRjbLcbRjbRibRsbRiRsm
bRsbRibsbRibRhbsbLibLibRiRsmbRhbLibRhbRibRibsbRiLsbRhbLgbRcbRibsbLibLi
bRsbsbRsRsmbRibLgbRjbRcbsbLsbRsbRibRsLsbLsLsmbLsbLsbsbsbRsLsbRebLoRsbL
cbsbRgbLsbLjbLcRsbRhLsbRsbLhLsbRjbReRsmbLcbLsbLcbLgbLibRhbLsbLjbRibRgb
sbLsLsmbRsbRsbLsbLsbLgbRibLjbLcbRgbRhbRibRibLsbLebLcbLcbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 2; Drug: Control Apo 0.5 然
bRebRsbRgbRgRsmbRcRsmbsbRgbRcRsmbLsbRjbLebRhbsbRcbRiRsmbLsbLebLjbRcbRc
bLebLcbLcbLsbLsbRcbRsRsmbRhRsmbRgbLgbRibRgbRgRsmbsbsbRgbRibLibRsbRibsb
sbRibRibsbRcbRsLsbRiRsmbLsRsbRebLobLobLsbLgbLcbLiLsbLjRsbLhb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 3; Drug: Control Apo 0.5 然
bLhbsbRcRsmbRjRsmbLobRgbRibRiRsmbsbRcbRcbRibRsbsbLsbLsbLjbLsbRcbRoLsbL
sRsbLsbRcbLgbRcbLiLsbRjbsbLjbRsbRsRsmbLcLsRsmbRcbLgbRgRsmbsbRgRsmbRsbR
iRsmbLgbRibRiRsmbLsbRsbRhRsRsmmbsbRsbRgbRibLjLsmbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 4; Drug: Control Apo 0.5 然
bRgbLebLsbRobLsbLsbRsbLebLebLebLsbLsbRsbRsbLebLcbLsbRjRsRsmmbRebLjbLhb
RhRsmbLsbLcbLibLoRsRsmbRsbRgbLsbLsbRsbRsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 5; Drug: Control Apo 0.5 然
bRsbRsbRgbRsRsmbRibLsbRcbRibRhbLsbRsRsmbsbLhbRsbRcbsbRgbRsbLhbsbLgLsbL
ibRcbRiRsmbLibRibRgbRcbLgbLsbLsLsmbLiLsbRhbRsbLibLhbRibsbLjbRcbRhbRjbL
jbLibLgbLsbLcbLsbLgbRebLsRsbRsbRibRsbRgLsbRgbRsbRgbLsbRsLsbRibLsbsbRib
sbLsbRgRsmbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 6; Drug: Control Apo 0.5 然
bLjbRsbLsbLjLhbLhbLgLsbRebRhbLjbLcbLcbLgbsbLsbLsbLgbRgLsbLsbsbsbRjLsRs
bLhbRsbLibRcbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bLsbsbRsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bLsbLsLsmbRsbsbLgbRsLsbRibRobRibLsbLsbRsbLsRsLsbsbsbsbLhbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bsbLsbsbLsbRsLsbRibsbLibsbLsbsbLcbLoLsmbLgLsbLgbLgbRsbsbsbsbsbsbLsbsbR
sbsbsbsbsbsbRsbRobLcbLsbRiLsRsbsbRjbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bLcbLoRsbLcbsbsbLcRsbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bLjbsbsbsbsbLsbsbsbsbsbsbLsbLsbsbRsbLsbsbRsbsbLsbsbLsRsbRsbsbLsbLsbsbL
sbLsbRsLsbLsbLsbLsbRsbLsbRsbRsbLgbLsLsmbRsbLsLsRsmbRsLsbRsbRsLsbsbLsRs
bLsbRsRgbRgbLsRsLsbLsbLsRgbLsRsbLsRsbRsRsmbsbRsRsmbRsbLsbLsRsRsLsLsmmb
RsRsLsmbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bLgRcRsRsmmbLgbLebLsbRsbRjbRibRgRsmbLsbLobsbsbLsbsbsbLibRsLsbRiLsRsbLc
bsbLoRsbLobLhLsbRcbLibsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bLsRsbRsLsbRgLsbsbRsbLsRsbLebRibLsLsmbLibLsRsLsbRjbRobsbRcbsbLibsbRsRs
mbLsbRgbLjbRcbRibRsRsmbLsbRsbRsbRibRibRgRsmbRsbLsbLsbsbRsRsLsmbRsbLsLs
LsmmbLsbRsLsRsbRsLsbRebLoLsmbLibRsbRiRsmbRibRjRsmbReLsbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bLcLsLsLsmmmbLhRsbLhbLsbRsRsmbLebLsbRiRsmbRibRibLsbLibLhbRgbLibRibRcbs
bRibLhLsLsmbsbRjbRsbLgbLgbLhbRgbLibRjbRibRcbsbsbLjLsmbLsLsmbRsRsRsmmbL
sLsmbLjbLibLsLsmbsbLsLsmbsbsbLhbRjbRsRsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bLibLibRhbLgbLgbsbRibLgbRcbLsbLibLjbLibRsbsbLgLsbRgbRsbRsbLibLhbLibRsR
sLsmbLgbLsbRjbRgLsbRgbLcbLhbLgRsbLgbLgbRsbLsbRsbRsbLsbLsLsmbRobRsLsLsm
bRgbRsbRsbRsbRsRsmbLgbLibLibsbLsbLgRsbRgbRgbRsRsmbLgRsbLgbLcLsmbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bLsbRsLsbLsRsbLsbRsbLsbLsbLsbRsRsmbRsbRsbRsLsRsbRsbRsbRsbRsbRsbRsbRsbR
sbLsbLsbRsbLsRsbRsbRsbLsbLsRsbRsbLsLsmbRsLsbLsbLsRsbsbLsbLsbLsbLsbRsbL
sLsmbLsbRsbRsbRsbRsbLsLsmbRsbLsbsbLsbLsbLsbLsLsmbLsLsRsmbRsbLsbLsRsbRs
bLsbRsbRsbRsbRsbRsbRsbRsbLsbRsbRsLsbLsbLsbLsbLsRsbsbLsbLsLsmbLsbLsbLsR
sbRsbLsbLsbRsbRsbRsbRsbRsbLsbLsbLsbRsbLsbRsbLsbRsbLsbLsbLsbRsRsmbRsRsR
sRsRsmmmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bRsRsmbsbRsbLsRsbLgbRgbLjbLiRsbRsRjbRibRsbRgbRsbLsbLsRsbRibsbsbRsbLsbR
sRsmbRsbLjbLjbsbsbLjbRsRsLsRsmbRjbRibRcbLhbLhbLiRsbRsRsmbRsbLjbRsbsbRg
RsmbRsbLsbRsbRgbLgbRebRgbRibRgbLsbLsRgbLjbRjbLsLsmbsbRsbRsbLsbLsLsRsRs
mmbLsRsbLsbLgbLsRsRsLsmbLsLsmbLsbRsbRiLsLsmbRgRsmbLgbRgbLjbRibsbRhbLgb
RjbsbLsbsbRjbLsRsLsbRibRibRgbLgRsbsbLgbRgbsbLsbRjbsbRsRsRsmmbRsbRsbRsb
RsbsbsbsbsbsbLsbRhbLibRgbRcbLgbLsbLsbRgRsmbLjLsmbRiRsmbLjbRgRsmbLsLsmb
RsbLsbsbRsLsbsbLgbRsbRebRhbRgbLiRsbRibLiRsbLibsbRebLgbRgRsmbLibRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bRgbLgRsbsbLsRsLsbRsRsmbsbRsRsmbLgbRjRsmbLgLsbRsRsmbLcbRgbRsbRsRsmbLeR
sbLibRobLsRobRhbsbLhbRgbRjbLgbLsbRiRsmbRgRsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bLgRsbRgbRgbLiRsbLgRsbLsbLsbLibLsbRsbLsbRcbRiLsbLsbRgbRsbRibRiRobLgLsR
sbRsLsRsbRhbRgbRibLsbRgbLgbRibRsbRsbLiLsbRsLsLsmbRiRsmbRsbRsbsbsbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bsbsbRsRsLsmbLsLsRsmbRsLsbLsbLsbRsRsmbLsbLsbRgbRsbLgbsbLhLsbRsbLsLsmbL
sbRjbRiRsmbsbsbRhRsmbRsbsbRgbRsbLsbLibsbsbLjbRsbLcbRjLsbLsbRsbLjLsLsmm
bsbLsLsLsmmbsbRjbRsRsmbLsbRsbLhbRgbLgbLsbsbsbsbsbsbLgLsbRgRgbsbsbsbLsb
sbRsbRsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bLsbLgbRobLsLsmbRobRibRgbRgbLjLsmbLhbLsbLsbsbRibsbRibRcbRgbLgbLgbLsbLi
bLsbRgbRsbLcbLsbRibLsbsbLjbRibLibRsbsbsbsbLsLsRsmbsbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLibLibRhLsLsmbRsbLibRebRibLobLgbRgLsbLibRgRsmbLcbLibLsbRibLsbRgbRhbLs
bLjbLibLgbLcbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bRjRsmbLibLsbRgbLjbLsbsbRcLsbLsbsbLobRibRibLgbLsbLsbLsbRobRibLobRgRsmb
sbLjLsLsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bLgbRibRiRsmbRibsbsbsbsbsbsbsbLibLiRsbLsbLsbRibLibLibsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 25; Drug: Control Apo 0.5 然
bLsRsLsbLsbLsbRsbLjbRcbLgbLeRgbRcbRhbLobLgbsbLcbRjbLcbRob

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 26; Drug: Control Apo 0.5 然
bRjbRgbRibRebRibRsRsmbLebRsbRibRgbLsRiRsmbLsbRcbRsbRhbRiRsmbRibRhRsmbR
jbsbRibRgRsmbRsRsmbRgbRgbRiRsmbRsRsmbRsbRgbRcbRcbRgRsmbRibRsbRsbLiLsbR
sbLgLsbRsbLgbLiLsbRsbLsbRebRgRgbRsRcbRsbRibRsbRibRsbRgbRsbRsbRsRsmbRiR
smbRsLsbRjbRibRiRsmbRhbRsbRsbsbRcbRgbRsbRgbRgbRibRsbRsLsRsbRsbRsbsbRiL
sbLsRsbLgbRebRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 27; Drug: Control Apo 0.5 然
bLjRsbRibLsbRoLsRsbLsbRjRsmbLobRcbLgbRibRgbRobsbsbRobRsRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 28; Drug: Control Apo 0.5 然
bsbsbRsbLgbRgbRhbLsbLgbLibLcbLibLcbsbsbsbsbLsbRsLsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 29; Drug: Control Apo 0.5 然
bLhbsbRobRoRsmbRsbRgRsmbLsbRgRsmbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 30; Drug: Control Apo 0.5 然
bLhbLibRsbLjbLobLiLsbLibLibLsLsmbsbRsbRsbRjbLibLjbLgbLgbsbLgbLibLgLsbL
sbRibsbRgRsmbLsbRsbLcbLsbRjbLibRsbRsRsRsmmbLgbLibRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bRebsbLsbLibsbsbLsbLcbLobLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bsbLgbRgbsbLsbLsbLgbRgRsmbsbLibRjRsmbRgbsbsbLgbRjRsRsmmbLgbRgbsbRsbLeb
LsbRobRcbLgbRcRsmbRibRobRibRibLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bLobLobLobRobLcbLibRobRcbLcbRobRgbLobRobLcbLebLobLobRobLgbLobLobLobRib
RebRebRgbRebLobLgbRcbLgbLhbRgbRobLsbLcbLobLgbRcbLsbLobRebRhbRobRebLebR
obRobLebRobLsbRebLcbRobRebLobRobRobRobRobRhbRobLsbLgbLobRobLcbLebLobLe
bRgbRebLobRcbLobRobLobLebLcbRobRebRcbRhbLgbLobLobRsbLibRobRebRebRibLib
RobRcbLobRcbRobLobLebLebLebRobRcbRgbLebRebRhbRobRobRobRibRebRebRebLebR
obRobLibLhbRcbRgbRobRebRcbRobLebRobRobLebRobLobRcbRebRobLebLebLobRobRe
bRebLebLobLebLebRebRebLobRebLobRibRcbRobRobRebLibRjbLcbRebLobLcbRebRcb
RgbRobRibLobLebLcbLobRobLibLibRsbLibRebRebLobRgbLibRcbLobLobRjbLcbLcbL
obRibRobLibRcbLcbLobRobRebRobLebLobLobLebRcbLgbRebLibLebLgbRjbLcbRebLo
bRibLobRobRhbRebLcbRobLebRobLobRcbRobLhbLobRobRcbRcbRebLobRobLibRsbRob
LobRgbLobRobLgbRebRebRobRcbRcbLebLebRebLgbLebRobLobRobRobLcbRebLebRobR
ibRobRebRobLebLhbRgbRebLhbRcbRibRobRibLgbRcbLcbRobRgbLebRhbRgbRobRcbLe
bLobLobLcbRobRgbRcbRobRibLsbLobLibRebLhbRcbRobRhbLobRobRgbRibLobLcbLob
LobLebLgbRebLibRobRobRibLebRebRobRcbRobRcbLobRobLobLebRgbLobLobRobLjbR
ibRobRebLibLcbLobLsbLcbRebRebRcbRobLcbRcbLobLobLhbLebRcbLhbRjbRobRobRo
bRcbRobLgbRcbLobRobRcbRgbLobRsbLcbRcbLcbRibRcbLobLobLjbRobRebLibRibLob
LgbLibLobLebRobLgbLobLcbRobRobRibLgbLsbLibLobRibRgbLgbRebRcbLebRebRsbL
gbRibLobRobLobRcbRebLibLobRebRobLobLobLobLobRobRobLebLibLhbLebRobRgbLc
bLobLhbRcbLgbLebLobLibRobRobLibLobLebLobRobLobRcbLcbRcbLobRcbRebRobRcb
RobRebRibRobRobLibRibLobLobRibRhbRcbRobRhbRobLebRebLobRebRobRsbRcbRobR
ebRobRibRobRgbRebLsbLcbRobLobLobLobRibRsbRobRobRibRobRcbLebRobRobLobRc
bLebLcbLcbLcbRobRobLebLibRobLobRobLobRobLobRgbLibLobRcbLibRebLebRibLob
RibRobLobRobLcbRebRebLcbLebLobLobLobLobLibRebRobLcbLcbLobRcbLsbLobRebR
cbRgbRobLobRcbLobLobRobRobRobRobRobLobRibLsbLcbRobLsbRobRebRebRebRebLh
bRcbLcbLhbRcbLgbLgbRjbRibRobRobLobRebLcbRcbLebRebRobRobLobLcbRgbLebRob
RibLebLcbRcbLsbRgbRobRhbLobLobLobLobLobRebLobRobLobRibRebLibRcbRobRcbL
obLobRobRsbRibLhbRcbLibLibLebRobRobRobLebRobRebLibLgbLgbLobLobLibRibLo
bRebLobLsbRibRobLebLibLobLgbLobLobRcbRebLsbRibLcbLobLobRebRebLebRebLcb
LebRebRebRobLobRebLobRobLobRibRobRebRobLobLibLgbLcbLobRobRcbLobLobLebL
cbLobRebRobRobLgbLobLcbRobLobRobRcbRsbRsbRebLobLebLobRobRebRobLebLobRs
bLobLobLibRobLcbLobRobLobRobRebRobLsbRobLobLobLobRobRobLobLobRcbRobLcb
RebRcbRebRibRcbLebRobRcbRibRobRobRcbRebRcbLebRibRsbLebLobLcbLebRsbRobL
gbRobRcbLobRebRcbRcbRobLebLebLcbLobLcbLobRebRobLebLcbRobRibLobLobLebRo
bRobRobRgbLobRcbRibLsbLebRobLobLcbRebLebRebLcbRgbRgbRsbRebRebRibLobLib
LcbRebRobLobLobLebLobRobLebRobLebLebLcbLcbLibRibRobLibLobRebLsbLcbRebR
cbLobRgbLcbRebLcbRhbRebRobRebLebRcbRibLhbRebRcbRebLsbRebRgbLobLhbRcbRh
bRobLsbRcbLcbLobRibLebRobLsbRobLobRgbLgbLhbLhbLobLobRobRobRobLebRobLeb
RcbLebRebLobRebLgbRsbRebRebLcbRobRcbRsbRgbLcbRcbRebRobLcbLobLibLobLobR
ibRobRcbLcbRobRobLebRebRcbRebLgbLobRibLcbRgbLcbRgbRobRobRebLebRobLebRo
bLibRobLobRcbRobRobRobRcbRsbLibRebRobRobRobLobLobLgbLibLobRcbLhbLebRob
LibLebLebLcbRebRgbRjbRebLibRsbLobRobLebLebLsbLgbRobRobRobRgbLcbRebLebR
cbRcbLebRobLsbLobLsbRobRobLobLebLcbLcbLobLcbLibLobLobLobRebRobLobRcbRo
bRgbRcbLcbRcbLobLobLcbLebLebRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bsbRoLsbLgbLgbRibLgbLobLobLibLibRsbLcbLibLsbsbLjbRgbLsbRsbLsbLcLsmbLib
RsbRjRsmbLibRsbRsbLjbRhbRibLsbLcbLcbRcbRibRgbLsRsbRsbRsbRgLsbRgbRsbLjb
RibLhbRcbRjbLcbLhbLcbLjbRibsbLjbRjbRjbRhbRcLsbLsbLsbRgbLsbLsbLsbLibRgb
LobRibLibRsbRsLsbLibRgbLoLsmbLibLsbRgbLobRibLibLgbLsLsmbRsbRebRibLobLg
bLsbLoLsmbRgbRsbRgbRsbRgbRgRsmbRgRsmbRgbRsbRgRsmbRsbRibRibLsbLibRsbRiR
smbLsLsmbRsbRibLsbLsbRsbRibRibLibRhbLgbRgbRibLsbRibLibLsbRibRoRsmbLgRs
bLsLsmbRibRibRcbLgbLibRibRcbLibLsbRsbLibRgbLsbLgbLibRjbLjbRcbRibRsbRgb
RsRsmbLjbLgbLsLsmbLgbRsRhbRibLjbRibRhbLgbLgbRibRsbRsbRiRsmbLgbRibLsbRg
bRsbRsbRsbRsRsmbLjbRcbRibRgbRsbLcbRcbRcbLgbLsbLjbLibRgbRhbRibLobLibRgb
RjbLibRsbLibRsbLgbLsbLhbRsbRgbLiRsbRibRjbLibRhbLcbsbRjbRibLjbLiLsbLibL
ibRibLsbRibLsbLjbLcbsbRcbRgbRibLgbLgbLjbRcbRiLsbLgbLsbRiRsmbLobRjbLjbL
ob

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bsbRiRsmbLcRsbRhbRhbLsbsbRibRcbsbRcbRcLsbRjbRgbRiLsbLibLsbRsbLsbRsbLsb
LgbsbLjbLsbLjbsbsbLjbLhbRibLsbRcbLsbRibRobRjbRsbRiRsmbRcbRsbRsbsbRoRsm
bLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bRgbLcLibRjRsmbLsLsmbLibRhRsmbRsRsmbsbsbRsRsmbLobRcRsmbRcRsLsmbLoRsbRs
bRcbLobLgbsbsbLibRcbRcbsbRebLjLsmbLcRsbRcbLoRsbRgRsmbLobRgbRcbLibLcbLi
bRibRhbRcbLgLsbRsRhbLgbRibLjbLobLcbRgRsmbRgRsmbRcRsmbLgbRibRsbsbLsLsmb
RsLsbLsRsbRsbRcbRobLgbRgbLgbLsbLsbLgRsbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bLgbsbsbsbLibRobLebRobLsbRiRsLsmbLcLsmbsbLhRsbLibLibLsbLobLcbLgbLiRsbL
iRsbLibLibLoLsLsmmbLibLibLibLibLcbLcbLsbLibLgLsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bLiRsRsmbRiRsmbRcLgbLibRjbLiRsbsbLsbLgLsbLjRsbLhbLjLsLsmmbRsRsmbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bRcbRobRebRobRgbLebRebLcLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bLiRsbLjRsRsmbRcbLcbRcbRgbRsbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bRibsbRibLcbLsbsbLsbLsbLsbLsbRcRsmbLsbLsbRibRebRebRjbRjbLcLsRsmbLebLjb
RibRgbLgRsbRgbRibRsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bLsbLsbLjbLibLcbRjbRobsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
bLcbLibLoRcbLsbRsbRsbRobRsRgbLiRsbRgbRsbRsbLsbRiRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bRgbRsbLibLibLibLhbRobRsbRsbRsbRgRsRgRsmmbLibRsbRcbsbLsbRobLibLhRsbLib
LibLsbLibLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bLcLsLsmmbLsbRsbRsbLsLgbLsbLgbRgRsmbLibRsRsmbRgbLsbLgbLibLcbsbLcbLiRsb
RsbLgLsbRsbLsbRibRsbsbsbRgbLsbRsbsbLibsbLgbLebRsRsmbRsRsmbRgbLsLjLsmbs
bsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bLgLsLsmbRgbRsbLgbLjbLsLhLsbLgbLsLsmbLgbLobsbLiRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bsbsbLsLsLsmmbRsLsRsbLsbRsLsbRobLebRibLsLsmbLsbLcbLeLsRsbsbRsbRsbLsbRg
bLsbRsRsRsRsmmmbLgbRgbRgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 133235; End: 133735;
Recording: 10-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bLsbRibLsbLibRsLsbRcbLsbRcbLsLsmbRibRibLcbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 1; Drug: Control Apo 0.5 然
bRsLsbRjbLcbLsbRcbRibRibRcbRhbRcbRibLjbRhRsmbRibLibRibRsbLibLhbRjbRcbR
sbRjbRsbsbLsbLsbRibsbRcbRcRsLsmbRhbRibLibRcbRhbRibLcbLebRcbRcRsmbRibLs
bLgbLeLsbLsbRcbLsbsbLjbLsbRsbRhbRsRsmbRsbRsbLsRsRsLsmbsbLsRsbsbsbLsbLs
bLsbLsbRsbLsbLsLsmbLsbRsbsbLsbLsRsbRsRsLsmbRsbLsbLsbRsbLsbLsLsmbLsbLsb
Rsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 2; Drug: Control Apo 0.5 然
bRibLsbLsbRsbRiRsmbRgbRgbRsbRsbLsbRoRsmbLsbRibRsbRiRsmbLsbLsbRsbsbsbsb
RiRsRsmmbLibRsbsbLcbLebLcbRcbRcbLsbLebLibRobLiLsbsbsbsbsbsbLobRcbRibLg
bsbRjbLjLsmbLgbsbsbRcRsmbLsbRebRsbRjbRsLsbRgbLgbRiLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 3; Drug: Control Apo 0.5 然
bRjbLibLcbRsbRjRsmbRsbLsbsbRsbsbsbsbsbLsLsmbsbsbsbsbLjbsbLgbRjbsbLhbRg
bRsLsbRjbRebRibRsbRjbRsbRibLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 4; Drug: Control Apo 0.5 然
bRsRiRsmbRsbLibRsbLiLsbLibRgbLcRsbRsbLgbLcbsbRsRsmbRsbRsbLiLsbLsLsmbLs
bLgbLsbRjbLibRobRibRgbLibLhbLgbLsbLsLsmbLsbLgbLsLsmbLibRsbLiRsbLsRsbLg
bLsbLgbLsbLsLsRsmbLgbLsbLibRsbsbRibRcbLjbLcbRsbRjbRgbLibRiRsmbRsRsmbRg
LsbLsbRsbRsbRgRsmbRgbRgLsbLibRibLcbLobRgbLobRcbLcLsmbsbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 5; Drug: Control Apo 0.5 然
bRcRsmbRjbRcRsmbRsRsmbRgbRsbRibsbRhbLsbRgRsmbLgbsbLsbRjRgbLsbRcbRcbRsR
smbRcbRsbRsbRsbRsbLibRsLsbRsbRjbLgLsLsmbRsbRgbLgbRibRgbRcbRsbRsbRgbLiL
sbRcbRcbLcbRobRebLsbRsRsmbRiLsbRiLsbLsbLibLsbRcbLgbRsbLsbLjLgbRibLgbRg
bRhRsmbRsbLsbLhbLiLsbLgbRsbLibRsLibLiLsbRsbRsbRcbRsLsbRsRsmbRhbRgbRgbR
sbLsbLibRobRjbReRsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 6; Drug: Control Apo 0.5 然
bLjbLcRsRsmbLibLcbsbLgbLjbLhbLjbLcbLibLjbLcRsbLhbLcbsbRsbRiRsLsmbRibLg
bRcLsbLgbLsbRcbRobLcbLsbLgbLgbRibLjbLcbRsLibsbsbLibLibLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bLsRsbsbsbsbLobLibRcLsbLibLcbRjbRibRsbsbRibLjbLsbsbRiLsbRjbRjbLjbLibLi
RsbLibLiLsbRibRgbRgbRgRsmbRiRsmbRsbLsbRjbRibRibRibLsbLjbLibLgbRgbRgbRi
bRgbRgbRsbRsRsmbRobLgRsbRibRibLiLsbLibLjbLgbLhLsbRjRsRsmmbRsbRgbRgbLsb
LsLsmbLgbLgbLjbLhbsbRjbLibLhbLgRsbRsRgbLsbRjLsbRgbRgbLsbRoLsbLgbLgRsLg
bLibRjbRibLibLgbLgbRsbLibRgbLiRsbLgLsbRsbRgbRsbRsbRcbLgbRgbRgbRgbLsbRs
bRsbRsRsRsLsRsRgRsRsmmmmbRgbRgRsRimbRgRsmbRsbsbRsRsRsmmbRsbRsbRgbRsbRg
bRiRgbRiRsRgmbRgLsbRgbLsbRibRsRsRsRsmmmbRgLsbRsbRjbLsbLjbLhLsbLhbLcbLg
bRgbLgbLgbRsbLgbRsbRsbLebLiLsbRsbLgbRsbLsbLibRsbLgbLgbLgbRsbRgbRgbLjbR
hbsbRjbRibLgbRgbLsLsmbLgbRibRgbRgRsmbRsRsmbRgbRsbRsbRgbLsbRgbRsbRgbLsL
smbRsbRgbRgLgbRibLgbLsRsbRjbLjbRobLgbLjbLibLibRsbRcbLibRsbRsbLsbRsLsbR
gbLibLibLgbLcbRjRsmbRibRgbLjbRgbLsbLsRsbLgbRgbRobRiRsmbRsbLgbLsbLjbLjb
Rjb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bLibLhbLsbsbLcbRhRsmbRsbRobsbLsbLcRsRsLsRsmbRgbLsbLjLcRsbRsbLcbLsLsmbL
sbLcbRsbRsRsmbRhbLsbLobRsbRsbLoLsmbRcbRcbRoLsbLoLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bRibLgbRjRsmbLcbRibLgbLsbLgbLsbLcbRhbRjRsmbRcbRcbRjbRcbRjRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bRsRsmbsbLibsbsbsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bRgRsmbRsbLgLsbsbsbsbLsRsbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bsbRsbsbsbsbsbsbsbRsbsbsbsbRsbsbsbsbsbRsbsbLsbRsbRsbRgbRcRsmbLsbRobLiL
sbLcbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bLjRsbRiRgLsbRcbsbLsbLjbRcbsbsbRsLsbRgbLsbRsLsbLgLsLsmbRsbLsRsbRsLsLsL
smmbLsbLsbLcbLgbLsbRsRsmbLsLsmbLsbLibLobLgLsbLibLibRsbLcbRsbRjbRibRibR
ibRebLobRjbRobRiRsmbRsbRsRsRsmmbRgbLsbLsLsmbLgbLcbsbLcbLsLsmbRcbsbRgRi
bRiRsmbRibLibLcbRsbLobLibRgRsmbRsbsbLgbRsRsmbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bRibLsbRcbLsbLcRsbRgRsmbRcbLjbLcRsLsbRsbLgbRjbLhLsbLgRsbLsLsmbRsLgbsbL
iLsRsbRibLsbRjRsmbLibLebLgbLhbsbRsbReRsmbLsLsmbRibLjbLcbLsbRhbRcbRcbRg
bLsbLobLsbLiLsRsbRjbRobRsbsbRobRjRsmbLsRsbLibRjbLjbRsRoRsmbLsbRgbRhbRs
bLibRoRsmbRgbRgbRsbLebRibLhbLgRsbLcbLsRsLsbLobLsbLsbLibLobLib

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bsbsbLsbLgbsbLgbRsbRsbRsbLjbLsRsLsbLgbLoLjbRsbsbLsbRibLsbLjbLobsbRsbRs
bRsbRjLsbLibRsbLibRcbRcLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bLebLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bLsbLsbLgbLsbRsbRjbRsbsbsbsbsbsbRsbRsbRgbLsLsmbLebRsbLhRsLsbLibLhbLibL
gRgbRgbLibRhbLjbRsbLsbRsbsbRsbRsLsbLgbLsbsbRsbsbRsLsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bLgbLgbLsbLsbLsbsbRsRsmbRgbLjbRsbRsbRgbLsbLibLgbRgRsmbRsbLsbRsbsbRsbRj
RsmbLgLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bLsbLgLsbLeLsbRjbRjbRibLjLsLsmmbLgLsbLsbRcbLsLsmbsbLibLcLsmbsbLsRsbRgb
RibRgRsmbsbLsRsbLgbLebLsbRjbRibRiLsbLsbRobRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bsbsbLsbsbsbsbsbLsbRgbLsbsbRsbRsbsbRsLsbRsbLsRsbsbsbLsbsbsbRsbsbsbLibR
jbLibRjbsbLiLsbRjbRcbRiRsmbLgbLibRsRsmbsbRsRsmbLsbsbRsRsmbsbRsbLsRsbsb
LsbRgbLgbLcbRcRsRsmmbLsLsmbsbRsbLjLjbLcLsmbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bLiRsbRcLsbLsbRcbRobRcbLcbsbRcbRsbLibRcRsmbLcbRoLsbsbLcbLsbsbsbsbLcbRs
RsmbRjbRobLobLobRsbRsLsbLsbsbLsbsbLsLobsbLsbLcbRcbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLgbRcbLgbLgbLgbLgbLgbRcLsbLjbRjbLgbLsbLgbLgbLgbRsbLhbLsbsbLobLgbsbLgb
LgbRcbLibLgbLhbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bLjbLjbsbLobRgbRsbLsbLoLsmbRibLobLsLsmbLgbLcLsmbRsRsmbRsbRsbLcLsmbLibL
ibRibsbLobLibRibRsbLcbLsbsbLoLsmbRjRsRsmmbRibRsbRsbLsLsmbRibsbLibRcbRs
bsbsbsbLsbLsLsLsmmbLsbLsLsmbLgbLgbLibsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bsbLsbsbLjLsmbLsLsLsmmbRibLgbRsRsmbRsbRsRsmbRcbRsbRebRsbLsbLsRsbRobRgb
LsbsbRiLsLsmbLibRcLsLsmbsbRsbRoLsbsbRsbLsbRcbRsbRsbsbsbsbRsbRsRsmbLsbL
gb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 25; Drug: Control Apo 0.5 然
bsbRsLsbLoLgbRobRiRsmbRsRsmbsbsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 26; Drug: Control Apo 0.5 然
bsbLsbLsbsbLsRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 27; Drug: Control Apo 0.5 然
bLcbRhbLsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 28; Drug: Control Apo 0.5 然
bsbRsbsbLsbLsbRgbRsbLibLibLibLsbRsbsbRiRsmbRsRsmbRhbRebRobsbRhLsbLsbLc
bLibRobRebLcbRcbRhbRcRsRsmmbLibRcbRjbRibRibsbLiLsbLsbRcbLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 29; Drug: Control Apo 0.5 然
bRsbLoLsmbsbLsbRjbLibRcbLibLgbLobsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 30; Drug: Control Apo 0.5 然
bLcbRcbLjLsLsmmbLgbLgbLibLgLsLsmbsbsbsbsbsbsbLobRcLsbRsbLsLibRcbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bsbLsbRsLsbLsbLsbsbLobRsbsbRgbLgbLsbLcbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bLgbRcbRibLsbRhRsmbRibLsbLjbRcRsmbRgbRibRsbRhbRibLjbRcbLgbLgbLibRobLiL
sLsmbLsbReLsbLibRcbLsLsmbRcbLsLgbLjbLibLgLsbRsbLgRsbRsbLiRsbRgbLcbRiRs
mbLoRsbLcRsbRgbRgbRsbRgRsmbLsbRibRsbRjRsmbRsbRgbLsbLgLsbLhbLsbRobRoLsb
sbsbLsbRgbsbsbsbRcbLcbRhbRcLsbRcbLsbLgLsbsbLibRcRsmbRsbRoLsbLgbRsbRhRs
mb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bRibRobLebLobLibRcbLcbRebLibLjbLobRobLobLobRobLsbLebRsbLgbRcbLobRobRob
LobRebLobLibRebRcbRobRobLebRcbLobRebRcbLebRebLebRobLcbRhbLobLobRobLsbR
cbLobLobRebLebRcbLibRobRobLcbLobLibLibLibRobLobRebLobRibRcbRebLebLobLe
bRibLibLebLebRebRebRobLobLibRcbLobLcbRcbLebRcbRebRebRobLebLibLibRibRob
LebRebLobRibLebRobRebRcbLcbRebRobLcbRobLebRibRebRcbLebLobRobRebRobLebR
obLsbRcbLsbRibLcbRcbRsbRibRobRobLobLebRobLgbRebRobLebRobLobRobRobLobRo
bRobRobRobLobRobRsbRobRobLobLcbLsbLjbRsbRebRcbLsbLebRcbRobLobRsbLobRib
LobLcbLebLobRebRebLobRcbLcbRsbRibLebLebLobLobRcbRebRobLobRebLobRobRebR
gbLobLobRobRgbRobLobLebLobRobRobRobRebLebRobLobLobLebRgbRibLebLobLebLe
bLobLobRgbRobLebLobRobLobRsbRobRobRobRebRgbLebRobLobRgbLebLsbRebLobLeb
LebLobLhbRobLibRsbLebRobRebLebLebRhbLebLsbLobLebLebRobRebLcbRobLcbLcbR
obRibLgbLsbRcbRcbRebRebRobRobRcbRebRobLcbLgbLobRebLobRcbRgbRibRcbLibLg
bLobLobRibRebRibRcbRcbLcbRobLebRobLgbLhbLebLobLebLobRibRcbLcbLcbLebRob
LgbRobRebRgbLcbLcbRcbRgbRobLibLebLebLobRcbLsbRebLobRgbLebLebLobLjbRebL
obRgbLcbLobLibRobRobLebLobRobRobLhbRobRobRcbLobLobLobRsbLcbRgbLobLobLi
bLobLhbLobLebRebLobRcbLobRibLebLobLobRobRobLobRhbRobLibLobLebRebLebRcb
RebLobRobRgbRsbLcbLibLgbRsbRobRibLobLcbRobLobLobLobLebLobRsbRcbRgbRobL
ibRobLobRobRobRibLobRobLebLsbRcbLsbRebRobLibRobRgbRobRebRcbRobRobRobRo
bRobLsbRobRebLebRobLobLebRebLobLobRcbLsbLobLebLebRibLgbLobLcbLibRebRob
RcbRobLcbRibRobRgbRcbRcbLcbLibRobLebRsbRebLebRcbRibLcbRebLebLebRibLobL
gbRsbLcbRcbRobLobLebLobLsbRebLobLobRcbLebRcbRcbLebLobRobRobRobLobRgbLo
bRebLhbRcbLobRebRobLebLobLcbLebRhbLcbRobLobLebLobLobRebRebLsbRobLhbReb
RobRobLcbRjbRebLobLebLcbLobRgbLebRebRebRobRebLobLebLobLgbLobLobLhbLcbR
obLsbLebLebLobRobLjbRcbRibLobLebLcbLcbLjbRgbRcbRcbLobLobLgbRobLobRobRo
bRgbLsbRebLobLobRcbLobRgbLobLgbLobRobLebLebLobRobLcbRebLobLcbRcbLobRib
RebLebLobRsbLcbLobLebRcbRcbLobRcbRhbRobLobLgbLcbLobLobRcbRebLcbRcbRebL
obRgbRhbRibRcbRcbLobRebRobLobRcbLgbRgbRebRobRcbRebLobRobRhbRcbRsbLcbLi
bLcbRobRobLibRobLcbLobLebRcbRobLebLobRobRobRibLobRcbRibLobLgbLobLebLob
RobRhbRobLobLobRobLcbLobRebLobRebLobRobLcbRibRebRobRobLcbRobRobRobRobL
gbLebRebLobLhbLebLgbRebLebLobLobLebRobLcbRobLobLebLobLobLobRobLcbLobLi
bRobRcbRobLobLobRebLobRhbRcbLobRobLibRobLcbLobLobLibLobRebRcbRobRebLcb
RcbRebRcbRcbLobLobLobRgbLsbLobLobLobLibRobRobRebRobLcbLobRsbLcbLcbRebL
obRgbRobLjbLebLobRebRjbLebLcbLobLebRebLobLobRobLobRhbRobRebLobRhbLobLo
bRcbLebLgbRobRsbRobRjbRobLhbRibRobRobRobRibRebRcbRcbRobRcbLebRobRobRcb
LobRebLebLibRobLcbLobLobLobRobRjbRobLebLcbRobRsbLobRibRobLobRsbRobRobR
ibLcbLobRebRobRobRebRobRobRobRhbLobLcbRobLebLebLebRobRobRibLcbRebLobLe
bLobRobRsbRobLcbLcbRebLebRibRobLebLjbRcbLobRobRobRobRobLobRobRobRebLcb
LcbRibLgbLobLobLibRjbLobLcbLcbLebLobRobRebRobLobLhbRsbLcbRebRobLibRibR
obLhbRsbRobRebRibRobLjbLobRobLebRcbRobRjbLebRebRcbLcbRebLibLcbRobLgbRi
bLobLebLobRcbRobLobLibRsbLibLcbRcbLebLobLibRibRobRobRibRobLhbRcbLobLob
RobRebLcbRibLsbLebLobRobLcbLgbRebLgbRjbLobLebRobRobLobRsbRibLcbRcbRobL
obRobRibLebRcbRibRobLobLobRobLebLobRobRibRsbRibRcbRobRobRobRobLebRcbRc
bLibRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bLgbRibLgbLcbRibLcbLibRgbLgbRsbRsbLibRsLsbRgbRcbRibLibRiRsmbLebLgbRcbL
ibRcbRiLsbLgbLoLhRsbLibRiLsbRibLhbLibLgLsbLgbRsbRjbLhLsbRcbRgbRsbLgRib
LhRsLsbLgbLsbRhbLcbLsbLibLsbRobLjbRsbLiRsbLibLibRgbLibRsbLibLcbLcbLibL
ibLsbRibRsbLgbLibLoLsmbLgbRsbRgbRsbLgbLgbRibLsbLcbLibLgbsbsbLgLsbsbsbs
bsbRsbRcbRsRsmbRcbLjbLibLibsbsbLsbRsbRcbLsLgLsbLsbRcbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bRcbLsbLsbRibLsbRcbsbRjRsRsmmbRsbRsbRsRsmbLsbRibRcbLsbRibLsbLsbRsbRibR
gbLsbLsRsbRsRsmbLcbRgbsbRgbRgbRsRsmbRsbsbsbRoLsbRcbRiLsbRsRsLsmbRibRsb
RsbLsbRibRgbRsLsbLsRsbRobRcbRhbRsbRsbRcbRcRiRsmbRibRsbRgbRsbLhbRjRsRsm
mbLibLhb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bRgbLibRjRgbRcbLgbRsLsbRebRhbsbLcRsbRiRsmbRgbRgbRiRgRsmbRgbRgbRibLibLi
bLsbRebRcRsmbLgbLsbLcbLebLcbLoRsbRgRsmbRebLgbLgbLgbRebLgbRiRsmbLjbLhRs
bRcbLgbRgbLsbRobRibRsbLsbsbRebRcbRebLsbRibsbLsbRgRsmbRobLgbRgbRgbRcbLg
LsbLgbLibLgbLgbLgbRobLgbRobLgLsbRsbRiRsmbRsbRibRsbRiRsmbRgbRgLsbRibLgb
LjbRiLsbLibLcRsbRcbRgbReRsmbLibRsRsmbRsbRobLibRgbLgbLsbLgbRcRsmbsbRibL
gbRobLibLgbRsbLsbRibLjRsbRcRsRsmmbsbLgbLobLcbRcbRhbLhbLeLsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bLjRsbLgLsbLsbLsbRgRsmbLsbsbRsbLsbRibsbRsRsmbRobLobLcLsmbLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bRsLsbRsbLgbLiRsbRsbsbsbsbLgbRsbRsbLsbLsRsbRsbLsRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bLiRsbRsRibLgbLibsbRgbLjbLhb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bRjLsbLibRgLsRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bRgbRsLsbsbRgbRibLgbLjRgbRcbLgbLibLhbLhbRobLsbRsRsmbsbLhbLibLibLebRiRs
mbLibRibRebLobLiLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bRhLsbRibRibsbsbLibRsbRsbLsLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
bRsbsbLobsbsbsbsbLobsbLsbRsLsbLsRsbRsRsmbLsbLsLsLsmmbRsbRsLsbLsLsmbRsb
RsbLsbLsbRsbsbLsbRsbLsbLsRsbLsLsmbsbLsbLsbRsbRsLgbLsbLsLjbLsbRsbRsbLsL
jbRsbRsbsbLsbRsbLjbLsbLsRsbRsbLsRsbsbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bLebLhbLsbsbLgbLibLgbRcbLobsbRsLsbsbRibLoLsmbRiLsbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bsbLsLsLsmmbLiRsbLsLsmbRsLsbsbRsLsbRsRsLsmbLsbLsbRgbRjbLebLgbRsbRsRsmb
RibLsbLsbLgbRibLcbRibsbsbsbRsbsbsbsbRsbLcbRsRsmbLsbRhbRhRsmbLebRcRsmbs
bRib

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bLgbRcbRibLsRsbLjbRsLibRsbLsbLgLsbLgbRsLsLsmbLibsbLibLebRibRgbLhbLjLsm
bRgbLjbLibRgRsmbRcbRsbRgbRsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bRgbRsbLsbsbLjLsRgmbLgLsbRgbLobLgRsbLsRsbLsbRsLsRsbLgbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 133738; End: 134239;
Recording: 11-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bLsLsmbLsbLjLsmbLsbLsRsbsbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 1; Drug: Control Apo 0.5 然
bRcbLsbRsLsbsbsbRgbLobRibLcbRhbRibLgbLgLsbLibLsLsmbLebLcLsmbRebRebRcbR
iRsmbRsbLibRcbRjbRcbRsRgbLiLsbRcRsmbRcbLgLsbLcLsmbLjbRcbRcbRjbRcbLjbRh
bLsLsmbRibLsbRsbsbLsbRsbLiRsbRgbLsLsmbLsbsbRsbLgbLsbRhbRibLgbLcbLgbLsb
LcbRibRibRobRobRibRhbRhbLgbLibLcLsmbLsbRcbRcbLjLsmbLibLebRgbRcbRgbLjLg
LsbRhbRgbLibLsbLgbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 2; Drug: Control Apo 0.5 然
bRjbRcbRibLgbLcbLobRgbLcbRgbLibRsRsRgmbLgLsbRgbLcbRebRhRsmbLgRsbLibRgb
LsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 3; Drug: Control Apo 0.5 然
bRebLcbRibLiLsbRgbLiRsbLsLsmbRgLsbLgbRsLsbRjbRhbLobRcbLjLsLsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 4; Drug: Control Apo 0.5 然
bRcbLjLsmbRjRsmbRsbLsbRgbRibLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 5; Drug: Control Apo 0.5 然
bLhLsbLgbRcbRibRsbLsbRsbLgbRgRsmbRgbRgbRsbRgbRgbRgbRsbRgbRsbRgbRgLsRsb
RcbRgbRsbRsbRobRibRsbLcLsRsmbRsbRhbRibRgbRsbLsLsLsmmbRcLsbLgbLsbRcbRsb
LjbRibLgLsbRcbRsbRjbLgLsbLsbLsbLcbLiLsLsmbRsLsbRgRcbRibRhbLsLsLsLsmmmb
LsbRjbLhLsbLsLsmbRibLsbLsbRgbRsbLibLgbLibLgbRjRebLib

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 6; Drug: Control Apo 0.5 然
bRibLsbRgRsmbLebLibLebLgbLjbLibRibLcbLibLibLsbLcbRibLgbRgbRgRsmbLsbRgb
LiRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bReRsmbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bRibLoRsLsLsmbRsLibLoRsbLob

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bLibRjRsmbRcbRcRsmbRhb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bLob

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bRebLsbLsbRjbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bRebRoRsmbLcbLsbRcLsbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bLobLjbsbRsLsbRsRsRsmmbLsRsLsRsbRsbLebsbLsRgLsbRsRsmbRgbRgLsbRjRsmbRgb
RgbRgRsmbRsRsRsmmbRjbLjRsbsbRgRsLsmbRsbRibRsbRsRsRsmmbRgbLjbLcLsmbLcLs
mbRsbRhbsbLsLsmbRgRsmbRgRsmbRsLsbRsRsmbRgRsRsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bRhbLiLsbLsLsmbLgbLsbLibLibLsbRgbLiLsRsbLiLsbLebRjRsRsRsmmmbLsbLcRsbLg
bRcbRibLobLibLobRcbLcbLsbLebLebLgLsRsbLibLjbLibRgRsRsmmbLsbLiLsbLcbRoL
sbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bLcbLgbRsbLhbLibRhbLhbLcbLcbLibRsbRsbLgbLcbLcbLsLsmbRgbRsbLsbRsbRgbRsb
RgbLjbRhbLcbRgbLjbLgbLhbLibLsbRsbLiLsbRcbRibLsbLjbRcbRsbRsbRsLsbLsbLib
Rcb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bLsRebRobLsLgLsbLsbLsbLgbLgbLsbLgbRgbLgbRcLsbLibLcbLhbLhbLgbLsbRgbRobR
sbLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bLsRsbRgbRgRsmbRibLgbRgbRgbRgbLgbRgbLsbRcbRsbRibRsbRgbRgbRsbLsbRgRsmbR
gRsmbLgLsbRgRsmbRobRgbLibRsbRsbRobRgbRgbLibRoLsbRgbLsbLgbRiRsmbRibLobR
ibRiRsmbRsbRsbsbsbRibLjbsbRibRgbRibLoLsmbLgRsbLsbLsbLiRsRsmbRobRgRsmbL
ibRibRjbLiLsRsbLsbLhbRgbLgbRgbLibLibLsbRcRsmbRibLibLsbLgbLsbLsbLsbRsLs
bLjbLsRsbLjbLsbRebRgLsbLsbLsLjbLjbRjbRibLibLsbRsbsbLsRsLsbRsRsmbsbLibL
obLobRgRsmbRebRibRsbRgLsbLjbRibRobLsbRgbRibRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bLcRsbRiRsmbLsbRgLsbRsbLobLiLsbLsLsmbLobLgbRibRsbRcbLsbLsbLibLhbRcbRsb
RiRsmbRiRsRsmmbLsLsmbRsRgbLsRsbsbReLsbRsRgbRibLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bLcbRsbLobLcbLhbRibLibRsbRgbRiRsmbRsRsmbLibLhbRhRsmbRsRgRsmbRsRsmbRgbL
sbRobRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bRsbRjRgbRcbLebLcbRcbRsbLsLsLsmmbRsbsbLgbsbsbRsbsbsbLsbRsbRsbsbsbLsbLs
bsbsbsbLgbsbRjbLsbRsLsbRsRsmbLsbsbsbsbsbsbsbLsbsbRsLsbRsbsbLsbsbRsbsbL
sbLsLsLsLsmmmbLsbsbLsbsbsbLsbsbRsRsmbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbRsbs
bsbsbLsbsbLsbLsbLsbsbsbLsbLsbsbRsbsbsbsbsbLsbsbRsbsbsbsbsbLsbsbsbsbsbs
bsbsbsbsbsbsbsbLsbLsRsbLjbLsbLsLsLsmmbRsLsbLsLsmbsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bRebLibRcbRcLsbRibRibRibRjbRibLcbRjbRcbRhbRibRsbRgbRoRsmbLjbLobRsbLibL
jbRcbRibLsbLcLsmbLcbsbLsbLsbRcbRgbLjbLibRjbLcbRjbLcbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLsbLgbRcbRobLgLsbLsbLgRsbLgbRibLgbLgbLgbLgbRcbLsLsmbLgbRibLsbLgbLgbLg
bsbLgbRhLsbLgbLgRsbLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bLcbLibRjRsRsmmbLibRibLgbRhbLsbRgbRsbRebRobRhRsmbRgbRibRsbRsbRsbLiLsbs
bLsbLgbLsbLebRibLgbLgbRibRgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bRebRibLoRsbLhbRgbLhbLgbLibRsRsRsmmbLiLsbLhbRsRsmbRsbLsRoLsbRiRsmbLsbL
ibRibRibRibRcRsmbRsbLhLsbRsbRibRhRsmbRiLsbLibLsbRgRsRsmmbRiRsmbRhLsLsm
bRgbLsbLsbRibRgbRsbRgLsLsmbRibLsbRibRiRsmbLsRsLsbRgLsbLsRsbRgbRgbLsbRs
bRgbRgbLsRsbRgbRgbRsbRibRsbRgRsmbLsRsLsbRsbsbRgbRsRsmbRgRsmbRgRsmbLgbL
gbRiRsRsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 25; Drug: Control Apo 0.5 然
bRcbRobLobLobRjbRebLsbRsbLjbLebLebRebLjbRebRjbLebLobLobLobRobRebRcbRcb
LobRobLcbLobLebRobRobRjbRobRobLebLobRjbLebRjbRobRobLobRebLobRobRsbRobR
obLebLsbRebLobRjbRobRjbLobLebLobLebLobLobRobRcbRjbLobLjbLebLjbLebLobLo
bLebLobLjbRjbRjbLjbLsbLjbRebLebLjbLebRjbRebRobRobLcbRjbRobRcbLjbLobRjb
LsbRobLebRebRjbLjbRjbLobLebLjbRobRobRobLobRebLjbLebLebLobRebRebLcbLcbR
gbLobLebLcbRobLcbLebRcbRobRsbRjbRjbRjbLebRobRebRjbLcbLebLobRjbRebRobRe
bRcbRcbRebRobRcbLebRcbLjbRebLebLcbLobRobLjbRobRcbLebLobLcbLobLjbRebLob
LobLibLjbRjbRebLcbLobRcbLcbLjbRjbLobRobRjbLobRcbRebRjbLobLobRebRobLjbL
obLsbLjbRobRobRobRcbRobLjbLcbRcbLobRjbLobLcbRobRsbRcbRobRebRobRobRobLo
bLobRjbRebLobRjbLjbLjbLebRebLobLebRcbRobLobLobLcbRobRsbLcbLobRebLebLob
RjbLebLobRcbRobRobLebLobLebLjbLebRebRobLobLebLjbRebLcbRobRobRibLobRebL
obLebLcbRobRobLobRobRobRebRibRobRebLsbRobRobLibRobLcbLebRobRebRobLobLe
bRebRjbRibLebRcbRibRsbLsbRobLibLobRebLibLibLobLebRobRebRobRobRobLebRsb
LhbRibLcbRebLobLebRcbLebRobLcbLgbRebLobRebRobRebLebLgbLobRibRobRsbRobR
cbLobRibRobLgbRobLebLobRobLcbRobRobRgbLsbRobLcbRobRjbRhbLobLsbRgbRobLi
bRibLcbLcbLobRobRobLebRgbLobRobLebRobLobLgbLobRebLobRebRibLebRobLgbRob
RsbLcbLobRcbLobLebLebRgbRobRobLobRebRsbRcbLobLebRobLobLobLebLobLebLebL
obLebLibLobRibRobRsbRobLhbLcbLebRebRcbRobRobRobLebRobLobLebRsbLibLobLe
bLjbLebLobLebLebLebRobLobLsbLobLgbLebRcbRcbRcbLobRcbLobLebLobLobLgbRob
RebRobLgbRebRobRcbRebRobLobRebRobRsbRjbLobRibRjbRsbLcbRobRebRgbRcbRcbL
obRebRobLibRobRobRsbRcbLobLgbRobLebRibRcbRobRhbLobLgbRebRobRebLebRcbLo
bLobRcbLobLobLobLobLjbLcbLobLobLobLsbRobLebRobRgbRebLcbRjbLgbLobLgbRob
RibLibRsbRgbLebRcbLjbRobRebRcbRobRibRcbLebLebRobRsbRobLibLgbLebLibLgbL
obRobRebRibLebRebRebLgbRcbRebRibLebLobLcbLibRcbRgbLcbRibRobLobLobLobRc
bLcbLobRobRjbLgbRobLcbLobRobLcbRibRobRobLobLebLsbLobLebRobRebLebRcbLib
RsbLobLgbLebRobLcbLjbLcbLcbLebRcbLobLobRobRobLsbLjbRibRcbLebRibLebLjbR
obRobRobRibRcbLobRjbRobRobRcbRibLcbRobLibRjbRebLebRibRibRebLobLcbLcbRi
bLobLibRobRcbRebLobLibLobRobLebRobRebRebRobLebRgbRebLobRebLobRebLebLob
LgbLobLobLobLgbRobRcbRobRobRgbLobLobRobRcbLobLcbRcbRcbRobLcbLobLebRobL
obLgbRobLcbLebLebLebRobRebRobRobLjbLobRebRhbLgbLebLobRobRcbLobRobLobRo
bRobLcbLobLebLobRebLibRebRebRjbLhbRjbLobRobRsbRibLebRjbRjbRebLobRobLob
RcbRjbRebRcbLobLcbLibRgbLobRobLcbRcbRobRobLobLobRobRcbLebRebLobRjbLobR
cbRjbLebRcbRobRebLobLobLsbRcbRjbLobLobLcbRobLjbLobRjbLcbLcbLjbLebLobLj
bRobLobLebRebLgbRebRobLsbRebLjbRobLobLobRebRebRobRjbRcbRobRebLebLebRob
RobRcbLebRebRebLibRebLjbLjbRjbRobRjbRobLebLjbLebRjbRebRibLobLobRebLgbR
obLebRebLebRobLobLebLsbLobRebRobRebLcbLjbLobLhbRobRsbRobLobLebLebLobLe
bLobLgbRsbLobRebLebRsbRcbLobRobRobRobRhbRobRobRsbRobRobRebLcbRobRebLcb
LjbRcbRebLobLebRibRobLibLsbLebLcbRobLsbLebLebRebRobRgbRcbRobLcbRcbRcbR
obRibLobLobRgbLibRebLebLjbLgbLebLebRebLobRibLobLibRebRcbLobLobRobLcbLc
bRobLibLcbLobLibRobRobRobLobRibLibLebLebLobLjbLobRobLcbLobRobLebRebRib
RibRobRibRcbRobLebLcbLobRobRcbLcbLsbLcbRibRobRobLobLobRebRebRsbRebRobR
ebLebRobLobRobRcbRjbRobRobRobLgbRsbLsbRobLoLsRsmbRsbLsLsRsmbRebLsbRcLs
bRobRebRsbRsLsbLsbLoLsmbRobRsbLcbRobLebLsbRsLebRebLebLebLebRsLebRobLeb
RebLebRobLebRobLsbLjLebLsbLebLibRsbLsbLjbRibLibRsbLobRobRjbRobLgbLobRo
bRcbRebRcbLobLhbLobLjbRobLobLobRebRobRcbLebLebRebLsbLobRobRobRobLebReb
LebRibRsbRcbRobRcbLjbLobRobLobRobLebRebLobRobRebLobLebLebLobLobRgbRobL
ebRobRobLobRsbLcbLebRjbLjbLobLcbRobRobRobRobRobLobLebRcbRobLobLobRobRo
bLobRobLebLcbRobLobRobLobLebLsbLobRcbRobRsbRobRobLcbLebLebLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 26; Drug: Control Apo 0.5 然
bRebRsLsbRibLoRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 27; Drug: Control Apo 0.5 然
bLibRibLcbLgbRsLsbRcbRgRsmbRcbLcbLsbLibLcbLcbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 28; Drug: Control Apo 0.5 然
bRebRibLibLsbRcbRcbRibRiRsmbRibRhbRibRibRcbRcbRgbLsbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 29; Drug: Control Apo 0.5 然
bRibLsbLcbLibRgbLgbLibLjbLjLsmbLibLibLgbLsbLsbLsLsmbRgbLgbLsbLjLsmbRcb
RjLsbRcRsmbLsRsbRebLoLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 30; Drug: Control Apo 0.5 然
bLcbRhbLibLgbRjRsmbLjbLjbLcbLibLibLgbLibLgbRobLibLsLjbLibLcbLgbRibLhbL
ib

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bRebLgbLcbLiLgbRsbLibRsbLebLgbLcbRebRob

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bRebRcbLsbLobLjbLoRsbLobRcbLsbRhbLibLsRsbRsbRsbLgbLgbRgbRgbRsbLobRibRi
RsmbRgbLgbRgbRgbLgbRibReRsmbRcLsbRsbLibRjbRibLgbLibLgbLibLgLsbLsLsLsmm
bLgbLsbLsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bLgbLibLgbLibLobRibLebLjbRcbRsbRobRcbRcbRibRibRgbLobLcbRebRsbRcbLobReb
RebLibRgbRobRsbRobRobLgbLcbLibRobRobRhbRobRebLobRcbLobLgbRobRebLobLibL
obLobLobLobLibLibRcbRsbLcbRobRobRobRibLgbRebLebRobRgbLobRebRobLobLibRo
bLobRebLcbLebLobRebLebRobLebRsbRobRgbLcbRcbLgbRobRebRebLebLobLcbRhbLib
LcbLgbRebRcbLobLcbLebLobLobRobLhbLcbLcbRebRsbRcbRobLjbLebRebLcbLobRgbL
ibLobRobRgbRsbRebRebRobRibRibRcbLibLobLobLobRsbRibRobLobRobRobRobLobRo
bLobRobRsbLobLobLobRibLobRebLobRobLgbRobLobRobRobRibRobRhbLebRcbLobReb
LebRobLebLcbRsbRobLcbLobLobLebLobRobRobLebRebLcbLebLebLebRebLobRobLebR
cbLobLgbLebLobRcbRebLgbRobRobLgbLsbRsbLebRebRobLobRgbLobLebLobLobLobLo
bLobLebLobRcbRebLcbLebLobLibRebLsbLobRjbLobRobRobRobRobLcbRebRgbLebLob
LcbLebRobRcbLobRebLobLgbRcbRobLobLsbRobLibRgbLebLobLibLobLcbRobLobLsbL
gbRobLobLcbRobLobLsbLobLebRobLibRobLobRebLobRibLcbLgbLsbRobLobLobLebLo
bLcbLcbRibLebRobLobRebRebRhbLebRsbRobLobRibLibRhbLsbRobLobLobRcbLobRob
LobLebLobRobLcbLsbLgbRobRobRibLobLobRcbLobLebRobLcbRibRibLobRobRobLobR
obRobRobRcbLgbLgbRobRobLobRsbLibRebLobLhbRebRcbRobLibLgbLsbLobLebLcbLi
bLsbRgbRebLcbRsbLebRgbLgbRhbRgbLobRgbLobLobLebLobRibLobRibLebRcbRobLob
RobRibLcbRobLibLobLebRobRobLcbRobRebLcbRcbRobRebRobLgbRobLjbLobLobLebR
obRebRobLobLgbRebRebRobRibRibLebLcbLebRhbRibLhbLcbRsbRobRebRobLebRobLc
bLebLobLobRebLcbRsbRobRcbLebRibLobRibLobLobLobLobRobLobLibRgbRobLobRob
RebLsbLgbLcbRibLcbLgbRobRobRebLebRsbRobLebLobLibRebLobRebLhbRobLobRcbR
ebLebRgbLobRebLobRobLgbLobRgbLobRobLgbRobRibLgbRobLcbLobRcbLobLobLobLo
bRebLobRobRebRgbLobLebRobLebRebLibRibLgbLobLebRobLobRebRebRibRebLobRob
RebLcbRgbLobRebRebRgbLsbLcbLebRobLobRhbRsbRobLsbLjbLcbLhbLobRobRebRobL
cbLebRjbRebLobLobLobLobRebRcbLobRcbRcbLebLcbLobLobLobRobLobLobLebLibRh
bLobLobLobRibLebRcbLsbLibLobRobLebLgbLobLibRebLcbLobLebRcbRibLcbRcbRib
LobLcbLobRebRebRcbRibRibLobLhbRcbLobRobRcbLebRcbRhbLobLebRobRobRobLibR
obLgbLsbLobRsbLobRgbRebRjbRobLgbLobLobRebRobRcbLobLebRcbLebLobLobLgbLi
bRebRobLebRcbLibLebRgbRhbLebLhbRobRcbLcbRibLsbLebLebRibRobRobLobLobLib
LebLobRcbRobRobLcbLobLobRcbLibRgbLobRibLobLobLcbRcbLobLobRgbLobRibLebL
cbRobRobLobLobLgbRebLcbLcbRsbLobLobLibLobLobLobLebRebLebLobLobLobRgbLe
bRobRcbRgbLebRebLgbLibLcbRebLebRibLebLcbRebRcbLcbLobRobRsbLibLcbLobLcb
RgbLobLibLobRsbLgbRibRebLobRgbLebLcbLobRsbLobLobRebLobLebRebLobRebRjbL
ebLobRebLobRsbLebLobRobLobRebLcbRobRibRibLebRcbLebRobLcbRobRebRhbLobRo
bRobRobRobRebLebRhbLobRcbLsbLobRobRobRebRhbLcbRebRcbRebLhbLobLibLebLeb
LibRcbRobLobRcbLobRobRebLobRobLhbRibRobLebLebRobRcbLobLobRebLcbRcbLobR
ibRobLobRibLobRobRcbLobRcbLcbLobRibRobRcbRebLcbLobLobRcbLobLobRobLobRc
bRibRhbRobLsbLobLobLgbRobRebLsbLibLebRobLobLebRebRobLobRcbRobRcbRibRib
RobLobRhbRebRobRobRgbRgbRebLcbRcbLgbLcbLebRebLcbRhbRibRebRcbLebLibLobL
ebLcbLobLcbLgbRgbRgbRobLebLebRebRebLcbRgbLobLcbLcbRobRobLcbLgbLobRobLe
bLcbLcbRibRebLobRcbRcbRcbLgbRgbLhbRgbLcbRibLobLcbLebRib

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bRjRsmbLgRsbRsbLsbRsRsmbLobRcbRcbRibLjLsmbLgbRhbRcbLgbLsbLsbLibLsLsmbL
sLsmbRsbLibRjbLoLsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bLcbRsbRibLsbRsbRibsbRobRgbRsbRibRibLsbRsbRsbLsbLgbRsbLsbRjbRcbRibRgbR
ibRgbLsbRgbRjbRib

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bRebRcbRoLsLsmbRoRsmbRcbRebRjRsmbLcbRoRsmbLcbRgbRcRsmbRebLcbRgLsbRcRsm
b

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bRebLgbLcbRjRsmbRibLgLsbRsbLsbLeLsbRobLsbRjRsmbLsLsmbRgRsmbRgbLsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bLcbLgRsbRibLebLgRsbLhbLgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bRebRsbLcLsLsLsmmmbLsbLobRsRsmbLibRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bLibRsbLjbLgLsbRcLsbRsbLobRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bLcbLsbRibRcRsmbRgbLsbLcbRsbLiLsbLgbLsbLibLibRgbRiRsmbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
bLcbLjbRsbRhbRsbRsbLiLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bLcbRsbRobRobRobRibLibLhRsbLsLsmbRsbRgbRsbRsbRobRibRibRcbRibLgbLobRibL
ebLiRsLsbLibLcLsmbRsLsbLibRsbRjbLgbLibLibLgbLsbRsbLsLhbLobLibLgbLebLib
RjbRcbRhbLgbRsbRibLjbLjbLcbRsbLgbLgbLsbRibRgbRiRsmbRibLsbRgbRjbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bRjLsbRsbLsbRsbRgLsLsmbRgLsbRsbRiRgbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bRebRhLsbRibLgbRgbRsbLsLsmbLsbRhbLhbRgbLsbRsbLsLsmbLgRsbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bRebLibLgbLibLibRsbRsbRgbRgRsmbRsRsmbRsRsmbLsLsmbLcLsmbLgbRiRsmbLsbLjb
LebRgbRsRsRsmmbRobRsRsmbRebRgbLsLsLsLsLsmmmmbRsLsbLgbRibLsRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 134240; End: 134740;
Recording: 12-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bRebRgbRcbRcbLjbLsLsmbLibRjbLgbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 1; Drug: Control Apo 0.5 然
bRgbLgbRgRsmbLsbRgbLebRjbLobRcbRgbLsbRcbLgbRsbRibLebRcbRgbRgbLsbLgRgbR
ibLhLsbLoLsmbsbRhRsmbRsbRebRhbLgbLoLsmbLhbRibLiRsbRibRhRsmbRhbLsbLibLg
bRiRsmbLeRsbRobRibsbRiRsmbsbLgbRsbRhbRgbLebLcbRjbRcbRcbRhbLgbRgbLsbLiR
sbRcbRibLsRsbRsbsbLsbLsbRgbLgbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 2; Drug: Control Apo 0.5 然
bRibRibRsbLsbRgbsbsbsbsbLsLsmbLobLebLgbsbRsRsmbRjbRsbLebLjbLjLsmbLjbRh
RsRsmmbLibLibLhbLsbRsbLgbLsbRibsbsbLebLsbLjRsbRhRsmbRibRgbLibRjbLjLsmb
RsbsbsbsbRibLjbLcbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 3; Drug: Control Apo 0.5 然
bRsLsbLgbLsbLgLsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 4; Drug: Control Apo 0.5 然
bRibRiLsbRibRibLgbLsLeRsbLgbRjbRibLgRsbRiRsmbLeLsbRsbRcbLcbLobRgbLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 5; Drug: Control Apo 0.5 然
bRcbRhbLsbLibRcbLcbLsbRibsbLsbLibLgLsLsmbRsbLsbLibLsbRjbRcbRsbLibLsbRg
bLsbLibRsbRiRsmbRsbRsbRcbLhbLsbRhbLsRsbLsbLibRcbLibLibRsbLsbLibLsLsmbL
sbLsLsmbLjLgLsbLhbLhbLibRsbLsbLibRsbLiRsbLjbRsLsbRsbRsRsmbRsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 6; Drug: Control Apo 0.5 然
bRobRibLjbLcbLjbLiRsbRgRsmbLhbLgLsbRgbLsbRcLsbLcbsbLcRsbLibRgLsbLgbLsR
sbLgbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 7; Drug: OSU6162 1 然 Apo 0.5 然
bLjbLcbLcbRsbRobLobRjbLobLebLobLjbLebRobLcbLebRobRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 8; Drug: OSU6162 1 然 Apo 0.5 然
bRsLsbLgbRsbsbsbLsbLhLsbLsbLsLsmbLcbRsbsbsbLibRsRsmbRsbRsbLsbRgbRsbLsb
LhRsbRoRsmbLobLsLsmbRobRcLsLsLsmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 9; Drug: OSU6162 1 然 Apo 0.5 然
bsbRjRsmbLjbLsbRjbsbRsbLsbLsbRsRsmbLsbRsbRsbRsbRsbRsbLsbRsbsbLsbRsLsbL
sbLsbLsbsbsbLsbRsRsmbLsbLsbLsLsmbsbRsbLsbsbRsbLsbRsbLsbsbRsbLsbLsbRsbs
bRsbLsbRsbRsbLsbRsbRsbRsbRsbLsbRsbLsbRsLsbRsbRsbRsbLsbRsbLsbLsbRsRsmbL
sbLsbLsbRsbLsbRsbLsbLsRsbLsbLsbRsbLsbLsbLsbRsbRsbRsbRsbLsbRsbLsbRsbRsR
smbLsRsbLsbLsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 10; Drug: OSU6162 1 然 Apo 0.5 然
bRsRsRsmmbLjLsmbLsbsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 11; Drug: OSU6162 1 然 Apo 0.5 然
bsbsbsbRsbsbLsLsmbsbRsbsbsbsbsbRsbRibLobLsbsbLsbsbRoRsmbRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 12; Drug: OSU6162 1 然 Apo 0.5 然
bRobRobRibRcRsmbsbsbRsbRsbLsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 13; Drug: OSU6162 3 然 Apo 0.5 然
bRsbRsbRsRsmbRsRsLsmbRsbLsRsbRgbLcbLibLsbLcLsmbLibRsbLsbLgbLsbLsbsbRcb
RcbRsbRsbsbRsbRsRsLsmbsbLjbLsbLsbRsLsbsbsbLobRiRsmbRcRsmbLibRiRsmbLobL
sbLibRhLsbLobLgRsbLhbRobRcLsbRiRsmbLibLgbRsbLcbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 14; Drug: OSU6162 3 然 Apo 0.5 然
bRcbLjLsmbLcbRgbLhbLiRsbLibRgRsmbLgbLhbRsbRgbRsbLsLsRjmbLibRgbRibsbRjb
LhLsbLibLgbRobRcbLobRcbLsbRhbLcbLibRsbLsbLiLsbLsbLsbLibsbsbLibLjbRibsb
RcbRsbRsbLibLibLcbLsLsmbRhbLsbRibRgbLibRiLsbLibLibRibRjbLhLsbRgbLibRhb
sbRhbLgLsbsbLcbRhbLsbLsbRsbLsbRjRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 15; Drug: OSU6162 3 然 Apo 0.5 然
bRibLgbRsbRgLsbRgbLgLsbRgbRgbLgbRgbLsbsbLsbRibLibLsbRgbsbRsbRsbRsbLjbR
sbRsbRsRsmbRsbLibLebLsLsmbsbLibLgbRsbLsLsmbRcbsbLjbLebLcbLibRgbLgbsbLh
RsbLgbLgbLgbLiRsbLibRibLibRibsbLibLgbLibLgbsbRjbLhbLhbLgLsbRebRiRsmbLg
bLibLsbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 16; Drug: OSU6162 3 然 Apo 0.5 然
bLsbRsbLsbLsbRsLsRsRsmbLsLsLsmmbRsLsbRsRsRsRsmmmbsbRsRsmbRsRsRsmmbRsbR
sRsmbRsRsRsRsRsmmmmb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 17; Drug: OSU6162 3 然 Apo 0.5 然
bRibLgbLgbRibRgbRiRsmbLibRgbRobRgbRgbLcbRcRsmbLobRcbRibLsbRsRibLibLjbR
jbRsbRgbRgbLgbRsbLsLcbLgLsbLiRsbRsbRgbRsLsbRsbLsbRobRibRgbRsbRibLgbRib
LebRibRibLgbLibRgbRgbLcbLcbRobRibRgbLgbLjbRjLsbLgbRsRsLsmbLgbLsbRsbLsR
jbRsRsRsmmbRibRibLcbLibRjbRsbLibLsbLsbRgbsbLibRsbRebLobLiRsbRsbLgbRibL
ibLsbLsLsmbRsbRsbRebRsbLobRjbRsLobRgRsmbLjbRsbRobLjbLiRsLsbLsbLsbRgbRj
LsRsbLobRgbLiRsbRsbLsbLgRsbLgbLjLsmbLsbRjbLjbLcLsmbsbRibLibLibRgLsbRsb
LibRsbLsbRgLsbRsbsbLsbLsLsLsmmbLsbLsLsRimbsbsbsbLgbRsbRsRsmbRibsbRsLsL
smbLsbLjbRibsbLjbRiRsmbRsbsbLsbsbRsbRsLsbsbLsbLjbLobRsbLsbsbLjbLsLsmbR
ibLiLsbLsbRebLgbRsRsmbRgbRgbRgbRgbRsbRgbLsRgbRsbLgbLjbLibRjbLjbLobRibL
jbRsbsbRsbRsLsbLsRsbRgbRsbsbRgbLsbLebRibsbRgbLobLjbLgbRgbLgbsbLhbLgbLg
bLgbRsbLgRsbRjbLcbLgbLgbLgbLsbRcLsbRibRsLsbRsbRgbRsbRsbRgbRgbLsbRgbRgR
smbsbLhRsbRiRsmbRjbRgbRgbRgbRsbRsbLjbLgLsbLhbRjbLjbRibRsbRhbRcbRgRsmbR
gbLsRsbRsbRgbLsbRjbRgbRgbRgbLgbRgRsmbRsbRgbRsbRsbsbRgbRsbRgbLsbRgbRibR
cLsbRibRibLhbLsLibRgbLibLsbLsbRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 18; Drug: OSU6162 3 然 Apo 0.5 然
bLsRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 19; Drug: OSU6162 10 然 Apo 0.5 然
bRsbLjbLcbLibRsbLsbLsbLgLsbLibRsbRgbRsbLeRsRsmbLcbLgbLgLsbRsbLibLcbLsb
RsbLiRsbLjbRobLsbLibLibRsbRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 20; Drug: OSU6162 10 然 Apo 0.5 然
bsbLsbRsbRsbsbRsbLsbsbLsRsbsbsbsbsbsbsbLsbLsbsbsbRsbsbsbsbsbsbsbsbsbLs
bRsbsbLsbsbsbLsbRsbRsRsmbsbsbRjb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 21; Drug: OSU6162 10 然 Apo 0.5 然
bLibRibRcbLjbRsbLjRsLsbRsbLsbRsbLgbLgbLgbRcbRsbsbRhbRibRsbRgbLsbLsbLsb
LjbLjbRjbLjbLibRjbRebLjbLhbRcLsbRcbLgLsbLibLcbLjbsbRibLhbRjbsbRjbLsLcb
LibRibRgbRcbLjbLhbRjbRobRibRibRjRsmbRsbLsbLebRibLebsbLsbLibLsbLibRibLh
bLsbRsbLgbLsbLgbLsbRsbRgbRjbLibRjRsmbRibRcbLsbsbsbsbRsRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 22; Drug: OSU6162 10 然 Apo 0.5 然
bLgbLebRjbLebLebRsbLgbLgRsbLgbsbLsbLsbsbLiRsbRcbRgbRobLcbLgbRsRsmbRgbR
sbLgRsbLgRsbRsRsmbLgLsbLsbLgbLgbsbRsbLgbRsbLsbLsbRcLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 23; Drug: OSU6162 10 然 Apo 0.5 然
bLsRsbRsbLsbLeLsbRebLcbLcbLobRjLsbsbRibsbRsbLobRibRibsbLhbLjbRibLibLjb
RhbLsLsmbLsbLgbLsbLsbLibLobLgbsbsbRhbRsbLsLsmbRcbLgbLsbLsRsbRibLsbRobL
gbLsbRiRsmbsbLebLibLgbRcbRgbsbRsbsbLcb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 24; Drug: OSU6162 10 然 Apo 0.5 然
bRsRsmbsbsbsbLsbsbsbLsbLgLsbRibLgbLsRsbRjbLcbRcLsbLsLsRsmbRibRcb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 25; Drug: Control Apo 0.5 然
bRgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 26; Drug: Control Apo 0.5 然
bsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 27; Drug: Control Apo 0.5 然
bLsRsRsmbRsLsbRsbsbRsRsmbLgbLsbLgbRcbRoLsbLjb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 28; Drug: Control Apo 0.5 然
bsbRsbLsLsmbLsbRebLgLsbLgbLsLsmbRjbsbLibLcbLobLhbLibLibLibLsLsmbLiRsbs
bRcbRobLgbLsbRsbRsbLoLsRsLsmbLcbLcbRsbLhbRobsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 29; Drug: Control Apo 0.5 然
bRsbLobLgbLsbLibRjbLcbLibLibLibLibLgbLsbLsbLgbRsbLsbLibLiLsbLibLsbLsbL
gbLsbLibLsbLsLsmbLibRsbLiRsbLsbLsbLsbLobLibLibLibsbRsRsmbLibLgbLibRsbL
sbLgbLsbLgRsbLsbLgLsbLgbLsbLgbLibLgbsbLibRgbRsbRgbLsbLjbLsbRgbRgbRjbLi
bRibLibsbsbsbRhbLjbLsbLjbRsLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 30; Drug: Control Apo 0.5 然
bRcLsbLibLhLsbsbLoLsmbLiLsbLibLsbLibLjbLjbLsLsmbsbsbLsLsmbLsLsmbRcbRsb
RsbLgLsbsbsbsbsbLobLgbsbRsLibLibLgbLgLsbsbRcbLgbLibRjRsmbRsbLjbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 31; Drug: OSU6162 1 然 Apo 0.5 然
bsbRsbRsbsbLsbsbsbLcbLoRsbLebLhbRibRibRibRebsbLsRsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 32; Drug: OSU6162 1 然 Apo 0.5 然
bLgbLibRibRobRsbRgRsmbRgbRgbRgbRsRsmbRibsbLgbRcbRjbsbsbLjLsmbRcbRibRhR
smbRcbLibRcbLiLsbLgbRibRibRhLsbLjLsmbLgbLgbRobRcLsbLjLibLsbRcRsmbRcbRc
bLibRcbRibLgbRgLsbLgbRibRibLiLsbRibRibLjbRibRibRsbRgbRgbRgbLibLsbRobRi
bLcbRjbRibsbRibLjbsbRibRgbLsbRsRsmbsbLgbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 33; Drug: OSU6162 1 然 Apo 0.5 然
bRibRgbLebLobRebLibLebRobRobLobLobLobLebLobLcbLobLhbRebLibRobLebLcbLhb
RebRebLcbLibLgbLobRcbLobLsbLobRebLebLobRobRhbLibRcbRcbRobLobLgbRobLibR
cbRibLgbRcbLobRebLgbRgbLobLcbRebLobRcbRebRobRobLobRgbRibRgbLobRobLobLe
bRobRebLcbLobLebRobRobRcbLobRobRobLobLibRobRebRobRsbRobRsbLcbRobRgbRcb
LibLcbRobLgbLobRibRibRebRobRobRobLebRobLgbRebRobRsbRobLebRibRibRhbRobL
ebLobRibRcbRobLebRobLcbLobRcbRobLsbRobLebLobRobLobRobLobRobRebRobRcbRo
bRebLobLobRobRcbRobRebRgbLobRgbRobLobRebLcbLobLibLcbRcbLebLebLebRibReb
LobLobLobRcbLibLobLobRgbRobLcbRibLobRobLobRhbLibRebRebLobRobRobRobLcbR
gbRebRobLsbLobRgbLebLebLebRibLcbLobLcbRobRsbRobLhbLgbRobRobLibLebLcbLo
bLcbLebRebLcbRobLcbRebLgbRobRcbLcbLebLebLgbRobLobRobLsbRobRibLebLebReb
RobLgbRobRobLibRgbRebRobLebRcbRobRhbRebLobLcbLobLebLgbRhbLsbLobLebRebL
gbLibLobRebRgbRobRhbRcbLobRebLobLcbLcbRobLebRebRibRebLgbRobRhbRebRcbLg
bLobLobLebLobRobLobLcbLsbRobLobRobRebLobRobRebRgbRobLebLcbRobRcbRobRib
RobLobLobLobRcbRebRobRibLibRsbLobLibRebRobRcbRobLcbRobRcbLobLgbLebLibL
ebRhbLcbRhbLcbRebLebLebRibLebLebRobRobRgbRobRibLcbRebLobRsbRebRcbRebLo
bRcbRobRobLobRgbRcbRcbRgbLobRgbRobRsbLebLcbRibLcbLsbRobRobLobRobLcbLcb
RgbRobLhbRebLobRgbLcbLcbLobRobRibLobRobRibRobRobRgbRobRcbLebRebRobRobL
hbLobRjbLobRobLcbLsbLibRgbRgbLobRebLsbRobRgbRhbRgbRhbRobRebRobRobRcbRi
bLebLcbRsbRebRibLobRcbLebRcbLobLcbRibRobRobRcbLebLobRgbLobLobLobRsbLob
RgbLibLsbRebRobLobLibLcbLobLebLcbLcbRobRcbRobLobLebLebRebLcbLobRsbLgbR
obLcbRobRsbLobRcbLobRobLibRgbRobRobRobLibLcbRcbRobLcbRobRebLcbLcbLobLc
bLobRobRebRibLobRobLobRebLebRcbLibLobLgbLsbRcbRibRibLobLcbRcbRebRgbReb
LcbLcbRobRcbLibRgbLobLsbLibLobRobRcbLebRobLebRobLebLobRebLcbRebLobRobR
obLebRebLobLhbRobLobLobRobRobLebLsbLobLcbRobLebRebRobLcbRcbRebLibRcbLi
bLobRobLsbRebRibRebLcbRobLobRobRcbLhbLcbRobLsbRobRibRcbRsbRobRebLebRob
RebLobLebRhbLobLebRebLgbRebLobRobLebLobLebRibLobRobLobRebRhbLobLgbRobR
cbLhbLebRcbRcbLibLebLsbLobLsbLobLcbRobRobRcbLcbRsbLcbLobLcbRobRobLgbLe
bLcbLebRebRcbLobLcbLebLobRebRebLibRobLebLjbRcbRobLebRobRsbRgbLcbLebLsb
RibRebLobRsbRgbRibRebRobRobLobRobLibLobLebRgbRobRgbRobLibRobRobRobLobL
gbLobRebRcbRcbRebRebRobRobRobLobLobLobRcbRcbLobLibLebRobRobRobLebRgbRh
bLobLebRcbRsbLgbRcbRcbLibRcbLobRibRobLobRsbRgbLcbLobRobRebLobLobRobRgb
RobRobRebRobRebRobLebLebLobLebLcbLhbRcbRcbLgbRobRcbRcbRobLobLcbRebRebL
sbLebRobRobRibLhbLobLebRobLobRhbLobRgbLobRobLsbRobLobLobLobRebLobRobRo
bLgbLobLcbRobLcbRsbLebRebRcbLsbRcbRobRcbLcbRebRgbLebRebRobRebRobRhbLeb
RcbLibRobRobLgbRobLcbRcbLebLobLobLebLobRhbRobRcbRobRobLcbLcbRobRebRobR
cbLgbRobLcbRobRgbLobLjbRibRobRobRcbRebRebRcbRcbLhbLebRsbRibLgbLibRcbLo
bRgbLgbRebRebRobRsbRebRhbRibLhbLobLgbRebLobLibRobRsbRobRsbLebLebRebLob
RobLhbLcbRibLsbRgbRebLobRobLibLobLobLobLcbLcbRobLcbLebLebRobRebLsbRebR
obRcbLcbRgbLgbLcbLobRobRobRibRobLebRobRebLebLebRebLebLobLcbRobRobRcbLo
bLhbRebLobLgbRobLebRibLibRgbLobRobLobRsbRcbRobRgbLcbLjbLcbLcbLibLgbRob
RcbRobLebRib

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 34; Drug: OSU6162 1 然 Apo 0.5 然
bsbsbsbsbsbLsRsRsLsmbLsbRsRsmbRsLsRsbLsLsLsRsmmbLsRsbsbLgLsbRjbLibLcbL
sbLsbLibsbLgLsbRgbLsLsmbLeLsbsbsbsbLjbLibLgbRhbRibRgLsbLhbLgRsbRibRsLs
LsmbLcbLgLsbRcbLibsbLsbRsLsLsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 35; Drug: OSU6162 1 然 Apo 0.5 然
bRjRgbRibLjLsmbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 36; Drug: OSU6162 1 然 Apo 0.5 然
bsbLgLsbsbLsLsmbRibRhRsmbRcbRcbRsbsbRibRsbsbRjRsmbRcRsmbRcbLibRcbRcbLo
bsbsbLsbsbsbRsRsmbRsbRsRsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 37; Drug: OSU6162 3 然 Apo 0.5 然
bLsbRjRsmbLjbLsbLsbLsRsbsbRgRsmbRgRgRsmbRibRsRsmbRsbRsRsmbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 38; Drug: OSU6162 3 然 Apo 0.5 然
bsbRsRsLsmbRsbLsbLibRsLsbsbRsbsbLsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 39; Drug: OSU6162 3 然 Apo 0.5 然
bLibRobRiLsbLiLsbLibLsbLcbRsRsmbRsbLhbLobRiRsmbLsbRsRsmbRhbRsbLibRibRs
bRibLsbLgbRibLjbLsbRibRsRsmbRsbRiRsmbRsbRsbRibRsRsmbLsRsbRsRsmbRcbRsRs
LsmbLgbRsbRibLsRsbsbRgbRibLsbRsbReRsmbsbRibRsbRsbLibLibRsbLgbLgbRsbRgb
RsbLiLsbLsbLgLsbRsbLgbLgbLsLibRsbLsLsmbLgRsbLgbRjbRsbRibRcbLgbRiRsmbRi
bRibRsbLsRsbRsbLcbsbRjbRibRjRgbLibRibRsbRsbLsbLsbLsbRhbLgbRgLsbLsbLjbL
ibRsbLibLsLsmbsbLsRsbsbRebRjLsbLibRsbLgb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 40; Drug: OSU6162 3 然 Apo 0.5 然
bRibLhbRcbLsRsbsbLsbRsbRsLsbRsbLsbRsbRsbLsbLsbLsLsmbLsRsbLsbLsbsbsbsbs
bsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 41; Drug: OSU6162 3 然 Apo 0.5 然
bRibRgbLibsbRgbRsbRsbReLsbRjRgbRibRsbRgbLsLsRsRembLsRobLsbsbsbRebLeb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 42; Drug: OSU6162 3 然 Apo 0.5 然
bRsLsbLgbRgbLsbLsbLsbLsbLgLsbLcbsbLsbLsbLibLsbLsLsmbLsbLhRsbLhbLsbLobL
sbLgbRsbLsbRsbLgbLsLsmbRgbRibRgbsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 43; Drug: OSU6162 10 然 Apo 0.5 然
bsbRsLsRsbLsLsRsmbLsbLiLsbsbRobRibsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 44; Drug: OSU6162 10 然 Apo 0.5 然
bLibRobRsbLibRebLsbLhRsbRsbRebRsbRsRsmbRsbLcbRoRsmbRsRebLibRibLgbLebRc
bLjbLsbLsbLhbLhbLsbLcbRibLibRibRibRsbRsbLibLsbRsbRsb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 45; Drug: OSU6162 10 然 Apo 0.5 然
bsbRibsbsbRsRsmbRsbsbRgbLoRsbLcRsbRsRcbRibRibsbRibLsbLcbsbsbsbsbLgbRjR
gb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 46; Drug: OSU6162 10 然 Apo 0.5 然
bLjbRibLjbLsbsbLjbRsbLsLsmbLsbLgbLgbRjbRibsbLjbsbLgbsbLib

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 47; Drug: OSU6162 10 然 Apo 0.5 然
bRobRsRsmbRsbRoLsLsmbRibRgRsmbRgbRebRsRsmbLsbRsbLsbRsRsmbsbRsbRsLgbLsb
RgRsmb

>ZF Recording 2016-08-17; tW: 300s; Start: 134742; End: 135242;
Recording: 13-1; Individual: 48; Drug: OSU6162 10 然 Apo 0.5 然
bRoRsmbLibLibRibLgbRjRsmbLcLsLsmmbsbsbLjbLobsbsbRibLsbRsbLgbLsb

